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Four studies on vascular and exercise physiology are presented in this document. The 1st 
study examined the relationships between measures of fitness and FVF in 55 young [22.6 
± 3.5 years] adults. Estimated VO2peak correlated with arterial inflow (Ainf) [r=0.54; 
p=0.012] and resting venous outflow (Vout) [r=0.56; p=0.016]. Lastly, HG strength was 
associated with Vcap [r=0.57; p=0.007] and Vout [r=0.67; p=0.001].  
The 2nd study examined the relationship between FVF and exercise tolerance 
(ExT) in 20 patients with HF [age: 59 ± 13 years] and 10 age-matched controls [age: 51 ± 
16 years. The ExT was measured as the maximum walking distance (MWD) in 6 
minutes. FVF [Ainf: HF 15.3 ± 6; controls 22 ±6.7; Vcap: HF 1.4 ± 0.5; controls 2.0 ± 
0.4; Vout: HF 24.5 ± 9.4; controls 33 ± 10 mL • 100 mL tissue-1 • min –1; and forearm 
vascular resistance: HF 7.8 ± 3; controls 4.6 ± 1.4U] indices and MWD [HF: 178 ± 65 m; 
controls: 562 ± 136m, P = .0001] were different between groups. Correlation analysis 
revealed significant associations between FVF indices and MWD.  
 The 3rd study examined the effect of 25% (LO) and 75% (HI) of MVC short-term 
HG exercise training on FVF in 28 healthy men [Age:23+4.3]. The 4-week program 
consisted of non-dominant HG exercise performed 5 d/wk for 20-min. Training resulted 
in increased Ainf in the non-dominant arm in the LO and HI groups by 16.51% and 
20.72%, respectively.  
The final study examined the time-course FVF adaptations to HG exercise 
training in 17 men [Age: 22.6 ± 3.5]. The HG exercise was performed in the non-
dominant arm 5 d/wk for 20-min at 60% of MVC. The 2 X 5 ANOVA revealed arms X 




increase in Ainf following the 1st week. Additional 2 X 5 split-plot ANOVA tests 
revealed arms X visits interaction [p=0.04] for venous compliance (Vcomp) with LSD 
post-hoc demonstrating a decrease in trained arm Vcomp in visit 2 followed by an 
increase in visit 4 and return to baseline level at visit 5. 
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CHAPTER 1. INTRODUCTION 
The original understanding of vascular physiology has evolved from a passive conduit, 
transporting blood to and from body tissues, to a multifaceted system that is interlinked 
with many other body systems, regulated by a variety of mechanisms, and adjusts to 
different conditions. Our daily poor lifestyle choices, such as high fat meals, cigarette 
smoking, inactivity, and work-related stress exposes the vascular system to numerous 
assaults. These assaults result in a variety of deteriorating diseases including 
atherosclerosis, coronary artery diseases and hypertension. Many studies have 
demonstrated that exercise training can improve sympathetic vascular tone, insulin 
sensitivity, and lipid and haemostatic profiles as well as lower blood pressure, obesity, 
and stress hormones. Therefore, hand-in-hand with dietary modifications, exercise 
training appears to be an effective tool to minimize the influence our daily choices and 
may results in numerous health benefits.   
The current document presents four research projects, designed to examine the acute 
and chronic effects of exercise training on vascular function and control in health and 
disease. These research projects are introduced in the subsequent four chapters and aimed 
at: 
1. Addressing technical concerns and determining the reproducibility of vascular 
outcomes using strain gauge plethysmography,  
2. Examining the ability of vascular measures to differentiate between various 
populations, AND  
3. Evaluation of the influence of interventions on changing measures of vascular 
function.   
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Chapter 2 addresses methodological considerations for mercury strain-gauge 
plethysmography (MSGP) and the reliability of measuring arterial and venous function 
indices as well as examined the relationships between fitness and vascular indices. 
Standard recommendations for venous occlusion pressure and duration have been 50 
mmHg and 2 minutes, respectively (7, 11). Others have used, venous pressure “just 
below” diastolic blood pressure (22). However, the rationale for these recommendations 
are not clear. Additionally, few studies have examined the influence of physical fitness 
(cardiovascular and/or muscular) on indices of venous function. The majority of these 
studies report improvements in venous hemodynamics secondary to changes in blood 
volume following endurance training (6, 13, 15). More recently, Wecht et al. attributed 
venous modifications, in part, to enhanced vasomotor tone, vessel compliance and vessel 
responses to mechanical and neural stimulation (22). Therefore, the major aim of this 
study was to examine relationships between measures of physical fitness and arterial and 
venous function. It was hypothesized that individuals with the highest levels of fitness 
would have greater arterial inflow and venous outflow patterns. However, considering the 
lack of standardization and reliability of the protocols used to examine the venous 
function, a secondary aim of this study was to examine the effects of different venous 
occlusion times and pressures on venous capacitance and outflow as well as the reliability 
of MSGP. 
Chapter 3 focuses on the effect of vascular function on exercise tolerance in heart 
failure (HF). Chronic HF is a complex clinical syndrome characterized by an abnormality 
of the heart and by a recognizable pattern of hemodynamic, renal, neural and hormonal 
responses (17). Despite of the research describing the effect of HF on blood inflow and 
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the subsequent treatments aimed at improving arterial function, many patients continue to 
experience activity-related symptoms (4), possibly suggesting the involvement of other 
factors. Interestingly, the role of the venous system on exercise tolerance in patients with 
HF has not received much attention, despite evidence of changes in venous structure and 
function in patients with HF (12, 18) and in patients with a variety of vascular diseases 
(16, 20). Accordingly, the purpose of this study was to examine the relationships between 
indices of arterial and venous function and exercise tolerance in chronic HF patients and 
age-matched controls. Given the complexity of the HF syndrome, it was hypothesized a 
direct relationship between indices of vascular function and exercise tolerance.  
Chapter 4 examines the effect of low and high intensity localized exercise training on 
arterial function. Exercise training induces arterial adaptations characterized by increased 
working muscle perfusion and reduced vascular resistance. The precise mechanisms for 
these adaptations are not known however they appear to be exercise training modality 
dependent (3, 8, 9). Interestingly, vascular adaptations following small muscle group 
exercise training programs using different intensities have not been adequately explored. 
A study by Yasuda et al. (23) was the only study where subjects performed 6-weeks of 
HG exercise training at intensities of 33 or 50% of maximum voluntary contraction 
(MVC). Peak forearm blood flow increased similarly in both groups. However, the 
difference between training intensities was only 17% and may have been insufficient to 
determine whether the adaptations are indeed intensity-dependent. Accordingly, the 
purpose of this study was to determine the effects of low and high intensity short-term 
HG exercise training programs on localized vascular function in healthy young men. It 
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was hypothesized that a training exercise intensity of 75% of MVC would promote 
greater vasodilatory capacity compared to a training exercise intensity of 25% of MVC. 
Finally in chapter 5, the time course changes to 4 week HG exercise training program 
on arterial and venous function indices were examined. Structural and functional changes 
in the arterial system following exercise training are well documented (2, 5). Recent 
studies report training-induced adaptations may be observed following one week of 
training in animal models (14, 19), and in human single large conduit arteries (i.e. 
brachial) (1). Interestingly, the effect of exercise training on venous function has received 
considerably less attention despite compelling evidence demonstrating its dynamic role 
beyond a typical role as a “passive volume reservoir” (10, 21). Therefore, the purpose of 
this study was to examine the influence of 4-weeks of handgrip exercise training on 
arterial and venous function. A secondary aim of this study was to determine the time 
course of change for both arterial and venous indices associated with the handgrip 
exercise training program. It has been hypothesized that handgrip exercise training will 
result in changes in arterial and venous function indices following the 1st week.   
Appendix A includes an extensive literature review of vascular function and control 
at rest and during exercise in health and disease. Appendix B is the proposal of the final 
study followed by the author’s vita.  
1.1. REFRENCES 
1.Allen JD, Geaghan JP, Greenway F and Welsch MA. Time Course of Improved Flow-
Mediated Dilation after Short-Term Exercise Training. Med Sci Sports Exerc 35: 847-
853, 2003. 
 
2.Alomari MA, Welsch MA, Prisby RD, Lee CM and Wood RH. Modification of 
forearm vascular function following short-term handgrip exercise training. Int J Sports 
Med 22: 361-365., 2001. 
 
 5 
3.Bond V, Jr., Wang P, Adams RG, Johnson AT, Vaccaro P, Tearney RJ, Millis RM, 
Franks BD and Bassett DR, Jr. Lower leg high-intensity resistance training and peripheral 
hemodynamic adaptations. Can J Appl Physiol 21: 209-217, 1996. 
 
4.Clark AL, Poole-Wilson PA and Coats AJ. Exercise limitation in chronic heart failure: 
central role of the periphery. J Am Coll Cardiol 28: 1092-1102, 1996. 
 
5.Clarkson P, Montgomery HE, Mullen MJ, Donald AE, Powe AJ, Bull T, Jubb M, 
World M and Deanfield JE. Exercise training enhances endothelial function in young 
men. J Am Coll Cardiol 33: 1379-1385, 1999. 
 
6.Convertino VA, Mack GW and Nadel ER. Elevated central venous pressure: a 
consequence of exercise training-induced hypervolemia? Am J Physiol 260: R273-277, 
1991. 
 
7.Cramer M, Langlois Y, Beach K, Martin D and Strandness Jr DE. Standardization of 
venous flow measurements by strain gauge plethysmography in normal subjects. Bruit 
VII: 33-39, 1983. 
 
8.Delp MD and Laughlin MH. Time course of enhanced endothelium-mediated dilation 
in aorta of trained rats. Med Sci Sports Exerc 29: 1454-1461, 1997. 
 
9.Green DJ, Cable NT, Fox C, Rankin JM and Taylor RR. Modification of forearm 
resistance vessels by exercise training in young men. J Appl Physiol 77: 1829-1833, 
1994. 
 
10.Hester RL and Hammer LW. Venular-arteriolar communication in the regulation of 
blood flow. Am J Physiol Regul Integr Comp Physiol 282: R1280-1285, 2002. 
 
11.Hokanson DE, Sumner DS and Strandness Jr. DE. An electrically calibrated 
plethysmograph for direct measurement of limb blood flow. IEEE transactions on bio-
medical engineering 22: 21-25, 1975. 
 
12.Ikenouchi H, Iizuka M, Sato H, Momomura S, Serizawa T and Sugimoto T. Forearm 
venous distensibility in relation to severity of symptoms and hemodynamic data in 
patients with congestive heart failure. Jpn Heart J 32: 17-34, 1991. 
 
13.Kenney WL and Armstrong CG. The effect of aerobic conditioning on venous pooling 
in the foot. Med Sci Sports Exerc 19: 474-479, 1987. 
 
14.Laughlin MH. Endothelium-mediated control of coronary vascular tone after chronic 
exercise training. Med Sci Sports Exerc 27: 1135-1144, 1995. 
 
15.Louisy F, Jouanin JC and Guezennec CY. Filling and emptying characteristics of 
lower limb venous network in athletes. Study by postural plethysmography. Int J Sports 
Med 18: 26-29, 1997. 
 6 
 
16.Monos E, Berczi V and Nadasy G. Local control of veins: biomechanical, metabolic, 
and humoral aspects. Physiol Rev 75: 611-666, 1995. 
 
17.Poole-Wilson PA, Buller NP and Lipkin DP. Regional blood flow, muscle strength 
and skeletal muscle histology in severe congestive heart failure. Am J Cardiol 62: 49E-
52E, 1988. 
 
18.Sato H, Ikenouchi H, Aoyagi T, Matsui H, Mochizuki T, Momomura S, Serizawa T, 
Iizuka M and Sugimoto T. Pathophysiology and evaluation of severity of congestive 
heart failure on the basis of venous characteristics. Jpn Circ J 53: 141-145, 1989. 
 
19.Shen W, Zhang X, Zhao G, Wolin MS, Sessa W and Hintze TH. Nitric oxide 
production and NO synthase gene expression contribute to vascular regulation during 
exercise. Med Sci Sports Exerc 27: 1125-1134, 1995. 
 
20.Tretbar LL. Chronic venous insufficiency of the legs: pathogenesis of venous ulcers. J 
Enterostomal Ther 14: 105-108, 1987. 
 
21.Tschakovsky ME, Shoemaker JK and Hughson RL. Vasodilation and muscle pump 
contribution to immediate exercise hyperemia. Am J Physiol 271: H1697-1701, 1996. 
 
22.Wecht JM, de Meersman RE, Weir JP, Bauman WA and Grimm DR. Effects of 
autonomic disruption and inactivity on venous vascular function. Am J Physiol Heart 
Circ Physiol 278: H515-520, 2000. 
 
23.Yasuda Y and Miyamura M. Cross transfer effects of muscular training on blood flow 




CHAPTER 2: MEASUREMENTS OF VASCULAR FUNCTION USING STRAIN-
GAUGE PLETHYSMOGRAPHY: TECHNICAL CONSIDERATIONS, 

























The relationship between exercise performance and arterial inflow is well documented 
(25). Surprisingly, the contribution of the venous system to overall cardiovascular 
function and skeletal muscle activities has received considerably less attention, despite 
compelling evidence demonstrating its importance beyond the typical role as a “passive 
volume reservoir” (3, 11, 31) 
Additionally, few studies have examined the influence of physical fitness 
(cardiovascular and/or muscular) on indices of venous function. The majority of these 
studies report improvements in venous hemodynamics secondary to changes in blood 
volume following endurance training (5, 16, 19). More recently, Wecht et al. attributed 
venous modifications, in part, to enhanced vasomotor tone, vessel compliance and vessel 
responses to mechanical and neural stimulation (33). Therefore, the major aim of this 
study was to examine relationships between measures of physical fitness and arterial and 
venous function. It was hypothesized that individuals with the highest levels of fitness 
would have greater arterial inflow and venous outflow patterns.  
However, considering the lack of standardization and reliability of the protocols 
used to examine the venous function, a secondary aim of this study was to consider 
several methodological and technical aspects regarding the examination of the venous 
system.  
2.2. METHODOLOGY 
2.2.1. Study Design and Inclusion, Exclusion Criteria 
 
This study consisted of 2 distinct phases. In phase I, 2 separate experiments were 
conducted to address methodological aspects (Experiment 1) concerning the examination 
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of venous function and to determine the reliability (Experiment 2) of vascular function 
using mercury in-silastic strain gauge plethysmography (MSGP). In phase II, 2 additional 
experiments were designed to examine the relationships of vascular function and 
cardiovascular fitness (Experiment 3) and handgrip strength (Experiment 4). Men and 
women between the age of 18 and 35 years were recruited to participate. Smokers and 
individuals with acute medical conditions (e.g. orthopedic injury), active infection and/or 
on pharmacotherapy with known vascular effects (e.g. anti-inflammatory therapy, 
cardiovascular medications) were excluded. Following comprehensive explanation of the 
study, its benefits, inherent risks and expected commitments with regard to time, all 
participants signed an informed consent approved by the Institutional Review Board of 
Louisiana State University.  
2.2.2. Vascular Assessments 
 
Instrumentations and measurements 
 
Forearm arterial inflow, vascular resistance, venous capacitance, and outflow for all 
experiments were obtained using MSGP (model EC5R, D. E. Hokanson Inc, Bellevue, 
WA, 99). Upon arrival, blood pressure cuffs were positioned around the participant’s 
upper arm and wrist, and a mercury-in-silastic strain gauge (13) placed around the 
forearm approximately 10 cm distal to the olecranon process while the subject in a supine 
position. The forearm was extended and slightly supinated and supported by a styrofoam 
block. Immediately before the blood flow measurements, hand circulation was occluded 
for 1 min by inflating the cuff at the wrist to 240mmHg. Forearm blood inflow was 
estimated at rest and following 5 min of upper arm arterial occlusion. Subsequently 
forearm venous capacitance and outflow were obtained following specific venous 
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occlusion pressures and periods as will be described below in each experiment. Arterial 
occlusion was achieved by inflating the cuff on the upper arm to 240 mmHg (1, 29). 
Throughout the testing procedures, heart rate and blood pressure were obtained at rest, 
and during and immediately following Occ. 
Experiment 1: Effect of varying occlusion pressure and time on vascular indices. 
 
This experiment was conducted on two separate days in eight apparently healthy young 
men and women (Age: 22.1 ± 1.4). Forearm blood inflow measures were obtained as 
described above in both days. Day 1: In order to examine the influence of varying upper 
arm venous occlusion pressures on venous capacitance and outflow, resting forearm 
venous indices were evaluated following four minutes of upper arm venous occlusion 
pressure at 7, 14, 21, 28, and 35 mmHg below diastolic blood pressure obtained in the 
opposite arm. Day 2: In order to examine the influence of upper arm venous occlusion 
durations, venous capacitance measures were taken every minute for a period of ten 
minutes, and venous outflow evaluated following 5 and 10 minutes of upper arm venous 
occlusion pressure using 50 mmHg.  
Experiment 2: Reliability of arterial and venous function measurements. 
Forearm blood inflow, and venous capacitance and outflow were obtained in 8 apparently 
healthy young men (Age: 24.0 ± 5.0) on three different occasions within 10 days to 
determine between-days reliability of MSGP. Vascular indices were evaluated at rest and 
following 5 min of upper arm arterial occlusion. Venous capacitance and outflow for the 
two conditions (rest & post occlusion) were evaluated following 6 minutes of upper arm 
venous occlusion at 7 mmHg below diastolic blood pressure.  
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Experiment 3 & 4: Associations between physical fitness measures and arterial and 
venous function. 
These experiments were designed to examine relationships between forearm arterial and 
venous function indices and measures of physical fitness (estimated VO2peak and 
handgrip strength). Cardiorespiratory fitness (Estimated VO2peak) was determined using 
the YMCA’s cycle exercise test (2) in twenty-one apparently healthy young (Age: 21.4 ± 
1.4) women and expressed in mL•kg-1•min-1. Maximum handgrip strength was 
determined, in twenty-two apparently healthy young (Age: 24.5 ± 5.0) men, as the 
average of 3 maximum consecutive contraction trials using a hand-dynamometer (model 
78010, Lafayette Instrument, Lafayette, IN, 02) and expressed in pound. Vascular indices 
were evaluated at rest and following 5 min of upper arm arterial occlusion. Venous 
capacitance and outflow for the two conditions (rest & post occlusion) were evaluated 
following 6 minutes of upper arm venous occlusion at 7 mmHg below diastolic blood 
pressure. 




Resting forearm blood inflow was recorded at a paper speed of 5 mm/second and values 
were derived from the slope drawn at a best-fit tangent using the first 3 pulses. 
Calculations were made as a function of 60 seconds divided by the horizontal distance 
(mm) needed for the slope to rise vertically from baseline to the top of the recording 
paper and multiplied by the full chart range. Peak arterial in-flow following occlusion 
was recorded at a paper speed of 25 cm/ second. Analyses were performed using a slope 
drawn at a best-fit tangent to the curves of the first 2 pulses of the flow curve post cuff 
release. The blood flows were then calculated from 60 sec. multiplied by the paper speed 
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(25 cm/sec) divided by the horizontal distance (mm) needed for the volume slope to 
increase by 20 mm vertically. Mean arterial pressure (MAP) was calculated using the 
standard equation: MAP = Diastolic Pressure+[(Systolic Pressure-Diastolic Pressure)/3]. 
Forearm vascular resistance (FVR) was calculated by dividing mean arterial pressure by 
forearm blood inflow (FVR = MAP/ forearm blood inflow).  
Venous indices 
 
Forearm venous capacitance was measured as the vertical distance (mm) representing the 
increase in forearm-volume graph after the designated period (as described for each 
experiment) for venous filling. Analysis of forearm venous outflow was derived from a 
tangent line that represents the vertical drop in volume-graph from the excursion line and 
drawn at 0.5 second and 2 seconds after the release of the venous occlusion pressure (7, 
12).  
2.2.4. Statistical Analysis 
 
All statistical analyses were performed using SPSS statistical software package for 
windows (version 11.0, Chicago, Ill). Group data were expressed as mean ± sd and alpha 
was set a priori at P < 0.05.  
Experiment 1: Effect of varying occlusion pressure and time on vascular indices. 
 
In order to evaluate the difference in forearm inflow, and venous capacitance and outflow 
following each venous occlusion pressure, repeated measure ANOVA and Bonferroni 
pairwise comparison were used. Dependent t-tests were used to compare vascular 




Experiment 2: Reliability of arterial and venous function measurements. 
 
Interclass correlation coefficient (ICCC) was used to determine the reliability of MSGP. 
Measures of the arterial and venous function indices at rest and following occlusion were 
included.  
Experiment 3 & 4: Relationship between physical fitness measures and arterial and 
venous function indices 
 
Pearson product moment correlation was used to examine the relationship between 
physical fitness measures (estimated VO2peak & handgrip strength) and arterial and 
venous function indices as well as the relationship between arterial and venous function 
indices. Additionally, with participants subdivided into above (HI) and below (LO) 
average fitness groups according to the YMCA and the Canadian Society of Exercise 
Physiology (22), and independent t tests were used to compare fitness measures and 
vascular indices. 
2.3. RESULTS 
2.3.1. Participants Characteristics 
 
Table 2.1. Subject characteristics 
 Mean ± sd Range 
Age (yrs) 22.6 ± 3.5 18-34 
Height (cm) 167.5 ± 8.5 150-185 
Weight (kg) 69.1 ± 15.2 43-114 
Arm length (cm) 25.5 ± 2.2 20-30 
Arm circumference (cm) 25.17 ± 3.0 21-35 
HR (bpm) 59.0 ± 10.0 45-93 
SBP (mmHg) 107.0 ± 10.0 87-142 
DBP (mmHg) 62.0 ± 8.0 46-86 
MAP (mmHg) 76.0 ± 8.0 60-105 
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A total of 55 individuals (28 men and 27 women) volunteered to participate in these 
experiments. The participants’ characteristics are presented in Table 2.1. 
Experiment 1: Effect of varying venous occlusion pressure and time on vascular indices  
 
The results for experiment 1 are depicted in Table 2.2 as well as Figures 2.1, 2.2 and 2.3. 
There was no significant affect in altering the venous occlusion pressure and time on 
forearm resting or reactive hyperemic blood flow (Table 2.2). The data indicate a 
stepwise increase in measures of forearm venous capacitance (Figure 2.1a) and outflow 
(Figure 2.1b) with increasing venous occlusion pressures. In contrast, forearm inflow was 
not affected by the pressure maneuvers. Furthermore, forearm venous capacitance and 
outflow were consistently greater following 10 minutes compared to 5 minutes of venous 
occlusion (Figure 2.2). Finally, venous capacitance showed a stepwise increase as the 
venous occlusion time increased (Figure 2.3).  
Table 2.2. Resting vascular indices following varying occlusion pressures 












2.5 ± 1 2.1 ± 1 1.9 ± 1 1.7 ± 1 1.5 ± 0.5 
FVR  
(U) 
37.7 ± 17‡ 53 ± 37 48 ± 24 54 ± 24 56.3 ± 17 
Venous Capacitance 
(ml/100ml/min) 
3.7 ± 0.7 *†‡ 3.3 ± 0.6‡ 3.0 ± 0.5†‡ 2.4 ± 0.7 2.2 ± 0.5 
Venous Outflow 
(ml/100ml/min) 
32.7 ± 4.5*†‡ 29.3 ± 7.5†‡ 24.3 ± 6†‡ 21 ± 5.5 17.3 ± 4 
Values expressed as mean±sd. *=p>0.05 vs. Press 3; †=p>0.05 vs. Press 4; ‡=p>0.05 vs. Press 
5. RBF = Resting blood inflow; FVR = forearm vascular resistance. 
 
Experiment 2: Reliability of MSGP to measure arterial and venous function indices. 
Between-day reliability values using the ICCC are presented in Table 2.3. The ICCC 
values for the peak blood inflow and vascular resistance were 0.81 and 0.75, respectively. 
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Additionally, resting and following upper arm arterial occlusion venous capacitance and 
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Figure 2.1a. Venous capacitance using different pressures.  
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Figure 2.1b. Venous outflow using different pressures.  

























Figure 2.2. Venous capacitance and outflow following 5 & 10 minutes of venous 
occlusion. 



































Figure 2.3. Venous capacitance over a 10 minute venous occlusion period. 










































































Rest 0.29 0.30 0.78 0.94 
Post occlusion 0.81 0.75 0.70 0.91 
ICCC = interclass correlation coefficient; RBF = resting blood inflow; FVR = 
forearm vascular resistance. 
 
Experiment 3 & 4: Relationship between physical fitness measures and arterial and 
venous function indices. 
 
The associations between measures of physical fitness and vascular function are 
presented in Table 2.4 and depicted in Figures 2.4 and 2.5.  Estimated VO2peak was 
significantly correlated with peak forearm blood inflow and vascular resistance, and with 
venous outflow. Further analyses revealed a significant difference in vascular function 
between those with higher VO2peak estimates (46.4 ± 6.6 ml/kg/min) compared to the 
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Figure 2.4b. Relationship between estimated VO2 & resting venous outflow. 
 
Handgrip strength was significantly correlated with venous capacitance and outflow at 
rest and following occlusion (see Figures 2.5 a & b). Moreover, as presented in Table 2.6, 
venous function indices were different between the HI (121.1 ± 10.64 lb) vs. LO (82.14 ± 
14.9 lb) handgrip strength. No significant associations were found between handgrip 
strength and forearm blood inflow at rest or following occlusion (see Table 2.4).  
Finally, resting and peak forearm arterial inflow and vascular resistance correlated with 
resting and post occlusion venous capacitance and outflow (see Table 2.4). 
2.4. DISCUSSION 
This study was designed to examine relationships between measures of physical fitness 
and arterial and venous function. In addition, methodological concerns and the reliability 
of arterial and venous function measures using MSGP were also addressed. Uniquely, the 
data indicate the magnitude of forearm venous outflow is positively associated with both 
cardiovascular (estimated VO2peak) and musculoskeletal (handgrip strength) fitness. 
Moreover, venous function measures are significantly influenced by the magnitude of the 
occlusion pressure and length of occlusion period without changes in arterial inflow. 
 19 
Finally, measures of arterial as well as venous function appear to be reasonably 


































































Figure 2.5b. Relationship between handgrip strength & resting venous outflow.  
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Table 2.4. Pearson product moment correlation between arterial, venous and physical fitness measures 
Conditions Resting vascular indices Post occlusion vascular indices Fitness measures 
















































































































































































Table 2.5. Differences between the cardiorespiratory groups in 
forearm arterial and venous indices 
 Group Resting Condition Post Occlusion. Condition 
  Binf Vres Binf Vres 
LO 1.6 ± 0.7 52.1 ± 18.7 18.5 ± 2.87 4.3 ± 0.7 Arterial 
Indices HI 1.6 ± 0.5 46.7 ± 13.8 22.2 ± 4.9 3.4 ± 0.8 
p-value  0.46 0.91 0.05 0.013 
  Vcap Vout Vcap Vout 
LO 3.8 ± 0.8 40.7 ± 7.9 2.6 ± 0.7 36.9 ± 8.2 Venous 
Indices HI 4.0 ± 0.7 49.5 ± 9.7 2.9 ± 0.8 48.9 ± 9.7 
P-value  0.54 0.05 0.30 0.014 
Binf = blood inflow; Vres = vascular resistance; Vcap = venous 
capacitance; Vout = venous outflow. 
 
Table 2.6. Differences between the handgrip strength groups in 
forearm arterial and venous indices 
 Group Resting Condition Post Occlusion. Condition 
  Binf Vres Binf Vres 
LO 3.48 ± 1.2 26.3 ± 12.4 19.39 ± 3.7 4.27 ± 1.0 Arterial 
Indices HI 3.53 ± 0.9 24.32 ± 4.9 20.60 ± 4.1 4.24 ± 0.8 
p-value  0.94 0.73 0.55 0.94 
  Vcap Vout Vcap Vout 
LO 4.9 ± 0.8 45.0 ± 10.7 3.61 ± 0.60 43.8 ± 10.0 Venous 
Indices HI 5.8 ± 0.6 56.2 ± 5.3 4.47 ± 0.60 54.6 ± 7.2 
P-value  0.030 0.038 0.014 0.04 
Binf = blood inflow; Vres = vascular resistance; Vcap = venous 
capacitance; Vout = venous outflow. 
 
2.4.1. Technical Aspects and Reliability of Vascular Measures 
 
In recent years the post occlusion reactive hyperemia model has been developed as a non-
invasive surrogate marker of cardiovascular risk (4, 6). Previous work from our 
laboratory has indicated adequate stability and reproducibility of the post-occlusion 
technique for the study of arterial reactivity under strictly controlled conditions using 
 22 
both ultrasonography (34) and plethysmography (20). Given recent information regarding 
the importance of the venous system on arterial function (3, 11, 31), the present study 
was designed to include information regarding venous function. Clearly, if the post-
occlusion model is extended to include information regarding venous function, it is 
essential the reproducibility and limitations of the technique be established.  
Data from experiment 1 indicates the importance of the selection of an 
appropriate venous occlusion pressure in the study of venous capacitance and outflow. 
The data reveals a stepwise decrease in venous capacitance and outflow as the magnitude 
of venous occlusion pressure from resting diastolic pressure was increased (see Figures 
2.1 a & b). The rational for the examination of varying venous occlusion pressures is the 
lack of consensus regarding the selection of a standard pressure. Two different 
approaches in the selection of venous pressure appear to exist. The first is the use of a 
standard (usually 50 mmHg) venous occlusion pressure (7, 12) and the second is the use 
of a venous occlusion pressure based on the individual’s diastolic pressure (33). The 
present findings indicate that a venous occlusion pressure of 7 mmHg below diastolic 
blood pressure appears to yield greater venous capacitance and outflow compared to 
occlusion pressures further below the diastolic pressure. This is particularly important 
when considering longitudinal trials in which blood pressure is subject to change.  
A second inconsistency in the literature is the duration of venous occlusion. 
Standard recommendations suggest venous occlusion periods of 2 minutes to examine 
venous capacitance and outflow (7, 12). The present data (see Figure 2.2) clearly indicate 
that venous capacitance and outflow were greater following 10 minutes of venous 
occlusion at 50 mmHg compared to 5 minutes. The magnitude of the difference was 
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particularly evident when comparing occlusion periods of 1 through 6 minutes, whereas 
the difference in the venous measures was less “drastic” with occlusion periods between 
7 and 10 minutes (see Figure 2.3).  
Thus, when implementing these measures in longitudinal trials careful 
consideration should be given regarding the venous occlusion pressure and period. 
Interestingly, alterations in venous occlusion pressures and times did not have a 
significant effect on the arterial inflow measures.  
Experiment 2 examined the reliability of measuring arterial as well as venous 
function using MSGP at rest and following occlusion over a 10 day period (see Table 
2.3). The magnitude of the forearm blood flow values at rest and following occlusion are 
consistent with data from our laboratory (1) as well as others (29). The reliability 
measures used in the current study confirm adequate consistency between days for the 
post occlusion in flow measures (20, 24). In addition, the ICCC results indicate adequate 
reliability for venous capacitance and outflow at rest and following arterial occlusion. 
Resting blood in flow measures appear to vary considerably from visit to visit, despite the 
fact careful standardization of many external factors, such as meal timing, testing 
schedule, testing environment, subject placements and clothing. This appears to be a 
consistent inconsistency in the literature and is difficult to rationalize (20, 24, 29). The 
values for these measures and the range from day to day are consistent with previously 
reported values from our (20) as well as other laboratories (24). However, it is important 
to consider the influence of the “wandering” baseline on the calculation of the blood flow 
difference between the peak blood flow response following the period of arterial 
occlusion and resting blood flow. The use of the absolute reactive hyperemic response 
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would therefore appear to be more appropriate when using this model during longitudinal 
trials.  
2.4.2. Relationship Between Fitness and Vascular Function  
 
The ability to distribute and deliver adequate blood flow, oxygen and nutrients to 
contracting skeletal muscle is recognized as a major contributor to exercise performance 
(25, 27). Data from the current study are consistent with this idea in that forearm vascular 
reactivity defined as the peak blood flow response following arterial occlusion was 
significantly related to estimated VO2peak (see Figure 2.4). It is believed the ability for 
greater performance is in part secondary to the repeated stimulus of exercise training 
which over time contributes to a series of arterial adaptations aimed at increasing 
vascular conductance and oxygen and nutrient delivery to working skeletal muscle (18). 
The main finding in the present study is the consistent associations between 
measures of venous function and cardiovascular and musculoskeletal fitness. These 
findings further confirm data from our laboratory suggesting that exercise tolerance in 
heart failure patients is related to venous function (35). The associations suggest the 
contribution of the venous system to overall cardiovascular performance and skeletal 
muscle activities is beyond the typical role as a “passive volume reservoir”.  
Uniquely, the data of this study reveal an association between venous outflow and 
estimated VO2peak; and greater venous outflow in the HI cardiovascular fitness group. 
These results suggest that factors associated with venous function might play a role in 
exercise performance. Considering the cardiovascular system is a close circuit, as well as 
the venous circulation enormous potential to act as a volume reservoir and its 
contribution to the end-diastolic volume (8), this segment of the vasculature might have a 
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profound impact on exercise performance. We hypothesize improved venous outflow 
may contribute to enhanced exercise performance secondary to greater metabolic waste 
removal from exercising muscles, increased venous return, and/or enable greater arterial 
inflow (3, 8, 11, 31). 
Another unique finding in this study is the association between measures of 
venous function and handgrip strength suggesting a link between muscular fitness and 
venous circulation. Further comparison reveals greater venous function measures in the 
HI handgrip strength group suggesting the importance of muscular fitness to venous 
function. Interestingly, individuals in the HI strength group reported long-term 
involvement in weight training. Given the numerous benefits of resistive exercise training 
in cardiovascular performance (9, 21, 37), as well as modification of cardiovascular 
disease risk profile and overall health (15, 32, 36), the current findings suggest that 
resistance training might also benefit the venous system. This is particularly relevant 
considering venous abnormalities in aging (17, 23), and patients with heart failure (14, 
28, 35) and venous diseases (10, 30). Therefore, recognizing the contribution of skeletal 
muscle in venous return and overall cardiovascular performance during exercise, factors 
associated with muscle strength modification might contribute to increased overall 
cardiovascular health subsequent to improved venous function, namely venous outflow 
and capacitance. However, it is recognized that the current study is limited to a cross-
sectional comparison and future studies should be designed to directly examine whether 
resistance training and subsequent strength modifications can indeed alter venous 
function in both health and disease.  
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The association between arterial and venous measures suggests an 
intercommunication link between the arterial and venous circulations. Interestingly, 
compelling evidence has emerged illustrating the importance of various aspects of the 
venous system beyond its typical role as a “passive volume reservoir”. For example, 
Barclay et al. demonstrated that muscle fatigue was delayed as a result of increased blood 
flow across the muscle bed and subsequent increased metabolic removal independent of 
oxygen and/or nutrient delivery (3). In a more recent study, Tschakovsky & Hughson 
reported greater arterial inflow patterns with increased venous emptying following arm 
elevation (31). The authors linked these findings to the local venoarteriolar sympathetic 
axon reflex. The presence of nerve fiber collaterals from the sympathetic arteriolar plexus 
to adjacent venules reflex was initially described in 1991 by Rygaard et al. and may serve 
as the anatomical substrate for the local venoarteriolar sympathetic axon reflex (26). 
Finally, evidences of cross-communication between the arterial and venous circulations 
indicate that venular endothelium releases a relaxing factor (s) that contributes to the 
vasodilatation of adjacent arterioles (11). The optimal position of the venous circulation 
might provide a monitor of the tissue metabolic status and a potentially valuable feedback 
mechanism to control the arterial circulation. Therefore, the relationship between arterial 
and venous function indices, suggests that vasoreactivity and muscle perfusion might be 
influenced by venous hemodynamics confirming the essential role of venous function in 
overall cardiovascular control, muscle contraction and exercise performance (3, 11, 31).  
2.5. CONCLUSION 
These findings indicate the importance of recognizing the possible influence of venous 
occlusion times and pressures on venous capacitance and outflow. Additionally, the 
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ICCC results indicate that MSGP is a reliable technique for measuring venous function 
on different days under controlled conditions and useful to differentiate between 
populations. Considering these technical aspects and establishing the reliability of MSGP 
are particularly relevant during cross-sectional as well as repeated measures designs, 
especially in cases when blood pressure may be altered. Finally, forearm venous outflow 
is positively associated with measures of cardiovascular (estimated VO2peak) and 
musculoskeletal (handgrip strength) fitness. The association between handgrip strength 
and venous system hemodynamics implies that muscular conditioning might be important 
for venous health, which warrants future studies examining the effect of muscular 
strength modifications on venous function. 
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CHAPTER 3. INFLUENCE OF VENOUS FUNCTION ON EXERCISE 
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3.1. INTRODUCTION 
Chronic heart failure (HF) is a complex clinical syndrome characterized by an 
abnormality of the heart and by a recognizable pattern of hemodynamic, renal, neural and 
hormonal responses (24). The manifestations of the profound multi-organ changes often 
become most evident during acute bouts of physical activity as many patients experience 
shortness of breath and early fatigue compared to age-matched controls. Indeed, much 
research has focused on the role of vascular and skeletal muscle alterations on exercise 
tolerance. Blood flow to exercising skeletal muscle is reduced in chronic HF patients 
(32). The proposed mechanisms for the reduction in blood flow appear to be quite 
complex but include cardiac insufficiency, neurohumoral hyperactivity (eg, sympathetic 
nervous system, angiotensin and endothelin mediated), and neurohumoral hypoactivity 
(eg, endothelium-derived-relaxing factors), and vascular remodeling (3). In addition, 
decreased skeletal muscle mass, alterations in fiber type composition and metabolic 
milieu further modify the regional distribution of blood flow (3). As a result of these 
findings, additional treatment strategies (eg, angiotensin- converting enzyme inhibitors 
and exercise training) have been developed and implemented in the care of the chronic 
HF patient. Yet, despite these interventions many patients continue to experience 
activity-related symptoms, possibly suggesting the involvement of other factors.  
Interestingly, the role of the venous system on exercise tolerance in patients with HF 
has not received much attention, despite evidence of changes in venous structure and 
function in patients with HF (14, 27) and in patients with a variety of vascular diseases 
(20, 29). Considering that the cardiovascular system is a closed circuit, cardiac 
insufficiency also may have a profound effect on venous function. Accordingly, the 
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purpose of this study was to examine the relationships between indices of arterial and 
venous function and exercise tolerance in chronic HF patients and age-matched controls. 
Given the complexity of the HF syndrome, we hypothesized a direct relationship between 
indices of vascular function and exercise tolerance.  
3.2. METHODS 
3.2.1. Subjects 
Class I and III (New York Heart Association Functional Classification) HF patients and 
age-matched controls were recruited to participate in the study. Individuals recovering 
from recent hospitalization, with unstable myocardial ischemia and/or angina, 
uncontrolled diabetes mellitus and/or hypertension, anemia, lung disease, or renal failure 
were excluded from participation. The patients continued to take the dose of medications 
as prescribed by their physicians. After comprehensive explanation of the proposed 
study, it benefits, inherent risks, and expected commitments, all participants signed an 
informed consent approved by the Institutional Review Board of Louisiana State 
University.  
3.2.1. Assessment of Vascular Function 
Forearm vascular indices were obtained using mercury in-silastic strain-gauge 
plethysmography (EC-5R system, Hokanson, Wash). Prior to the experiment, blood 
pressure cuffs were positioned around the participant’s upper arm and wrist, and a 
mercury-in-silastic strain gauge placed around the forearm approximately 10 cm distal to 
the olecranon process (1). Resting vascular indices were made in duplicate, after 15 
minutes of supine rest, with the measures separated by 5 minutes. Immediately before 
obtaining measurements, hand circulation was occluded for 1 minute by inflating the cuff 
at the wrist to 240mmHg (1). Forearm arterial inflow was obtained using an upper arm 
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venous collecting pressure of 50mmHg (1). Forearm venous capacitance and venous 
outflow were measured after an additional 2 minutes of venous occlusion (1). 
Subsequently, forearm vasoreactivity was examined after 5 minutes of forearm arterial 
occlusion achieved by inflating the cuff on the upper arm to 240mmHg (1). Forearm 
vascular indices were then determined as described above. Throughout the experiment, 
heart rate and blood pressure were obtained at rest, during and immediately after forearm 
occlusion. 
3.2.3. Assessment of Exercise Tolerance 
Exercise tolerance was measured on a motor driven treadmill as the maximum walking 
distance achieved on a 6-minute walk test (9). Participants were instructed to walk as far 
as possible in 6 minutes, avoiding chest pain, shortness of breath, or other symptoms. 
During the test the participants controlled the speed of the treadmill and allowed to 
change the speed at any time. The participants was not coached during the test, but made 
aware of time remaining to completion. Throughout the test, blood pressure and heart rate 
were monitored continuously by an exercise physiologist. 
3.2.4. Data Analysis 
Resting forearm arterial inflow was recorded at a paper speed of 5 mm/sec. and values 
were derived from the slope drawn at a best-fit tangent using the first 3 pulses. 
Calculations were made as a function of 60 seconds divided by the horizontal distance 
(mm) needed for the slope to rise vertically from baseline to the top of the recording 
paper and multiplied by the full chart range (4). Forearm arterial inflow responses after 
occlusion were recorded at a paper speed of 25 mm/sec. Analyses was performed using a 
slope drawn at a best-fit tangent to the curves of the first 3-pulse flows post cuff release. 
The blood flows were then calculated from 60 seconds multiplied by the paper speed (25 
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mm/sec.) divided by the horizontal distance (mm) needed for the volume slope to 
increase by 20 mm vertically (24). Forearm vascular resistance was calculated by 
dividing mean arterial pressure by forearm arterial inflow. Forearm venous indices at rest 
and following occlusion were recorded at a paper speed of 25mm/sec. Forearm venous 
capacitance was calculated as the vertical distance (mm) representing the increase in 
forearm-volume graph after 2 minutes of venous filling (4). Analysis of forearm venous 
outflow was derived from a tangent line that represents the vertical drop in the volume-
graph from the excursion line and drawn at 0.5 seconds after the release of the venous 
occlusion pressure (4). All vascular indices are expressed in mL • tissue-1 • min-1.  
3.2.5. Statistical Analysis 
Statistical analysis was performed using SPSS for Windows (version 10.0,Chicago, Ill). 
Group values are expressed as mean ± SD. Independent t tests were used to compare 
vascular indices and maximum walking distance between the HF and control groups. 
Pearson product moment correlation was used to examine relationships between vascular 
indices and maximum walking distance. Alpha was set a priori at p<.05.  
3.3. RESULTS 
3.3.1. Patient Characteristics and Compliance 
Twenty HF patients (age 57 ± 15) and age 10 age-matched controls (age 54 ± 17 years) 
volunteered to participate in the study (Table 1). Seventy-five percent of the patients were 
black and 55% were women. All patients were recruited from lower socioeconomic areas. 
The major etiologies of HF in this population included coronary artery disease (5 of 20), 
hypertensive heart disease (15 of 20), and idiopathic cardiomyopathy (5 of 20). Due to 
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equipment failure, forearm venous capacitance and venous capacitance and venous 
outflow after occlusion were not obtained in one and three HF subjects, respectively. 
Table 3.1. Participant characteristics 
CHF (n=20) Control (n=9)   
Mean ± sd Range Mean ± sd Range p-value 
Age (yr.) 59 ± 13 
 
33-80 51 ± 16 32-74 0.18 
Height (cm) 
 
170 ± 8 155-180 169 ± 10 152-180 0.78 
Weight (kg) 
 
97 ± 27 58-165 74 ± 12 57-91 0.03 
Resting Heart Rate  
(beats/min) 
72 ± 17 45-98 64 ± 8 55-82 0.24 
Resting Systolic Blood Pressure 
(mmHg) 
139 ± 12 117-164 131 ± 13 114-155 0.14 
Resting Diastolic Blood Pressure 
(mmHg) 
79 ± 9 60-95 75 ± 6 69-86 0.19 
Maximum Walking Distance 
(m) 
178 ± 65 75-321 563 ± 136 346-756 0.0001 















Left Ventricular Ejection 
Fraction (%) 
38 ± 18 10-70 N/A   
CAD= Coronary Artery Disease; HTN=Hypertension; ICM=Idiopathic Cardiomyopathy.  
3.3.2. Exercise Tolerance 
The maximum walking distance achieved on the 6-min walk test was significantly lower 
in the patients with HF compared to the control group (HF: 171 ± 75 m versus controls: 
541.1 ± 145 m; p=0.0001).  
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3.3.3. Vascular Function 
As depicted in Table 2, forearm vascular indices at rest were not different between 
groups. However, forearm arterial inflow, forearm venous capacitance, and forearm 
venous outflow after occlusion were significantly lower in the patients with HF. 
Additionally, forearm vascular resistance was significantly higher in the patients with 
HF. 
3.3.4. Relationship Between Forearm Vascular Indices and Exercise Tolerance 
Correlation analysis revealed significant associations between all indices of 
vasoreactivity and exercise tolerance (forearm arterial inflow: r = 0.58, P = .001; forearm 
vascular resistance: r = -0.52, P = .004). Lastly, as shown in Figure 1, indices of venous 
function after occlusion were significantly related to maximum walking distance (forearm 
venous capacitance: r = 0.57, P = .001). Forearm venous outflow is shown in Figure 2 (r 
= 0.67, P = .0001). 
Table 3.2. Independent t-test comparisons between CHF and control groups. 





Forearm arterial inflow  




3.20 ± 1.20 
14.8 ± 6.31 
 
  3.46 ± 1.17 












36.00 ± 14.87 
8.40 ± 4.50 
 
29.44 ± 10.26 







Forearm venous capacitance  




1.90 ± 0.36 
1.40 ± 0.54 
 
2.25 ± 0.13 







Forearm venous outflow  




24.30 ± 8.00 
29.50 ± 11.70 
 
27.25 ± 4.40 








3.4. DISCUSSION   
The unique finding of this study is the association between forearm venous capacitance 
and venous outflow and the maximum walking distance achieved on a 6-minute walk 
test. These data suggest factors that contribute to exercise impairment in patients with HF 
may extend to the venous system. Given the important contributions of the venous 
circulation to metabolic waste removal and end-diastolic volume, changes in this segment 
















r =0.57; p =001
 
Figure 3.1. Relationship between forearm venous capacitance and maximum 
walking distance. 
 
As expected, the maximum walking distance achieved on the 6-minute walking test 
was significantly lower in the HF patients, suggesting compromised exercise tolerance. 
The reduced maximum walking distance reported in the current study is consistent with 
previous reports (18, 23, 30) and have been attributed to pathophysiological abnormalities 

















r =0.67; p =0001
 
Figure 3.2. Relationship between forearm venous outflow and maximum walking 
distance.  
 
The use of the 6-minute walking test to examine exercise tolerance in patients with HF 
has received a lot of attention recently, due to the relative ease of its administration. The 
test is also thought to reflect a realistic effort as performed in daily life, and highly 
expectable by patients (9). Furthermore, the test appears to have adequate construct, 
criterion, and predicted validity, as well as have a high degree of reproduceability.16 
Construct validity has been shown by several investigators as the six-minute walk test 
appears to discriminate between various populations (8, 15, 16, 23). Criterion validity 
stems from studies showing adequate associations between exercise capacity (as defined 
by VO2peak) and maximum walking distance on the six-minute walk test (11, 26). Yet, as 
these findings are not consistent from one study to another, further work is needed to 
verify the validity of the test. Finally, several studies have reported the prognostic 
significance 6-min walking test in patients with HF indicating its predictive validity (16, 
19).  
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A number of studies have reported adequate test, retest reliability for the maximum 
walking distance achieved on the 6-min walking test (9, 11, 21). In the present study the 
average distance walked increased by 5% from the first to the second test. However, the 
interclass correlation coefficient of 0.97 and the CV of 8.9% indicate adequate stability of 
maximum walking distance over a one week period. These data support research by 
Guyatt et al, who recommend 2 walks be performed, and if the difference between the 
first and second walk is greater than 10% a third walk should be undertaken and used as 
the baseline measure (9). 
The reduction in forearm arterial inflow and elevation in vascular resistance observed 
in the current study are similar to previous reports (31, 33). Although the precise 
mechanisms for the alterations in arterial vasoreactivity is not entirely understood, 
proposed mechanism for the reduction in peripheral blood flow include cardiac 
insufficiency, neurohuromal hyper- (e.g. sympathetic nervous system, angiotensin and 
endothelin mediated vasoconstriction) and hypo-activity (e.g. endothelium- derived-
relaxing factors), and vascular remodeling. In addition, decreased skeletal muscle mass, 
alterations in fiber type composition and metabolic milieu further modify the regional 
distribution of blood flow. 
Previous investigations have related diminished venous function to respiratory-
cardiovascular hemodynamics, plasma norepinephrine (14) and severity of disease in 
patients with HF (14, 27). Data from the current study confirm differences in venous 
function following forearm occlusion between HF patients aged-matched controls. The 
unique finding of the current study is the demonstration that venous function are 
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associated with a measure of exercise tolerance, suggesting factors that contribute to 
exercise impairment in chronic HF patients may extend to the venous system. 
Examination of the literature regarding the reproducibility and validity of strain gauge 
plethysmography to investigate arterial and venous function is difficult due to variations 
in study aims, protocol, equipment, and interpretation of results. However in general the 
literature appears to indicate adequate reproducibility for measures of arterial 
vasoreactivity. In fact, unpublished data from our laboratory for within and between day 
reliability indicate interclass correlation coefficients between 0.82 and 0.95 for forearm 
arterial inflow and vascular resistance at rest and following forearm occlusion. The 
stability of the venous function measurements is currently not clear. However, strain 
gauge plethysmography is routinely used to detect venous dysfunction (12, 22, 25). The 
technique appears to have adequate construct validity as it is able to differentiate between 
patients with venous insufficiency and age-matched controls (7), and between patients of 
different age groups (13). Moreover, high sensitivity, specificity, and predictive values 
were reported when strain gauged plethysmography technique was tested against 
venography, the “gold dash standard”, to detect deep venous thrombosis (5). Preliminary 
data from our laboratory revealed less than 7% difference for within and between day 
measures at rest and following forearm occlusion. 
Given the important contributions of the venous circulation to metabolic waste 
removal and end-diastolic volume, changes in this segment of the vasculature could have 
a profound impact on the exercise response.  Evidence indicates that many HF patients 
are hyperadrenergic (34) and have elevated levels of endothelin-1 (17) and angiotensin II 
(6) suggesting a possible neurohumoral influence on venous function (20). Considering 
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the cardiovascular system is a closed circuit, we speculate cardiac insufficiency, 
decreased arterial reactivity, reduced muscle blood flow, venous alterations and elevated 
cardiac pressures may contribute to a reduction in the driving pressure across metabolic 
tissue. Consequently, decreased driving pressure could effect metabolic waste removal 
(2), alter cardiac filling kinetics (10) and decrease exercise tolerance.  
3.5. CONCLUSION 
This study shows both arterial and venous indices are altered in HF patients and are 
associated with impaired exercise tolerance. Given the important contributions of 
the venous circulation to metabolic waste removal and end-diastolic volume, and the 
association of venous function with exercise tolerance among patients with HF 
demonstrated herein, future investigations should address venous health in the 
management of HF. 
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CHAPTER 4. MODIFICATION OF FOREARM VASCULAR FUNCTION 












































Endurance exercise training promotes adaptations of vascular control mechanisms that 
contribute to an increase in vasodilatory capacity thereby facilitating the delivery of 
blood to exercising muscle. The precise mechanism for vascular adaptations following 
exercise training are not fully understood, however, changes in the responsiveness of 
vascular endothelial and/or smooth muscle may, in part, enhance the vasodilatory 
capacity. For example, Delp & Laughlin (3) reported enhanced endothelium-dependent 
dilation of the rat aorta by the fourth week of endurance training and concluded that the 
adaptation was in part mediated through the nitric oxide (NO) synthase pathway. 
Interestingly, the enhanced forearm peak vasodilatory capacity observed following four 
weeks of handgrip (HG) exercise training occurred without changes in the activity of the 
NO system as reported by Green et al. (4). This suggests that the exercise stimulus to 
induce changes in vasoresponsiveness may, in part, be dependent on the exercise training 
modality. Indeed the above-mentioned studies appear to indicate that exercise modality 
has a differential effect on vascular adaptations (2, 3). More recently, Hepple et al. 
reported a dissociation of peak vascular conductance and VO2max in body builders and 
endurance runners compared to healthy sedentary control, suggesting training-specific 
effects of the cardiovascular system to local skeletal muscle metabolic demand (6).  
An alternate explanation for the difference in vasoresponsiveness between 
training protocols is that these adaptations are, in part, intensity-dependent. Interestingly, 
vascular adaptations following small muscle group exercise training programs using 
different intensities have not been adequately explored. We are aware of only one study 
by Yasuda et al. (15) where subjects performed 6-weeks of HG exercise training at 
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intensities of 33 or 50% of maximum voluntary contraction (MVC). Peak forearm blood 
flow adaptations increased significantly, but similarly in both groups. However, the 
difference between training intensities was only 17% and may have been insufficient to 
determine whether the adaptations are indeed intensity-dependent. Accordingly, the 
purpose of this study was to determine the effects of low (LO) and high (HI) intensity 
short-term HG exercise training programs on localized vascular function in healthy 
young men. It was hypothesized that a training exercise intensity of 75% of MVC would 
promote greater vasodilatory capacity compared to a training exercise intensity of 25% of 
MVC. 
4.2. METHODS 
4.2.1. Experimental Groups and Screening Measures  
Twenty-eight males (Age: 23±4.3yrs) were recruited and randomly assigned to either a 
LO (n=15) or HI training group (n=13). Smokers and individuals with acute medical 
conditions (e.g. orthopedic injury), active infection and/or on pharmacotherapy with 
known vascular effects (e.g. anti-inflammatory therapy, cardiovascular medications) were 
excluded. Following comprehensive explanation of the proposed study, its benefits, 
inherent risks and expected commitments with regard to time, all participants signed an 
informed consent approved by the Institutional Review Board of Louisiana State 
University. In addition, each subject filled out a 24-hour medical and activity history 
questionnaire. 
4.2.2. Experimental Design 
The study was a randomized, prospective design consisting of two experimental sessions 
separated by a 4-week intervention period. The experimental sessions involved the 
measurement of forearm blood flow (FBF) at rest (RBF), following 5 minutes of forearm 
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occlusion (OCC) and OCC combined with 3 minutes of HG exercise (ROCC). The 
subjects exercised 5 days per week for 4 consecutive weeks at the exercise physiology 
laboratory of Louisiana State University.  Each training session consisted of 20 minutes 
of non-dominant HG exercise at a cadence of one contraction every 4 seconds. 
Participants in the LO group trained at 25% of MVC, participants in the HI group trained 
at 75% of MVC.  
4.2.3. Experimental Measurements 
Upon arrival to the laboratory, the subject’s height and weight were obtained. In addition, 
MVC was determined for both arms as the average of three maximum consecutive 
contraction trials using a Stoelting hand-dynamometer. Thereafter, each subject was 
placed in a supine position for 20 minutes prior to evaluation of forearm vascular blood 
flow. Forearm blood flow measurements were obtained from both arms (the non-
dominant first) using an EC-5R plethysmography system (Hokanson, 1995). Prior to each 
experiment, blood pressure cuffs were positioned around the participant’s upper arm and 
wrist, and a mercury-in-silastic strain gauge (7) placed around the forearm approximately 
10 cm distal to the olecranon process (13).  The forearm was extended and slightly 
supinated and supported by a Styrofoam block.  Immediately before the blood flow 
measurements, hand circulation was occluded for 1 min by inflating the cuff at the wrist 
to 240mmHg (10). All blood flow measures were made with an upper arm venous 
collecting pressure of 50mmHg (11) and reported in ml per min per 100 ml of tissue (13).  
Reactive hyperemia following OCC was achieved by inflating the cuff on the upper arm 
to 240mmHg (13). Blood flow measures were then determined as described above. 
Finally, vasoresponsiveness following ROCC was obtained. Handgrip exercise for the 
ROCC condition was performed at an intensity of 25% MVC and a cadence of 1 
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contraction per 4 sec during the 2nd, 3rd, and 4th minutes of occlusion. ROCC 
measurements were obtained following OCC and were separated by 15 minutes. 
Throughout the testing procedures, heart rate and blood pressure were obtained at the 
following time points: rest, during and immediately after OCC and ROCC. Throughout 
the testing procedures, which lasted approximately 120 minutes the subject remained in 
the supine position.  
4.2.4. Data Analysis 
Resting blood flow was recorded at a paper speed of 5 mm/sec. and values were derived 
from the slope drawn at a best-fit tangent using the first 3 pulses. Calculations were made 
as a function of 60 seconds divided by the horizontal distance (mm) needed for the slope 
to rise vertically from baseline to the top of the recording paper and multiplied by the full 
chart range. Blood flow responses following OCC and ROCC were recorded at a paper 
speed of 25 cm/sec. Analyses were performed using a slope drawn at a best-fit tangent to 
the curves of the first 3-pulse flows post cuff release. The blood flows were then 
calculated from 60 sec. multiplied by the paper speed (25 cm/sec) divided by the 
horizontal distance (mm) needed for the volume slope to increase by 20 mm vertically. 
Mean arterial pressure was calculated from the difference between SBP and DBP divided 
by three and added to DBP {MAP = DBP+[(SBP-DBP)/3]}. Forearm vascular resistance 
was calculated by dividing mean arterial pressure by the forearm blood flow (FVR = 
MAP/FBF).  
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4.2.5. Statistical Analysis 
Grip strength 
Dependent t-tests were used to compare the grip strengths of dominant and non-dominant 
arms observed prior to and following the training period. Separate t-tests were conducted 
for the LO and HI intensity training groups. 
Comparison of dominant to non-dominant arms  
Two 3x2 ANOVA’s were used to compare the FBF and FVR during each condition (rest 
vs. OCC vs. ROCC) in the dominant and non-dominant arms. The pre-training and post-
training data were treated separately. 
Effect of training on vascular responses.  
A 3x2x2 ANOVA was used to examine the effects of the training period on FBF and 
FVR as measured under the three conditions (rest vs. OCC vs. ROCC), and across the 
two training groups (LO vs. HI intensity). 
Alpha was set a-priori at p<0.05 for all statistical analyses. The LSD method of post-hoc 
testing was employed where indicated. 
4.3. RESULTS 
4.3.1. Participant Characteristics 
The initial number of subjects was thirty, however one participant was excluded because 
of noncompliance and one participant for violation of exclusion criteria (initiated 
smoking). As shown in Table 1 there were no statistically significant differences between 
the LO and the HI groups in the pre-training measurements for age, height, weight, 









Age (yrs) 22 ± 2.5 24 ± 5.8 
Weight (kg) 86 ± 7.5 70 ± 5.4 
Height (cm) 175 ± 15.4 174 ± 10 
SBPrest (mmHg) 106.5 ± 18.78 106.9 ± 9 
DBPrest (mmHg) 68.3 ± 12.3 68.3 ± 7.4 
MAPrest (mmHg) 81 ± 10 81.5 ± 6.3 
HRrest (bts•min-1) 62.1 ± 6.3 64.5 ± 7 
Values are mean ± SD. LO, low training intensity = 25% of maximum 
voluntary contraction (MVC); HI, high training intensity = 75% of MVC; 
SBPrest, systolic blood pressure at rest; DBPrest, diastolic blood pressure at rest; 
MAPrest, mean arterial blood pressure at rest; HRrest, heart rate at rest.    
 
4.3.2. Grip Strength 
All participants completed at least 18 sessions of HG exercise training over the 4-week 
period. The result of the t-test revealed no change in maximal grip strength in the trained 
and non-trained arms of both groups. However, there was trend towards an improvement 
in the trained arm strength in the HI group (35.3±8.8 to 38.3±8.8 kg; 8%; p=0.095). 
4.3.3. Comparison of Dominant to Non-Dominant Arm 
As could be depicted from figure 1 and 2 and table 2, the results of the ANOVA on the 
pre-training values of FBF revealed an interaction for test condition (p<0.0001) and arm 
(p=0.002). This interaction was such that OCC and ROCC resulted in a graded FBF 
response, with the greatest hyperemic FBF occurring following ROCC. Furthermore FBF 
following OCC and ROCC were greater in the dominant arm compared to the non-
dominant arm. There was also a main effect of test condition (p<0.0001) on FVR. FVR 
was lower following OCC and ROCC compared to rest, but not different from each other. 
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Figure 4.1. FBF changes in the LO group following HG exercise training.  
Values are means ± SD.  *p<0.05 vs. rest; §p<0.05 vs. OCC  ‡p<0.05 vs.  Pre 
Non-dominant; †p<0.05 vs. 
 
The results of the ANOVA on the post-training FBF values revealed a main effect of test 
condition (p<0.0001) but not for arm (p=0.718).  This main effect was such that the OCC 
and ROCC once again resulted in a graded response. However, following training the 
response of the non-dominant arm was not different from that of the dominant arm. FVR 
responses following OCC and ROCC were similar to pre-training values for both arms. 
4.3.3. Effect of Training on Vascular Responses.  
The results of the ANOVA on the effects of training on FBF in the non-dominant arm 
revealed a main effect for training period (p=0.005). However, the ANOVA did not 
reveal a group by training interaction (p=0.632). The main effect was such that FBF 
values following OCC and ROCC were higher after the training period as compared to 
pre-training values. However, there was no interaction with training intensity, suggesting 
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that both training groups responded similarly. The results of the ANOVA on FVR 
revealed only a main effect of the test condition (i.e. rest, OCC, ROCC). These main 
effects are the same as described above, and did not change significantly as a result of the 
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Figure 4.2. FBF changes in the HI group following HG exercise training.  
Values are means ± SD.  *p<0.05 vs. rest; §p<0.05 vs. OCC  ‡p<0.05 vs.  Pre 
Non-dominant; †p<0.05 vs. Pre 
 
4.4. DISCUSSION 
This study examined the role of a short-term HG exercise program on FBF and FVR. Our 
findings indicate that the degree of vascular responsiveness is directly related to the 
intensity of the vasodilatory stimulus, given that the blood flow measures were significantly 
different for all 3 conditions (ROCC > OCC > RBF). Furthermore, vasodilatory 
responsiveness prior to 4 weeks of HG exercise was significantly greater in the dominant 
compared to the non-dominant arm. Finally, following 4 weeks of HG exercise 
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performed 5 days per week for 20 minutes vasodilatory responsiveness improved 
unilaterally but similarly for the LO and HI intensity groups. 
 
Table 4.2. Dominant and non-dominant FVR changes in the LO and HI groups at 
rest, following OCC and following ROCC. 
  Dominant Non-dominant 
  Pre Post Pre Post 
LO group (15)      
 FVRrest 47.85 ± 13 42.2 ± 13.4 42.5 ± 15.4 44.6 ±17.0 
 FVROCC 3.3 ± 1* 3.5 ± 0.5* 3.5 ± 0.6* 3.5 ± 0.8* 
 FVRROCC 2.5 ± 0.5* 2.8 ± 0.4* 3 ± 0.4* 2.9 ± 0.7* 
HI group (13)      
 FVRrest 44.5 ± 19 45.7 ± 22.7 39.4 ± 15 34.4 ± 8.8 
 FVROCC 3.1 ± 0.5∗ 3.1 ± 0.5∗ 3.7 ± 0.6∗ 3.3 ±0.7∗ 
 FVRROCC 2.7 ± 0.3∗ 2.77 ± 0.4∗ 3.3 ± 0.7∗ 2.5 ± 0.7∗ 
Values are means ± SD. LO, training intensity = 25% of maximum voluntary contraction (MVC); HI, 
training intensity = 75% of MVC; FVRrest, forearm vascular resistance at rest; FVROCC, forearm vascular 
resistance following five minute of occlusion; FVRROCC, forearm vascular resistance following OCC 
coupled with 3-min. of HG of exercise. ∗p < 0.05 vs. rest. 
 
Previous studies have reported improved unilateral vasodilatory responsiveness 
following small muscle group conditioning programs (see Table 3) (4, 9, 14). The 
improvements in peak FBF following OCC in this study were similar for the HI group 
(20.6%) to those reported by Green et al. (23%) but lower than Sinoway et al. (30%). The 
discrepancy between our findings and Sinoway et al. could be the result of a difference in 
total minutes of exercise performed or methods of assessing forearm blood flow. For 
example, the training regime used by Sinoway et al. included four, 30-minute sessions 
per week (120 minutes per week) versus our five, 20-minute sessions per week (100 
minutes per week) for 4 weeks. In addition, Sinoway et al. evaluated the effect of short-
term HG exercise on vasodilatory responsiveness after 10 minutes of arterial occlusion 




Table 4.3. Literature overview 
Study Population Type of training Results 
 
Yasuda, 83 10 healthy, 
young 
HG, 33 & 50% MVC, 6X/wk (6 
wks) 
34 & 26% ⇑ BF, respectively. 
  
Sinoway, 87 6 healthy, 
young 
HG, 70% MVC, 4X/wk, 30min 
(4 wks) 
⇔ BFrest.  
30% ⇑ RHBF in trained arm 
Green, 94 11 healthy, 
young 
HG, 75% MVC, 4X/wk, 30min 
(4 wks)  
⇔ BFrest 
23% ⇑ RHBF in trained arm 
Bond, 94 7 healthy, 
young 
Plantar Flexion, 75% MVC, 
4X/wk, 6sets of 15reps (4 wks) 
⇔ BFrest. 
22% ⇓ in RHBF, ⇑ VR. 
Franke, 98 6 healthy, 
young 
HG, 70% MVC, (4 wks)  ⇔FVCrest. 




young & 7 CHF  
HG, 70% MVC, 4X/wk, 30min, 
(4-6 wks) 
⇔ in CHF. 
24% ⇑ RHBF in healthy, young. 
BF = Blood flow; RHBF = Reactive hyperemic blood flow; VR = Vascular resistance; FVC = 
Forearm vascular conductance.   
 
Our findings stand in contrast to other studies of different training duration or 
muscle groups (1, 12, 15). For example, Yasuda et al. reported an increase in FBF in the 
ipsi- and contralateral arm following 6 weeks of HG exercise training (15) and attributed 
the improvements to changes in neurogenic balance (15). In contrast, other investigators 
report a reduction in limb blood flow following short-term training programs. Bond et al. 
(1) attributed reductions in leg blood flow to an increase in muscle cross-sectional area 
without proportional changes in microvascular density, whereas Saito et al. attributed the 
lower leg blood flow to a more effective metabolic process (12). Clearly, more studies are 
needed to further understand the vascular adaptive responses to exercise training. 
 Similar to the study by Yasuda et al. (15) the current study found no statistical 
differences in the degree of change in vasoresponsiveness between the LO and HI groups 
following the training period.  Subsequent to training, FBF increased 16.5%, and 17.7% 
in the LO group, and 20.6%, and 29.2% in the HI group after OCC, and ROCC, 
respectively. The lack of a significant difference between the groups suggests that the 
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signal for vascular adaptations may have been similar for both groups. Moreover, it 
indicates that significant local vascular adaptations can be induced with small muscle 
group conditioning programs at intensities as low as 25% of MVC. Such adaptations may 
be particularly valuable in populations for whom low-intensity exercise training is 
indicated. In fact, recent studies have reported short-term HG training results in enhanced 
endothelium-dependent vasodilation in the forearm skeletal muscle circulation of patients 
with chronic heart failure (9). Likewise, patients with other disease conditions (e.g. 
diabetes mellitus, peripheral vascular disease, hypertension and coronary artery disease) 
who suffer from compromised vascular function might benefit from such small muscle 
group conditioning regimes. Clearly, further investigations are needed to verify this 
theory and whether such training programs can ultimately contribute to an individual’s 
improved exercise performance. 
Another finding of this study is the observed difference in vasodilatory capacity 
between the dominant and non-dominant arm. This data is consistent with Sinoway et al. 
who reported a 25% and 29% difference following OCC and ROCC respectively in the 
dominant arm versus non-dominant arm of tennis players (13). Likewise, in the current 
study, vascular capacity in the dominant arm was greater than the non-dominant arm 
(10% and 12% difference following OCC and ROCC respectively) perhaps as a 
consequence of preferential usage. The difference between Sinoway’s findings and ours 
is most likely the result of regular participation in the sport of tennis, as all the subjects in 
Sinoway’s study were considered advanced players (13). Significantly, the observed 
differences in FBF between the dominant and the non-dominant arm prior to training in 
this study disappeared after training. This indicates that forearm vascular adaptations in 
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the dominant arm were matched by short-term forearm HG exercise training in the non-
dominant arm.  
Although this study is not adequately or purposely designed to explain the exact 
mechanism of the training adaptations, several previous investigations have indicated the 
role of the endothelium. Shear stress associated with exercise has been proposed to 
contribute to the increased production of endothelial derived relaxing factors, such as NO 
(8). It is postulated that the contraction and relaxation phases of exercise results in brief 
circulatory arrest followed by a hyperemic response (3, 5). This intermittent blood flow 
might create shear stress on the vascular wall that is responsible for the vascular 
adaptations demonstrated in this study. Clearly, other factors (e.g. increased muscle 
capillarizations, or changes in local metabolites, neuroendocrine balance, other myogenic 
factors and/or cardiac function) associated with exercise might also contribute to 
improved vascular function (3). The fact vasoreactivity is a complex interplay of central, 
vascular and local control mechanisms limits this study’s ability to precisely identify the 
mechanism(s) for change.  
In conclusion, FBF and FVR at rest and following forearm occlusion (with and 
without HG exercise) showed a graded response with the greatest hyperemic flow 
recorded after five minutes of forearm occlusion with HG contraction. Furthermore, the 
non-dominant FBF was found to improve in response to low-intensity as well as high-
intensity short-term HG exercise training. Furthermore, blood flow in the non-dominant 
forearm following training was increased to match the flow in the dominant forearm. The 
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CHAPTER 5.  ARTERIAL AND VENOUS ADAPTATIONS TO SHORT-TERM 













































Structural and functional changes in the arterial system following exercise training are 
well documented. These adaptations are associated with reduced vascular resistance, 
improved blood delivery and diffusion in the contracting muscle and contribute to 
improved vascular modulation and exercise performance during subsequent exercise 
sessions. The mechanism(s) by which these adaptations are induced are not fully 
understood, but are thought to include alterations in the arterial endothelium and/or 
smooth muscle (4, 8, 12, 18, 32, 65). Recent studies report training-induced adaptations 
may be observed following one week of training in animal models (35, 61), and in human 
single large conduit arteries (i.e. brachial) (2).  
Interestingly, the effect of exercise training on venous function has received 
considerably less attention despite compelling evidence demonstrating its dynamic role 
beyond a typical role as a “passive volume reservoir” (22, 72). Most of the available 
studies have linked training-induced improvements in venous function to greater blood 
volume associated with increased VO2 (10, 29, 41), as well as increased venular cross-
sectional area (49) and density (70). On the other hand, Wecht et al. attributed enhanced 
venous function in “aerobically” trained individuals to improved venous hemodynamics, 
including venous emptying, outflow and compliance (76). However no studies have 
examined the effect of localized exercise training (i.e. handgrip) on regional venous 
function.  
Therefore, the purpose of this study was to examine the influence of 4-weeks of 
handgrip exercise training on arterial and venous function. A secondary aim of this study 
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was to determine the time course of change for both arterial and venous indices 
associated with the handgrip exercise training program.  
5.2. HYPOTHESES 
This study tested two specific hypotheses regarding the influence of handgrip exercise on 
arterial (Hypothesis I) and veno-dynamics (Hypothesis II).  
5.2.1. Hypothesis I 
Four-weeks of handgrip exercise training will result in an increase in arterial reactivity 
following 5-minutes of arterial occlusion; 
5.2.2. Hypothesis II 
Four-weeks of handgrip exercise training will result in an increase in venous capacitance, 
compliance and outflow at rest and following 5-minutes of arterial occlusion. 
5.3. METHODS 
5.3.1. Participants and Design 
Apparently healthy sedentary young adult males were recruited to participate in the 
study. Individuals with manifestations of cardiovascular, metabolic, orthopedic or 
neurological disease or on any medication (e.g., digitalis) which could affect the results 
of this study were excluded. 
The study was executed in 4 weeks, and involved once a week evaluation session 
and 5-time-a-week exercise training sessions. Prior to and at the end of each week, 
participants underwent handgrip strength and vascular function evaluations in the 
dominant and non-dominant forearms. The primary outcomes of this study include: (1) 
Peak blood inflow, defined as vascular response to 5 minutes of upper arm arterial 
occlusion (64); (2) Venous capacitance; defined as the changes in limb blood volume 
following 6 minutes of venous occlusion; (3) Venous outflow; defined as the changes in 
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limb blood volume following the release of venous occlusion and; (4) Venous 
compliance; defined as the ratio of change in volume to concomitant change in 
transmural distending pressure (i.e. occlusion pressure) (11, 23, 54, 76). Additionally, 
handgrip strength, arm exercise tolerance, and hemodynamic measures (i.e. blood 
pressure, heart rate and heart rate variability) were also assessed. Following the 
completion of the initial assessment, each subject was asked to report to the exercise 
physiology laboratory 5 days/week to perform 20 minutes of forearm flexion exercise at a 
cadence of 1 contraction every 4 seconds starting at an intensity of 60% of maximum 
handgrip strength. The non-dominant arm was trained while the dominant arm served as 
control. 
5.3.2. Study Measurements:  
Vascular function assessments  
Vascular function indices were obtained in the dominant and non-dominant forearms 
using mercury strain gauge plethysmography at rest and following occlusion (64) at the 
beginning of the study, and at the end of each week throughout the study period. This 
technique is noninvasive, and based on the assumption that alterations of pressures in 
strategically placed cuffs allows examination of the rate of change of limb volume 
thought to reflect venous function indices including blood inflow, vascular resistance, 
venous capacitance, venous outflow and venous compliance (11, 23). Prior to the 
experiment, blood pressure cuffs were positioned around the participant’s upper arm and 
wrist, and a mercury-in-Silastic strain gauge placed around the forearm approximately 10 
cm distal to the olecranon process (4). Resting forearm vascular function measures were 
obtained following 15 minutes of supine rest. Immediately before the measurements, hand 
circulation was occluded for 1 minute by inflating the cuff at the wrist to 240 mmHg. 
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Forearm blood inflow was obtained using an upper arm venous occluding pressure of 7 
mmHg below diastolic blood pressure. Forearm venous capacitance was measured after 
an additional 6 minutes of venous occlusion and venous outflow following the release of 
pressure (3, 66). Subsequently, peak forearm blood was examined following arterial 
occlusion achieved by inflating the cuff on the upper arm to 240 mmHg for 5 minutes. 
Forearm vascular indices were then determined as described above. These were then 
performed on the other arm. Prior to, during and following each procedure blood pressure 
and heart rate were obtained.  
Autonomic nervous function assessments 
Indices of autonomic function were assessed using measures of heart rate variability. 
These measures were obtained at the same time as the vascular assessments described 
above. The ECG electrodes were placed on the chest and interfaced with a Biopac 
MP100 and its companion software Acqknowledge (model MP100A, Biopac Inc., Santa 
Barbara, CA) to allow for continuous data acquisition. Five minutes (at rest and during 
forearm occlusion) of ECG data were analyzed for mean heart period (mean R-R 
interval), standard deviation (SDNN), low frequency power (LF) and high frequency 
power (HF) using the guidelines set forth by the Task Force of the European Society of 
Cardiology and the North American Society of Pacing and Electrophysiology (7, 71). 
These data were obtained at the beginning and at the end of the study period. 
Arm ergometer test 
Arm exercise tolerance was evaluated using a graded arm ergometer exercise test at the 
beginning and at the end of the study period (5, 48). The test was performed by initially 
turning the arm ergometer at a speed of 50 rpm and a resistance of 0.5 kp for 2 minutes 
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with the participant in a seated position. The resistance was then increased by 0.25 kp 
every 2 minutes until the subject reached exhaustion, requested to stop, or exhibited signs 
or symptoms, which require test termination. Prior to, during, and following the exercise 
test, heart rate, blood pressure measurements, and ratings of perceived exertion were also 
obtained at the end of each minute throughout the test using a standard 
sphygmomanometer and the Borg's perceived exertion scale, respectively.  
Forearm circumference and handgrip strength assessments  
The participant’s forearm circumferences and handgrip maximal voluntary contraction 
were evaluated at baseline and at the end of each week throughout the study period. 
Forearm circumference was examined using a weighted measuring tape 10 cm distal to 
the midpoint between the lateral epicondyle and olecranon process. Handgrip strength 
was evaluated using a handgrip dynamometer (Lafayette instruments, OH, 02) with the 
participant upright, but slightly bent forward at the waist. The test involved an all-out 
gripping effort for 3 seconds, without movement of the arm. The average of three 
consecutive trials was used as the measure of strength.  
Body composition 
Three-site skinfold method was used to estimate body percents of fat and fat-free masses. 
The recommended body sites for this method were chest, abdominal and thigh (80). 
Additionally dominant and non-dominant forearm skinfolds were obtained at the upper 
1/3 of the forearm. 
5.3.3. Data Reduction and Analysis 
Resting blood inflow was recorded at a paper speed of 5 mm/seconds and values were 
derived from the slope drawn at a best-fit tangent using the first 2-3 pulses. Calculations 
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were made as a function of 60 seconds divided by the horizontal distance (mm) needed 
for the slope to rise vertically from baseline to the top of the recording paper and 
multiplied by the full chart range (11, 23). Peak forearm blood inflow was recorded at a 
paper speed of 25 mm/second. Analyses were performed using a slope drawn at a best-fit 
tangent to the curves of the first 3-pulse flows post cuff release. Blood flows were then 
calculated from 60 seconds multiplied by the paper speed, and divided by the horizontal 
distance (mm) needed for the volume slope to increase by 20 mm vertically (4). Forearm 
vascular resistance was then determined by dividing mean arterial pressure by the blood 
inflow.  Forearm venous capacitance was calculated as the vertical distance (mm) 
representing the change in forearm-volume graph following 6 minutes of venous filling 
(11). Forearm venous compliance was calculated as the ratio of venous capacitance and 
occlusion pressure multiplied by 100 (76). Forearm venous outflow was derived from a 
tangent line representing the vertical drop in the volume-graph from the excursion line 
and drawn at 0.5 second and 2 second following the release of the venous occlusion 
pressure (11). All vascular indices were expressed in ml•100ml tissue-1•min-1. 
5.3.4. Statistical Analysis  
All statistical analyses were completed using the SPSS statistical program (version 11.00, 
Chicago, Ill). To examine the influence of 4-weeks of handgrip exercise training on 
arterial reactivity (Hypothesis I) a 2 (Arms) * 5 (visit 1-vist 5) split-plot ANOVA was 
used. To examine the influence of 4-weeks of handgrip exercise training on venous 
capacitance, compliance and outflow at rest and following 5-minutes of arm occlusion 
(Hypothesis II) a second 2 (Arms) * 5  (visit 1-vist 5) split-plot ANOVA was used. 
Pearson product moment correlations were used to examine the relationships between 
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handgrip strength and vascular function indices, between arterial and venous function 
indices as well as between arterial and venous adaptations. Finally a paired t-test was 
used to compare between pre and post training measures of HRV indices, the skinfold 
measures, and handgrip strength. Alpha was set a-priori at p<0.05.  
5.4. RESULTS 
5.4.1. Participants 
Twenty-two men participated in the study. Five participants did not complete the study 
due to personal decision (3 individuals) or lack of compliance (2 individuals). Participant 
descriptions are presented in Table 5.1.       
Table 5.1. Subject characteristics 
 Visit 1 
Age (yrs) 22.6 ± 3.5 
Height (cm) 175.4 ± 1.6 
Weight (kg) 75.5 ± 4.0 
Control arm length (cm) 27.5 ± 0.3 
Trained arm length (cm) 27.4 ± 0.3 
Sum of Skin fold (mm) 54.4 ± 7.7 
Values are mean ± SE. 
 
5.4.2. Hemodynamic, Anthropometric and Exercise Measures 
Table 5.2. Cardiovascular hemodynamics and HRV before 
and after 4-week handgrip exercise training 
Variable Visit 1 Visit 5 
HR (bpm) 58.2 ±1.6  57.5 ± 1.8 
SBP (mmHg) 112.6 ± 2.4 111.1 ± 2.1 
DBP (mmHg) 60.7 ± 1.9 59.7 ± 1.8 
MAP (mmHg) 78.0 ± 8.1 76.8 ±7.6 
SDNN (ms) 73.4 ± 4.1 79.6 ± 4.0 
LF power  36.9 ± 1.3 37.2 ± 1.4 
HF power  63.1 ± 1.3 62.8 ± 1.4 
Values are mean ± SE. 
 
 69 
Hemodynamic, anthropometric and exercise measures at baseline (visit 1) and the end of 
the study (visit 5) are presented in Tables 5.2 and 5.3. No significant changes in heart 
rate, blood pressure, and heart rate variability indices were observed. Moreover, there 
were no changes in anthropometric measures in the non-trained arm. In contrast, forearm 
circumference increased by 1.56% (p=0.03) in the trained arm. Handgrip strength was not 
modified in the non-trained arm, whereas the trained arm showed a 14.5% (p=0.014) 
increase in maximal voluntary contraction. Finally, there were no changes in the time to 
fatigue for the symptom-limited graded arm ergometer exercise test.  
 
Table 5.3. Arm ergometer exercise test, forearm skinfolds, 
and sum of three skinfolds before and after 4-week handgrip 
exercise training 
 Visit 1 Visit 5 
Arm ergometer test (mints.) 10.3 ± 0.6 9.75 ± 0.9 
Control handgrip strength (kg)  40.6 ± 2.9 42.8 ± 3.2 
Trained handgrip strength (kg) 36.1 ± 2.1 41.3 ± 1.7 * 
Control arm circumference (cm) 26.3 ± 0.5 26.5 ± 0.5 
Trained arm circumference (cm) 25.6 ± 0.6 26.0 ± 0.5 * 
Control arm skin fold (mm) 1.1 ± 0.2 1.1 ± 0.13 
Trained arm skin fold (mm) 1.2 ± 0.3 1.0 ± 0.13 
Values are mean ± SE. *=p<0.05 vs. visit 1 
 
5.4.3. Effect of Training on Vascular Function 
Values for the blood flow responses at rest and following occlusion for visits 1 and 5 are 
presented in table 5.4 and 5.5. Furthermore, Figures 1 through 5 present data for the 






Table 5.4. Resting arterial and venous indices 
 Control arm Trained arm 






2.9 ± 0.2 2.6 ± 0.2 3.0 ± 0.2 3.0 ± 0.2 
Vascular resistance 






4.6 ± 0.13 4.5 ± 0.13 4.8 ± 0.13 4.5 ± 0.13 
Venous compliance 






42.5 ± 1.9 43.3 ± 1.9 44.8 ± 1.8 45.4 ± 1.8 
Values are mean ± SE. 
 
Table 5.5. Post occlusion arterial and venous indices 
 Control arm Trained arm 






22.1 ± 0.7‡ 21.6 ± 0.7  19.0 ± 0.7 22.6 ± 0.7* 
Vascular resistance 






3.4 ± 0.13 3.4 ± 0.13 3.6 ± 0.13 3.5 ± 0.13 
Venous compliance 






42.1 ± 1.7 44.9 ± 1.9 45.1 ± 1.7 45.5 ± 1.7 
Values are mean ± SE. *=p<0.05 vs. visit 1; ‡=p<0.05 vs. Trained arm. 
 
Resting arterial function indices. 
The 2 X 5 split-plot ANOVA tests revealed no significant main effects for arms or visits, 
or for the arms by visits interactions for resting forearm arterial inflow and vascular 





























Figure 5.1. Changes in peak forearm blood inflow.  

























Figure 5.2. Changes in peak forearm vascular resistance.  
Values are mean ± SE. *=p<0.05 vs. visit1; ‡=p<0.05 vs. Trained arm. 
 
Peak arterial function indices. 
As depicted in Figures 5.1 and 5.2, the 2 X 5 split-plot ANOVA test revealed no 
significant main effects for arms or visits for peak arterial indices, however there were 
significant in the arms by visits interaction for trained forearm peak forearm arterial 
inflow (p=0.02) and vascular resistance (p=0.009). Subsequent LSD post-hoc comparison 
demonstrated increased peak arterial inflow, and decreased peak vascular resistance 
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following the 1st week in the trained forearm only. Finally, post-hoc comparison revealed 
greater peak forearm blood inflow (p=0.0013) and vascular resistance (p=0.05) in the 
untrained verses the trained arm at visit 1, however, no differences were observed in the 




























Figure 5.3. Changes in resting forearm venous compliance.  
Values are mean ± SE. *=p<0.05 vs. visit 1; ‡=p<0.05 vs. Trained arm; † =p<0.05 
vs. visit 2. 
 
Resting venous function indices. 
The 2 X 5 split-plot ANOVA tests revealed no significant main effects of arms or visits, 
or arms by visits interactions for resting forearm venous capacitance and outflow (see 
Table 4), however revealed significant (p=0.04) arms by visits interaction for venous 
compliance. As depicted in Figure 5.3, subsequent LSD post-hoc comparison 
demonstrated a decrease in trained arm venous compliance in visit 2 followed by a 































Figure 5.4. Changes in post occlusion forearm venous capacitance.  
Values are mean ± SE. 
 
Post-occlusion venous function indices 
The 2 X 5 split-plot ANOVA tests revealed no significant main effects for arms or visits, 
or arms by visits interactions for post-occlusion forearm venous compliance and outflow. 
However there was a significant main effect of visits (p=0.04) for venous outflow (see 
Table 5.5 and Figure 5.4). As depicted in Figure 5.5, Subsequent LSD post-hoc 
comparison demonstrated a decrease in trained forearm venous outflow in visit 2 
followed by a gradual return to baseline by visit 5. The control forearm venous outflow 
was greater at visit 2 than at visit 5.  
Relationships between handgrip strength, and arterial and venous function indices 
The Pearson product moment correlations are presented in Table 5.6 and Figures 5.6 
through 5.9. Significant associations were noted between handgrip strength and venous 
function indices (see Table 5.6 and Figures 5.6 and 5.7), and between arterial and venous 



























Figure 5.5. Changes in post occlusion forearm venous outflow.  




































Table 5.6. Pearson product moment correlation between arterial, venous and physical fitness measures 
 Variables  Resting vascular indices Post occlusion vascular indices 
 





















 Handgrip strength 
(kg) 1.0           
Blood inflow 
(mL/100mL/min) r=0.4* 1.0          
Vascular resistance 
(U) r=-0.26 r=-0.84* 1.0         
Venous capacitance 
(mL/100mL/min) r=0.58* r=0.35* r=-0.35* 1.0        
Venous compliance 














(mL/100mL/min) r=0.6* r=0.44* r=-0.5* r=0.81* r=0.52* 1.0      
Blood inflow 
(mL/100mL/min) r=0.30 r=0.05 r=-0.2 r=0.4* r=0.45* r=0.4* 1.0     
Vascular resistance 
(U) r=-0.05 r=0.08 r=0.17 r=-0.26 r=-0.5* r=-0.27 r=-0.87* 1.0    
Venous capacitance 
(mL/100mL/min) r=0.57* r=0.23 r=-0.15 r=0.63* r=0.42* r=0.6* r=0.34# r=-0.15 1.0   
Venous compliance 


















(mL/100mL/min) r=0.53* r=0.42* r=-0.51* r=0.76* r=0.56* r=0.95* r=0.43* r=-0.3‡ r=0.6* r=0.5* 1.0 
*p<0.05; #p=0.06 † p= 0.07. ‡p=0.08 
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5.5. DISCUSSION 
The main finding of this study was a unilateral improvement in regional peak forearm 
arterial inflow and vascular resistance following handgrip exercise training. Furthermore, 
the improvements were evident after the first week of training and appeared to plateau 
during the remainder of the study. These findings confirm data from animal models (35, 
61) as well as from human studies involving single conduit artery reactivity (2). 
Uniquely, this study indicates a significant decrease in venous compliance after 1 week of 
training followed by a gradual return to baseline measures over the remainder of the 
study. 
5.5.1. Effect of Handgrip Training on Arterial Indices 
Four weeks of handgrip training resulted in a 19% increase in regional peak arterial 
inflow. This increase confirms previous data from our laboratory (21%) (4) as well as 
others (25%) (65). Additionally, differences in peak arterial inflow and vascular 
resistance between the dominant (non-trained) and non-dominant (trained) forearms at 
visit 1 diminished by visit 2 suggesting vascular adaptations to habitual activities can be 
matched following only 1 week of training.  
The increased peak blood inflow in the trained arm without alterations in the 
contra-lateral arm vasoreactivity, cardiovascular hemodynamics (i.e. blood pressure, 
heart rate, and heart rate variability indices) and measures of cardiorespiratory fitness 
suggests that these adaptations are locally modulated. Although it is beyond the scope of 
this study to determine the mechanisms involved, these localized adaptations could 
involve either mechanical or chemical stimuli. The muscle contraction and relaxation 
phases associated with exercise training increase shear stress against the muscle bed 
arterial walls causing the release of endothelium-derived relaxing factor(s) (46). The 
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location of these changes is currently unclear. However, several studies have reported 
increase in vasodilator mRNA and proteins at the site of large conduit vessels (13, 14) 
while more recent studies suggest these changes occur in smaller distal vessels (36).  
Alternatively, local accumulations of metabolites and vasoactive substances in distal 
tissue beds could play a role in these adaptations. In fact, previous studies have shown an 
increase in oxidative enzyme activity may precede the increases in vasoresponsiveness 
(13).  
Other studies have suggested regional neurohumoral changes following handgrip 
exercise training (77). For example up-regulation of nitric oxide/prostacyclin is believed 
to inhibit the release of norepinephrine from adrenergic nerves (9) and blunt 
norepinephrine-mediated vasoconstriction (74). Handgrip exercise training also appears 
to result in attenuated sympathetic vasoconstriction (56) attributed to changes in muscle 
metaboreceptors (67), mechanoreceptors (63) or a combination of both (53). 
Additionally, Sinoway and colleagues demonstrated that this attenuation is accompanied 
by reduced norepinephrine arterial spillover and venous clearance (63). 
Additional potential candidates that may contribute to the changes in vascular 
reactivity include up-regulation of prostaglandin (35, 61) and endothelium-derived 
hyperpolarizing factor (47), increased sensitivity of arterial smooth muscle to 
vasodilatory agents (34, 69), smooth muscle sarcoplasmic reticulum calcium unloading 
(73) and reduced arterial wall sensitivity to endothelin-1 (28, 38). Clearly the 
speculations regarding the possible mechanism(s) for these adaptations need further 
refinement and experimental confirmation. Moreover, these speculations do not exclude 
the possibility of other plausible explanations for the regional vasoreactivity changes.  
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As depicted in Figure 5.1, post-occlusion blood inflow increased 13% after the 
first week, followed by a more gradual increase over the remainder of the training period. 
These results confirm previous data from our laboratory (2) and appear to be consistent 
with the hypothesis advanced by McAllister and Laughlin. The authors speculate that 
vascular endothelial function is enhanced after just a few days of training and these 
adaptations could serve to buffer the increase in shear stress experienced during exercise 
(47). Given that nitric oxide is an important signaling mechanism during exercise, and 
appears to be modifiable with exercise training, the nitric oxide system has emerged as a 
strong candidate responsible for the rapid changes in vascular reactivity. Both Wang et al. 
(75), and Sessa et al. (59) report an enhanced nitric oxide-mediated dilation in the dog 
circumflex coronary artery in vivo, following 7 and 10 days of chronic exercise training. 
More recently Johnson et al. (27) indicate increased acetylcholine induced relaxation and 
eNOS protein in porcine pulmonary arteries following 1 week of short-term training.   
Kingwell and colleagues speculate that exercise-induced adaptations aimed at 
meeting increased metabolic demands evolve from alterations in vasodilation to 
adaptations in metabolic enzymes and vascular restructuring (31). In fact, recent data 
suggest that nitric oxide contribution to exercise-training-induced arterial adaptations 
might be a signal for subsequent increase in arterial wall dimensions (40). Increased shear 
stress (6) and flow-mediated nitric oxide production (46), associated with rhythmic 
exercise, inhibits intimal thickening and promotes arterial diameter enlargement (12, 40, 
45). Wijnen and colleagues reported greater diameter of femoral but not brachial artery in 
cyclists as compared to age-matched controls (78). In a more recent study, the diameter 
of subclavian artery in the racket arm of tennis players was 19% greater than in the 
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opposite arm (26). Moreover, numerous studies have described exercise training-induced 
increases in cross-sectional area by either recruiting already existing or developing new 
vessels (24). These arterial structural alterations are associated with elevated skeletal 
muscle blood inflow (57), and are believed to normalize increased blood shear stress and 
to meet the increased metabolic demands associated with exercise training (12, 40, 52). 
The plateau following the 1st week suggests a possible diminishing role of the 
mechanism(s) involved in these early arterial adaptations. Since the individuals 
participated in the study were sedentary, it is not clear whether the current training 
regimen is sufficient to induce vascular adaptations in trained individuals. Therefore, 
future studies should examine the effect of greater intensity and/or longer exercise 
training program on arterial adaptations in sedentary as well as trained individuals. 
The unilateral improvements in vasoreactivity indicate that exercise benefits are 
specific to the trained arm confirming the importance of well-rounded exercise training 
programs as advocated by ACSM (1). Therefore endurance and resistive exercise training 
program targeting the heart and major muscle groups might be essential to induce overall 
vascular adaptations. This is particularly relevant given the role improved arterial 
function plays in blood delivery and perfusion, overall cardiovascular function, and 
exercise performance as well as in the prevention of cardiovascular diseases. In 1991, 
Silber et al. reported increased peak forearm arterial inflow following cycle endurance 
exercise training program (62). These findings were further confirmed following a 
combined endurance and resistance exercise training program in healthy middle age 
adults (44) as well as in patients with type 2 diabetes mellitus (42) and heart failure (43). 
Exercise training-induced improvements in arterial function were also observed in the 
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coronary circulation of animals (37, 51) as well as in patients with coronary artery 
disease (20), and recent myocardial infarction (25). Additionally, these arterial 
adaptations were associated with improved endothelial function and exercise capacity 
(42-44). 
5.5.2. Effect of Handgrip Training on Venous Indices 
As presented in Tables 5.4 and 5.5, four weeks of handgrip training did not result in an 
increase in forearm venous capacitance, compliance or outflow. In fact, venous measures 
in the trained arm, at rest, and following 5-minutes of arterial occlusion showed a 
consistent decline at the end of the first week followed by a gradual return to pre-training 
values by visit 5 (see Figures 5.3-5.5). Figure 3 depicts a significant drop in resting 
venous compliance in, the trained arm at visit 2 which remained below pre-training 
values during visits 3 and 4. 
The venous function responses to handgrip exercise training in this study are 
intriguing. Since these responses are previously unreported, they are difficult to compare 
to previous studies. However, the pattern of the data resembles the classic physiological 
theory known as the Stress-Response-Adaptation. Hans Selye hypothesizes that 
physiological stress causes an initial drop in physiological function followed by periods 
of recovery and adaptation (58). The behavior of the data in the present study may reflect 
the initial stress of training followed by a gradual recovery and beginning of an adaptive 
period. Given that venous compliance is mainly affected by the sympathetic nervous 
system (50, 76), regional elevation in sympathetic drive associated with the early phases 
of training (15, 56, 79) might result in venoconstriction. The increase in venoconstriction 
could lead to a reduction of venous blood volume in the forearm (15), which may account 
for the decline in venous function after the 1st week of training. Assuming that total 
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forearm blood volume remains the same following localized handgrip exercise training, 
increased venoconstriction might decrease venous volume by driving blood towards the 
arterial system. This theory may be supported by the concurrent increase in peak arterial 
inflow during the 1st week of exercise training. Further analyses of the present data 
revealed a weak relationship (p=0.023, r=0.58) between the magnitude of drop in venous 
function and the increase in peak arterial blood inflow at visit 2; but it is premature to 
suggest a direct link between those measures (see Figure 5.10).  
Resting venous compliance gradually increases during visit 2-5. This response to 
exercise training might be explained by two possible physiological changes. The 
persistence of the training stimulus may have resulted in an increased venous cross-
sectional area by either recruiting already existing or developing new venules (49, 70). 
Assuming the venoconstriction during the 1st week of training contributes to the increased 
arterial inflow, newly accessible veins may allow for the delivery of more blood away 
from the venous system into the arterial circulation. Additionally, venoconstriction may 
also be attenuated subsequent to the readjustments in the sympathetic/parasympathetic 
balance associated with exercise training (39). Although these mechanisms are simply 
mere speculation, they reflect the recovery and adaptation phases of Selye’s theory (58). 
The variations in training effect on the arterial and venous systems during the 
training period might be due to the fundamental differences in the arterial and venous 
structures and functions. For example, veins have thinner walls and are mainly composed 
of smooth muscles, fibrous proteins, collagen, and elastin tissues (19). Additionally, 
although an extensive neural network connects both sides of the vasculature, there are 
differences in adrenoceptor distribution that might cause differential vascular 
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responsiveness to sympathetic stimulation (68). Endothelium-dependent dilatation also 
appears to operate differently in the venous side as a result of reduced relaxation, 
vasoagent production and/or smooth muscle responsiveness (16, 60). Given these 
differences and the effect of handgrip exercise training on the sympathetic nervous 
system (56) and endothelial tissue (17, 33, 46), it is reasonable to observe greater 
stiffness, less compliance and subsequent lower venous outflow under such conditions. 
However, these speculations need further verifications in future studies. 
Moreover, the unilateral changes in venous compliance suggest a stress response 
mediated by regional neural reflex and/or adrenoceptor sensitivity changes. Alterations in 
metaboreceptors (67), mechanoreceptors (63) stimulation and/or a combination of both 
(53) have been proposed to induce attenuation in regional sympathetic activities. In the 
current study, cardiac autonomic modulation, supposedly a measure of autonomic 
nervous balance, did not change during the 4-week training program. However, heart rate 
variability might not be sensitive enough to detect localized neurohumoral changes. 
Therefore, future studies should probably examine the effect of exercise training on 
regional neurohumoral modulations of the venous circulation, particularly the 
venoarteriolar sympathetic axon reflex. 
The effect of an exercise training program with longer duration or higher intensity 
is unclear. Since the apparent increase in venous measures after visit 2 may lead to 
speculations regarding the adaptive changes using longer duration and/or higher intensity 
exercise training programs. Previous data from our laboratory showed a significant 
correlation between venous indices and handgrip strength as well as greater venous 
capacitance and outflow in individuals with higher handgrip strength. Individuals in the 
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higher strength group reported long-term involvements in resistance exercise training (3). 
Moreover, Wecht et al reported greater venous compliance and total venous outflow in 
“aerobically” trained individuals (76). As presented in Table 5.6 and Figures 5.6 and 5.7, 
results from the current study confirm the relationships between venous function indices 
and handgrip strength. Additionally, as in Figures 5.3-5.5, venous measures at visit 2 
gradually increased reaching baseline levels at visit 5. However since training ended after 
4 weeks, further venous adaptations to longer exercise training program are not known 
warranting future studies to examine the effect of different exercise training modes, 































Figure 5.7. Relationship between handgrip strength & resting venous outflow 
5.5.3. Relationship Between Arterial and Venous Functions 
Previous findings from our laboratory showed an association between forearm arterial 
and venous function indices (30). The results from the current study, as presented in 
Table 5.6 and Figures 5.8 and 5.9, confirm these relationships, suggesting inter-
communication between the arterial and venous circulations. Recent compelling evidence 
has emerged illustrating the importance of various aspects of the venous system beyond 
its typical role as a “passive volume reservoir”. For example, Tschakovsky & Hughson 
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reported greater arterial inflow with increased venous emptying following arm elevation 
(72). The authors linked these findings to the local venoarteriolar sympathetic axon 
reflex. The presence of nerve fiber collaterals from the sympathetic arteriolar plexus to 
adjacent venules reflex was initially described in 1991 by Rygaard et al., and may serve 































Figure 5.8. Relationship between post occlusion blood inflow & venous 
compliance 
 
Finally, evidence of cross-communication between the arterial and venous 
circulations indicates that venular endothelium releases a relaxing factor (s) that 
contributes to the vasodilatation of adjacent arterioles (21). Therefore, the relationship 
between arterial and venous function indices suggests that vasoreactivity and muscle 
perfusion may be influenced by venous hemodynamics, confirming the essential role of 
venous function in overall cardiovascular control, muscle perfusion and exercise 
performance (21, 72). Additionally, the correlation shown in Figure 10 between the 
decrease in venous compliance and the increase in arterial inflow following 1 week of 
handgrip training might further confirm the cross-communication between the arterial 
and venous circulations. The optimal location of the venous system in relation to the 
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arterial circulation may provide a mechanism for monitoring tissue metabolic status and 
potentially provide a valuable feedback mechanism for influencing the arterial 
reactivities. However more studies are certainly needed to further verify these 
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Data from the current study demonstrate a unilateral improvement in regional peak 
forearm arterial inflow and vascular resistance after the first week of handgrip exercise 
training and appeared to plateau during the remainder of the study. Additionally, the 4-
week training did not result in increase in venous capacitance, compliance, and outflow. 
However uniquely this study indicates a significant decrease in venous measures after 1 
week of training followed by a gradual return to baseline values over the remainder of the 
study. The unilateral responses to handgrip exercise training further advocate the 
importance of whole-body exercise training programs targeting major muscle groups as 
recommended by recent ACSM exercise guidelines. 
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CHAPTER 6. SUMMARY 
Four projects were conducted in partial fulfillment for the requirement of this degree. The 
main findings of these studies were arterial and venous measures are reproducible, can 
differentiate between populations, and are modifiable with exercise training.  
The results of the first study (chapter 2) indicate that a pressure of 7 mmHg < 
DBP and a period of 10 minutes venous occlusion produced the greatest venous 
capacitance and outflow, without altering arterial indices. Additionally, the examination 
of forearm vascular function indices using mercury strain-gauge plethysmography are 
reproducible and associated with fitness measures (estimated VO2peak and handgrip 
strength). The association between handgrip strength and venous system hemodynamics 
implies that muscular conditioning might be important for venous health, which warrants 
future studies examining the effect of muscular strength modifications on venous 
function. 
The results of the second study (chapter 3) indicate that arterial function indices 
are reduced in heart failure patients confirming previous studies (8, 15, 16). Additionally, 
venous capacitance and outflow are diminished and associated with maximum walking 
distance on a 6-minute walk test in heart failure suggesting the importance of venous 
function to exercise intolerance. 
The results of the third study (chapter 4) indicate unilateral improvements in 
arterial inflow following 4-week handgrip exercise training similarly for the LO and HI 
intensity groups. The unilateral improvements suggest that vascular adaptations are 
locally mediated confirming previous findings (11, 14).  
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The results of the final study (chapter 5) indicate unilateral improvement in 
arterial inflow and vascular resistance following 1 week of handgrip exercise training. 
Additionally, the exercise training resulted in a decrease in venous function indices 
followed by gradual increase to baseline values. The one week improvement in arterial 
function indices confirm previous findings from animals models (3) and human single 
artery (2) and suggest vascular adaptations to habitual activities can be matched 
following only 1 week of training. The venous function responses to handgrip exercise 
training in this study are previously unreported thus they are difficult to compare to other 
studies. However, the pattern of the data resembles the classic physiological theory 
known as the Stress-Response-Adaptation. Hans Selye hypothesizes that physiological 
stress causes an initial drop in physiological function followed by periods of recovery and 
adaptation (10). The unilateral responses to handgrip exercise training further advocate 
the importance of whole-body exercise training programs targeting major muscle groups 
as recommended by recent ACSM exercise guidelines (1). 
The findings regarding the venous system are particularly uniqe and relevant 
considering venous abnormalities in aging (6, 7), and patients with heart failure (5, 9, 13) 
and venous diseases (4, 12). Therefore, recognizing the contribution of skeletal muscle in 
venous return and overall cardiovascular performance during exercise, factors associated 
with muscle fitness modification might contribute to increased overall cardiovascular 
health subsequent to improved venous function, namely venous outflow and capacitance. 
However, it is recognized that the aforementioned studies are limited and more 
investigations are cairtainly needed to futher expand our knowledge regarding the effect 
of exercise training on the venous system.  
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SECTION 1. INTRODUCTION 
 
With the latest developments in technology various vascular functions can be measured 
in human, noninvasively, with minimum expense and relative ease. These functions 
include arterial inflow, vascular resistance, venous filling capacity, venous emptying rate, 
vessel diameter, vessel density, and volume changes. These recent advancements have 
created opportunities for unprecedented prospects in vascular physiology research. 
Presently, research is approaching integrative understanding of vascular function. This 
kind of understanding requires gathering information obtained from different vascular 
investigations and applying it to different conditions including exercise, diseases, 
pharmacological therapy and alternative therapy. Additionally relate this information to 
other physiologically-related disciplines including cardiology, neurology, endocrinology, 
microbiology as well as psychology.  
The main focus of this review is to discuss peripheral vascular function and 
control at rest and during activities as well as adaptations to exercise training. 
Additionally, vascular adaptations to diseases, the basic structure of the vasculature, 
physical characteristics of the circulation, and the available tools to assess vascular 
function are also discussed. This introduction is followed by seven sections. Section two 
of the review focuses on the basic structure of different segments of the vascular system 
including arteries, arterioles, capillaries, venules and veins. The wall component of each 
segment is described as well as the distribution and density of each segment throughout 
the body. The basic physical principles govern the circulation are discussed in section 
three. This section sheds the light on various vascular physical characteristics that 
contribute to the control of blood flow in the arterial and venous side of the circulation 
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including vessel diameter, vessel length, transmural pressure, and blood velocity. The 
relationship between pressure, vascular resistance, and blood flow as well as 
hemodynamics essential for the venous system are also explained. Section four is divided 
into two parts. The first part deals with central neurohormonal factors contribute to 
vascular function control whereas the second part addresses the peripheral aspect of 
vascular control. Acute responses and control of the vascular system to exercise are 
discussed in section five. Similar to section four the details of the central and peripheral 
aspects are addressed in this section. However, since the cardiovascular system is 
functionally integrated, cardiac as well as blood acute adjustments to exercise training are 
briefly discussed. Section six deals with vascular adaptations to exercise training. This 
section provides a review of some of the studies examined arterial as well as venous 
adaptations to exercise training. Exercises promote systematic vascular adaptations are 
first discussed followed by regional vascular adaptations to small muscle group exercises. 
In section seven, peripheral vascular adaptations to various diseases are briefly discussed. 
Finally section eight overviews some of the available techniques to measure peripheral 
vascular function.      
Since the subjects covered in this review spans over broad aspects of vascular 
physiology the author obtained information from various original articles, review articles, 
as well as textbooks. Additionally, text in this review is supported with illustrative figures 
and pictures selected from textbooks, review articles and original articles to explain some 
physiological phenomena covered in this review.         
This review is certainly less than complete, however it is an attempt to reveal the 
available knowledge pertaining to vascular physiology. Additionally, this review is 
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expected to serve as a self-learning tool and platform for future self-advancements in 



































SECTION 2. VASCULAR SYSTEM STRUCTURE 
Blood vessels of the body form a closed delivery system that allows blood to be 
transported from the heart to the capillaries and back to the heart.  Oxygenated blood 
leaving the heart passes through vessels of progressively smaller diameters referred to as 
arteries, arterioles and capillaries [1, 2]. On the other hand, deoxygenated blood, 
returning to the heart from the capillaries, passes through vessels of progressively larger 
diameters called veins (figure 2-1). The capillaries, which link the arterial side to the 
venous side, permit the exchange of nutrients and waste products between blood and 
living cells [1, 2]. This section will focus on the general structure of the peripheral 
vascular system. The functional anatomy details of all the vasculature segments, 
including arteries, arterioles, capillaries venules and veins, will be discussed.     
2.1. ARTERIAL SYSTEM 
There are two great arteries that emerge from the heart, the aorta from the left ventricle 
and the pulmonary artery from the right ventricle. The arteries are efferent vessels that 
carry blood away from the heart to the capillary beds throughout the body. All arteries in 
the body transport oxygenated blood from the heart to body tissues except the pulmonary 
vascular tree that carries deoxygenated blood from the heart to the lungs [2, 3]. 
Therefore, the most reliable way to classify blood vessels is by the direction in which 
they carry blood, either toward or away from the heart. Every artery enters an organ 
branches into 6-8 smaller vessels to become arterioles while arterioles branch 2-5 times 





The lumen, the central canal of all blood vessels, is formed from a thick wall composed 
of three layers or tunicae. These tunicae are tunica intima, tunica media and tunica 
adventitia [5]. The tunica intima, the innermost layer, has a lining of endothelial cells, a 
thin subendothelial layer of fine areolar tissue, and an internal elastic layer called the 
internal elastic lamina (figure 2-1 & 2-2). The tunica media (the middle layer) is the 
thickest layer of the arterial wall in large arteries [2, 3]. 
 
Figure LR2.1. Vessel wall characteristics 
Internal diameter, wall thickness, and relative amounts of the principle 
components of the vessel walls of the various blood vessels that compose the 
circulatory system. Taken from [6]. 
 
It is composed mainly of connective tissues, smooth muscle cells and elastic fibers. The 
tunica media of the largest artery walls have more elastic tissue than smooth muscle, 
whereas smaller arteries contain more smooth muscle cells than elastic fibers [5]. The 
greater prevalence of elastic tissue helps larger arteries to stretch in order to adjust for the 
large change in pressure as the ventricles contract forcefully and pump blood into these 
type of vessels. For example, the aorta and pulmonary wall elasticity allows these vessels 
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to adjust for the pressure created by the ejected blood from the ventricles [3].  The 
outermost layer of the vessel, the tunica adventitious, is mainly made of collagen and 
elastic fibers with some smooth muscle fibers extending longitudinally next to the outer 
border of the tunica media. This layer comprises nerves and lymphatic vessels in addition 
to a capillary network formed by small vessels called “vasa vasorum” to nourish the walls 
of large arteries (> 20 mm) [4, 7].  
 
Figure LR2.2. Typical elastic artery. 
Shown different segments of a vessel. Taken from [8]. 
 
2.1.2. Arterioles  
Arteries located further away from the heart branch into smaller and smaller vessels, then 
into arterioles shortly before merging with the capillaries. The arterioles contain more 
smooth muscle cells (figure 2-1 & 2-2). Arterioles and capillaries are connected by 
structurally intermediate vessels called terminal arterioles or metarterioles [7]. The 
metarterioles are wrapped around by highly innervated nerves and smooth muscles to 
form precapillary sphincters however they do not have an internal elastic layer or their 
 104
own blood vessel supply. When these sphincters contract, blood flow is routed bypassing 
the capillary bed, however when the sphincters are relaxed, blood flow to the capillary 
bed and surrounding tissues increases [7]. The opening of the sphincters depends on the 
metabolic needs of the surrounding tissues. As the metabolic activities of the surrounding 
tissues increase the sphincters are opened to increase blood perfusion. Whereas when the 
blood supply is no longer needed in larger quantities, the sphincters close [3, 7]. [4]. 
Therefore arterioles and metarterioles, due to their high content of smooth muscles, 
sympathetic innervations, and location are the segments of the arterial tree most 
responsible for mediating flow of blood to the capillaries [7, 9].  
2.2. CAPILLARIES  
As terminal arteries extend further away from the heart they branch out to form 
capillaries. The capillaries run throughout all body tissues to form capillary beds in each 
tissue. This serves as a point of connection between the arterial system and venous 
system. Capillaries are the most abundant blood vessels, which give them an enormous 
surface area available for exchange of gases, fluids, nutrients, and waste products 
between blood and nearby cells (figure 2-3) [5, 10]. They are the smallest among all 
vessels with a diameter of 8-10 µm, which is just large enough for the passage of one 
erythrocyte (figure 2-1). For example, the diameter of a medium-sized capillary is about 
500 and 600 times smaller than a medium-sized artery and vein respectively. However, 
capillary diameters vary depending on the function of the tissue that is being supplied [5]. 
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Figure LR2.3. Blood volume distribution in different 
compartments of the circulation. 
Taken from [2]. 
 
Capillary walls are mainly composed of only a tunica intima layer that contains 
endothelial cells on a thin basement membrane of glycoprotein (figure 2-1) [3, 11]. The 
endothelial cells are held together by tight junctions to prevent small molecule passage. 
However, these junctions have gaps of unjoined membranes called intercellular clefts to 
allow for molecular movement across the capillary wall [6]. However in areas where high 
rate of molecular exchange is required, there are fenestrations or pores that penetrate the 
endothelial tissue to increase the capillary permeability for small molecules. These kinds 
of capillaries are called fenestrated capillaries. They are found in areas like the small 
intestine and the synovial membranes of joints, as large quantities of fluids and nutrients 
are exchanged with blood. In low molecular exchange areas (i.e. skeletal muscle, skin, 
and the central nervous system) are fed with continuous capillaries, in which the 
endothelial tissues contains no pores or fenestrations [2, 3]. Most of the small molecules 
are transported across capillary walls through the intercellular cleft. Moreover, 
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cytoplasmic vesicles that invaginate from the plasma membrane and migrate across the 
cell are used to move larger molecules across. Whereas oxygen and carbon dioxide seem 
to be the only important molecules transported through diffusion [2].  
2.3. VENOUS SYSTEM 
As blood passes through capillary beds, it gets depleted of oxygen and nutritional 
molecules and loaded with by-products (i.e. carbon dioxide and hydrogen ions). 
Additionally blood pressure is reduced due to the high-resistance in arterioles and 
capillary beds. Moreover, blood returns back to the right atrium through the smaller 
venules then to the larger veins until it reaches the largest veins in the body, which are the 
superior and inferior vena cava [11, 12]. Therefore, veins receive blood from smaller 
vessels instead of giving blood off to branches as arteries do. Veins are more abundant 
than their counterpart arteries and are located superficially beneath the skin as well as 
deeply in body tissues (figure 2-3) [1, 3, 13].  
2.3.1. Venules 
Thoroughfare channels serve as an extension and are structurally intermediate between 
capillaries and venules. These channels are connected to postcapillary venules, which are 
the smallest of all veins. Postcapillary venules comprise of a thin layer of endothelium 
and sometimes function like capillaries as inflammatory fluids and leukocytes leave 
circulation through them. Whereas the larger venules consist of one or two layers of 
smooth muscle cells, a tunica media as well as a thin tunica adventitia (figure 2-1 & 2-4) 
[3, 5, 12]. 
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Figure LR2.4. Typical vein.  
Shown longitudinal cut for a medium-
sized vain. Emphasized the valves and 
different layers compose the venous 
vessel. Taken from [8]. 
 
2.3.2. Veins 
As blood approaches the heart through the circulatory system venules get larger to form 
veins. Opposite to their arterial counterpart, the tunica adventitia in veins is thicker than 
the tunica media. Moreover, the vein walls are thinner with larger lumens and contain 
less elastic tissue, collagen tissue, and smooth muscle thus veins are very distensible and 
comprisable (Figure 2-1) [5, 13].  
Blood pressure is considerably lower in the veins than in the arteries, which 
reduces the propelling power of the blood as it travels back to the heart [13, 14]. Venous 
valves prevent blood from flowing backwards and assist in moving blood toward the 
right atrium. These valves are formed by the in-foldings of the tunica intimae, where each 
fold forms a bicuspid valve [3, 13]. Venous valves are more prevalent in the lower 
extremities where blood is moved against gravity. Further, fewer valves are found in the 
head and neck veins and there are none in the veins of the thoracic and abdominal 
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cavities. Additionally the compression of the venous walls by contracting skeletal muscle 












































SECTION 3. CIRCULATORY HEMODYNAMICS 
The primary function of the peripheral circulation is to deliver oxygenated blood to 
tissues around the body and transport deoxygenated blood back to the heart. Meanwhile it 
also transports other essential chemical substances (e.g. hormones, enzymes, and 
minerals) to maintain the survival of the living cells [3]. In order to accomplish these 
physiological essentials blood flow is shunted according to tissue metabolic requirements 
for substrate delivery and waste removal, which differs during the course of various daily 
life situations. For example, skeletal muscle’s demand for nutrients and oxygen during 
exercise is higher than its needs during resting condition. Likewise, the nutritional 
requirements for stomach smooth muscle increase following a big meal [2, 6]. Several 
aspects within the cardiovascular system interact together to achieve proper substrate 
delivery and waste removal including cardiac muscle pump, vascular function, and blood 
volume. These functions are further controlled by neurohumoral modulation, electrolyte 
balance, and tissue metabolic activities [7].  
The vascular system plays a profound role in controlling the flow of blood to 
tissues throughout the body. The parallel arrangement throughout the vascular system 
allows for proper blood flow to organs around the body [2]. Small arteries and arterioles 
are the principal site of blood flow control where terminal arterioles act as “stopcocks” to 
accurately alter blood distribution to these organs according to their needs (figure 3-1). 
However due to its structure and arrangement the vasculature is governed by physical 
principles that control blood flow  [6]. This section will review the functional physical 
principles of the peripheral vascular system.   
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Figure LR3.1. Schematic diagram of 
the parallel and series arrangement of 
the vessels composing the circulatory 
system.  
The drawing shows small valves, 
“stopcocks” likes, to control blood 
inflow representing vascular 
resistance on the arterial side (on the 
right). Larger venous diameter is also 
shown indicating the capacitance 
specialty of the venous system. Taken 
from [15].   
 
3.1. GENERAL PHYSICAL PRINCIPLES OF PERIPHERAL CIRCULATION 
The vasculature is divided into arterial, capillary and venous systems and proceeds within 
the body in the order of arteries, arterioles, capillaries, venules and veins. Vessels of the 
arterial system progressively get smaller in diameters, reaching the smallest as they 
approach the capillary beds. This is in contrast to the diameter of the venous system, 
where vessels get larger as they reach the heart [16]. The capillaries operate as an 
exchange structure for metabolic substances between blood and tissues whereas the 
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arteries and veins serve as distribution and collecting structures, respectively, for blood 
[5, 17].  
The systemic circulation contains the largest blood volume (83%) of total blood 
volume with 64% stored in the veins, 16% in the arteries and 4% in the capillaries. 
Additionally, 8% is in the pulmonary circulation and 4% is usually within the heart 
chambers (figure 3-2) [2].  
 
Figure LR3.2. Blood volume distribution in different 
compartments of the circulation.  
Taken from [2]. 
 
The capillaries have the largest total cross-sectional area (2500 cm2) allowing for 
sufficient blood/tissue exchange. In addition, the total cross-sectional area of all veins is 
338 cm2, which is about four times that of arteries (62.5 cm2) (figure 3-3)[1]. Blood 
pressure also fluctuates at different segments of the peripheral circulatory system 
averaging approximately 100 mmHg at the aortic level and progressively declining to 
pressures approaching 0 mmHg in the venae cavae (figure 3-3). This drop in blood 
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pressure is a function of blood flow rate and peripheral resistance within the circulation, 
as will be explained later [6]. 
 
Figure LR3.3. Changes in blood pressure and 
velocity at different cross-sectional areas.  
Taken from [18]. 
 
3.2. VASCULAR DISTENSIBILITY 
The vascular system has an astonishing capacity to accommodate large changes in blood 
volume across all vessel segments due to vascular distensibility [19]. This physical 
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feature is characterized as the ability of the vasculature to expand and described as the 
volume of fluid needed to increase pressure by one unit. In other words, it is the ratio 
increase in volume for each millimeter mercury increase in pressure and could be 
expressed in the following formula [3, 20]: 
Vascular distensibility is vital for proper blood pressure control and to 
accommodates the pulsatile output of the heart. Additionally, it provides smooth and 
continuous flow of blood through the tissues by averaging out the pressure pulsations so 
that tissue blood flow will not be disrupted [20]. Arteries are far stronger and less elastic 
than the veins due to thicker walls and a greater smooth muscle content. Therefore, veins 
are about 6-10 times more distensible than their arterial counterparts, making them the 
ultimate blood reservoir within the circulatory system [21, 22]. 
Capacitance is similar to and influenced by distensibility however these two 
physical characteristics of the vasculature are not identical. Vessel capacitance or 
compliance is the ability to accommodate changes in volume for changes in pressure 
when fluid is added. Thus capacitance describes volume-pressure relationship with 
respect to blood vessel size and volume added as stated in the following formula [3]:  
All of the cardiovascular system compartments, including the heart, are 
considered capacitance vessels since they contain volume. However as the veins hold 
~70% of the circulating blood and large changes in veins’ volume cause little changes in 
pressure they provide the major capacitance function in the circulation [15]. Distensibility 
Vascular distensibility = Increase in volume*Original volume/increase in pressure 
Vascular capacitance = Increase in volume/increase in pressure  
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V=Q/A,  
Where V=velocity, Q=flow and A=area. 
decreases with aging as the lining of the vasculature becomes infiltrated with less elastic 
fibers. Additionally diseases (i.e. diabetes & atherosclerosis), changes in autonomic 
nerves balance, and various drugs might further increase the rigidity of the vascular 
system [2, 23, 24]. 
3.3. BLOOD VELOCITY AND BLOOD FLOW 
It is important to distinguish between blood velocity and blood flow in order to describe 
the hemodynamics of the peripheral circulatory system. Velocity is referred to the linear 
velocity or rate of blood displacement with respect to time and has properties of distance 
per unit time, for example, cm•sec-1. Meanwhile, flow is volume or quantity of blood 
passing through a certain point in the circulation in a given time and has properties of 
volume per unit time, such as, cm3•sec-1 [3, 16].  
For a given constant flow, the velocity varies inversely as the cross-sectional area. For 
example when 10 cm3•sec-1 of blood passes through a vessel with a cross-sectional area 
of 2 cm2, its velocity is 5 cm•sec-1. However velocity drops down to 1 cm•sec-1 when the 
cross-sectional area is 10 cm2 and it elevates to 10 cm•sec-1 when the cross-sectional area 
is 1 cm2 (figure 3-4) [3]. This relationship is expressed in the equation [16]: 
Velocity throughout the circulation depends on blood flow. Flow, which 
decreases as blood proceeds in the circulation, depends on blood pressure, fluid 
properties of blood and dimensions of the circulatory system [25]. Therefore, due to 
reduction in flow, blood velocity decreases as it proceeds in the peripheral circulation 
until blood reaches the capillaries. However, as blood drains out of the capillaries, blood 
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progressively gains velocity again as the venules continue to propel blood toward the 
venae cavae and the heart (figure 3-3) [3]. 
 
Figure LR3.4. Relationship between cross-sectional 
area, A, and velocity, v, in the systemic circulation.  
Taken from [6]. 
 
3.4. FLOW, PRESSURE AND RESISTANCE 
Blood flow (cardiac output) and peripheral resistance interact to create appropriate 
pressure (force) throughout the vasculature to deliver blood to needed tissues. This 
relationship is expressed in Ohm’s law [26]: 
This law states that cardiac output is directly proportional to pressure and inversely 
proportional to resistance. The heart pump eventually generates cardiac output whereas 
resistance depends mainly on vessel shape (length and diameter), blood viscosity, and 
type of tissue involved [3, 16]. 
3.4.1. Blood flow 
Total body blood flow or cardiac output (Q) at rest is about 5,000 ml•min-1 and increases 
to 35,000 ml•min-1 with a rise in tissue activities (i.e. exercise). Its called cardiac output 
because it is the quantity of blood pumped by the heart in volume unit per time [15]. 
Q=P/R  
Where Q is cardiac output, P is pressure and R is resistance 
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Laminar and turbulent flow 
Under normal conditions, the flow of fluids in a cylindrical tube is laminar. The thin fluid 
layer adjacent to cylinder wall is extremely slow or even maybe motionless (figure 3-5).  
 
Figure LR3.5. Laminar and turbulent blood flows within a vessel.  
Emphasized vortices develop from turbulent flow. Taken from [18]. 
 
However the fluid layer interior to this external layer must shear against this “motionless” 
layer and therefore move a bit faster. Similarly layers that are more interior, follow suite 
and travel more rapidly. Therefore, the velocity of fluid at the center of the laminar is 
maximal and is twice the mean velocity of flow across the entire cross-section of the tube 
(figure 3-6). In laminar flow, substances remain in one lamina as the fluid proceeds 
longitudinally along the tube [3, 27].     
 
Figure LR3.6. Laminar flow depicts the motion of a series of thin, concentric 
cylindrical shells sliding over each other.  
Velocity is higher as the shell position is closer to the central axis. Taken with 
permission from [27]. 
 
Turbulent flow of fluid in a tube however might develop forming eddies and 
vortices (figure 3-5). Under these conditions, rapid mixing occurs causing fluid elements 
not to remain in one definite laminae. Therefore, turbulent flow requires considerably 
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greater pressure than laminar flow to drive fluid through the same tube. This in turn 
requires a pump, such as the heart, to work harder to generate a given flow if turbulence 
develops. Reynolds’ number is a dimensionless number that represents the ratio of 
inertial to viscous forces for a fluid flowing through a cylindrical tube:  
 
When NR <2000, the flow usually is laminar; and it would be turbulent when NR >3000. 
Reynold’s number between 2000-3000 is in transition phase where both types of flows 
might exist. Thus Reynold’s number principle indicates that large diameter, elevated 
velocity, and low viscosity are sources for turbulence flow. Additionally, abrupt 
variations in tube dimensions or irregularities in the tube walls may produce turbulence 
[3, 27].    
3.4.2. Blood pressure 
Blood pressure is the force exerted against any unit area of the vessel wall by the blood. 
The rhythmic contraction of the heart generates this pressure during the left ventricular 
contraction and relaxation phases of the cardiac cycle [6]. Blood ejected from the left 
ventricle surges into to the aorta creates a pressure gradient throughout the entire vascular 
system. A portion of the ejected blood is stored by the aorta, which allows it to stretch 
and then recoil during ventricle relaxation, and drives the blood in pulsatile manner. In 
preparation for the next contracting phase the left ventricle expands and the left atrium 
contracts to drive blood to the left ventricle [4]. A pressure of 50 mmHg means that the 
force exerted is sufficient to push a column of mercury up to a level 50 mm high. 
However pressure is also measured in centimeters of water. Thus, a pressure of 10 
NR=ρDv/η 
Where D is the tube diameter, v is the mean velocity, ρ is the density, and η is viscosity 
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centimeters of water means that the force exerted is sufficient to push a column of water 
for 10 centimeters. 1 mm Hg = 1.36 centimeters of water [3, 26].       
Systolic blood pressure (SBP) 
During the contraction (systole) phase of the cardiac cycle pressure generated by the 
heart at rest is about 120 mm Hg. This measurement is usually referred to as pressure in 
the brachial artery at the level of the heart. Additionally, it is an estimate of the work 
generated by the heart and of the strain against the arterial walls during ventricular 
contraction [26]. Following contraction, the ventricle relaxes, however the elasticity of 
the arterial system maintains a driving pressure for steady flow of blood to the periphery, 
until the next surge of blood arrives [3].  
Diastolic blood pressure (DBP)   
Blood pressure in the brachial artery decreases to about 80 mm Hg during the relaxation 
(diastole) phase of the cardiac cycle [26]. The recoiling aorta and the contraction of the 
atrium maintain this pressure. Diastolic blood pressure is indicative of peripheral vascular 
resistance especially at the level of arterioles and capillaries [3].  
Mean arterial pressure (MAP) 
Due to a longer diastolic phase, the mean pressure across the circulation is not simply an 
average of systolic and diastolic pressures. However it is estimated from the following 
equation [3]:  
This formula provides an optimal estimation of MAP during rest. However when the 
intensity of physical stress changes (e.g. exercise or sleeping) and the length of the 
diastolic period is altered (e.g. an increase or decrease in heart rate), accuracy of the 
estimation is changed [3].  
MAP = DBP+[(SBP-DBP)/3] 
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Shear stress 
Shear stress is the external force applied against the arterial wall as blood is propelled 
down the arterial tree. This stress is the product of blood viscosity and shear rate as it 
would increase when viscosity and/or velocity of blood increases [28]. The stress of shear 
produces a differential motion in the layers of the flowing blood through the circulatory 
system thereby blood exerts shearing stress on the surface of the arterial wall in contact 
with blood. Shear stress is essential for the homeostasis of the vascular system as it 
stimulate the release of vasoactive agents, influence vessel wall structural remodeling and 
plays a role in the pathogenesis of the vascular system [29].   
Volume-pressure relationship 
The relationship between blood volume and pressure in the peripheral circulatory system 
is described with volume-pressure curves. Pressure in the arterial and venous systems is 
influenced by volume of blood within the circulation, however due to differences in wall 
structure each responds differently to changes in volume [19]. The walls of the arterial 
system have stronger smooth muscles and are thereby far less expandable than veins. 
Therefore slight modifications in blood volume result in huge changes in arterial 
pressure, whereas slight changes in venous pressure require tremendous changes in 
volume [22]. For example, mean arterial blood pressure would decrease from 100 to zero 
mmHg when blood volume drops from 750 ml to 500 ml. On the other hand blood 
pressure in the venous side decreases from 15 to 5 mmHg as a result of volume reduction 
of 500 ml (figure 3-7). Volume-pressure relationship is largely influenced by changes in 
vascular smooth muscle tone (i.e. due to changes in sympathetic drive) (figure 3-7) [3, 
20]. 
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Blood volume can continuously change within the circulation segments, however 
blood pressure integrity must be maintained to assure proper flow of blood to needed 
tissues [6]. Delayed compliance is a valuable mechanism by which changes in volume are 
accommodated in the circulation. An increase in blood volume will first cause a rise in 
blood pressure followed by a stretch in the vasculature, allowing pressure to be adjusted 
back to normal values. Vise versa, reduction in blood volume will cause a rapid drop in 
blood pressure, however the smooth muscle fibers readjust their tension to allow blood 
pressure to increase back to proper values. This mechanism is vital when a large loss (e.g. 
hemorrhage) or extra increase (e.g. infusion) in blood volume is exhibited within the 
circulation [15, 27].        
 
Figure LR3.7. Volume-pressure curves within the circulatory system.  
Shown the effects of sympathetic stimulation and inhibition. Taken from [3]. 
 
Vasculature wall tension 
Tension in the vascular wall is a function of vessel radius, vessel thickness and 
transmural pressure across the vessel. Transmural pressure in turn is the difference 
between inside and outside pressure. The exerted force on the inner side of the vessel 
wall causes the internal pressure, whereas external pressure is the combined pressure of 
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the vessel-surrounding environment. The relationship between these factors is expressed 
in LaPlace’s theory, which is [6, 27]:  
 
LaPlace’s theory indicates; wall tension increases as a result of transmural 
pressure increase, vessel radius increase or thickness decreases. In a normal vessel, radius 
and thickness are in approximate proportion, however wall tension differs as transmural 
pressure changes and the two will tend to stay in reasonable equilibrium (figure 3-8). 
Reaching this equilibrium is particularly important to avoid vessel walls from bulging. 
For example aortic aneurysm is due to weakening of particular point in the wall of the 
vessel [27]. Due to increased wall tension, this weak site will soon bulge, causing a 
decrease in wall thickness and an increase in the radius of the aorta, which will further 
weaken the aortic wall. This cycle of deterioration might require surgical restoration to 
avoid further damage or rupture of the wall [2]. 
Arterial pulse pressure 
The distensibility of the arterial system plays a role in tissue blood flow during the 
diastolic phase of the cardiac cycle. After blood surges from the heart with each vertical 
contraction the aorta expands then recoils to assist pumping blood through the 
vasculature during diastolic phase of the cardiac cycle, which causes pressure pulsation. 
Pulse pressure is estimated as the difference between systolic and diastolic pressure, 
Pt = Pi - Pe,  
Where Pt=transmural pressure, Pi=internal pressure, Pe=external pressure 
 
PtR 
T = ------------  (LaPlace’s theory) 
 µ  
Where T=Tension, R=radius, and µ=thickness 
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which would be ~ 40 in young normal adults. However, vascular resistance causes 
pressure pulsation to diminish as blood proceeds within the vasculature, thus minimizing 
its influence on tissue blood flow. Pulse pressure is influenced mainly by stroke volume 
and arterial compliance. For example, a greater stroke volume would require greater 
accommodation by the arterial tree thereby greater differences between systolic and 
diastolic blood pressures [2, 3]. 
 
Figure LR3.8. Pressure-volume-tension relations as described by Laplace's law  
Left (A); normal vessel. Right (B); aneurysmic vessel due to athrosclerotic 




Resistance is the combined forces in the circulation that obstruct the flow of blood to the 
periphery.  Direct measurement of resistance is not available, however it could be 
estimated using Ohm’s low (R=P/Q) and expressed in arbitrary unit (U). Blood viscosity, 
structure of vessels (diameter, length, and arrangement), and blood flow are factors that 
influence vascular resistance, which are included in Poiseuille’s law of fluid conductance 
in tubes.    
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Poiseuille’s law 
In 1846 J.L.M. Poiseuille demonstrated the relationship between steady flow and pressure 
in a cylindrical tube.  He discovered that the relationship between volume flow (Q) and 
the drop in pressure (P) along a tube of a given length (L) and inner diameter (D) was 
[30]: 
The coefficient K was found to be independent of Q, P, L, and D and changed with 
alterations in temperature. However, in subsequent developments, Wiedemann in 1856 
and Hagenbach in 1860 found that K was related to blood viscosity (K=π/128η); where η 
is viscosity and expressed in 1 dyn sec.cm2 or poise. Therefore, in the light of these 
developments, Poiseuille’s law has become [31]: 
This edition of Poiseuille’s law states that flow is directly proportional to 
difference in pressure between two ends of a vessel and the radius of that vessel. 
Additionally, blood flow is inversely proportional to the viscosity of blood and the length 
of the vessel (figure 3-9) [27].  
Q=KPD4/L. 
Q= π∆Pr4/8ηL 




Figure LR3.9. The relationship between vascular resistance and blood inflow as 
described by Poiseuille's law in a straight vessel.  
Taken from [18]. 
 
The theoretical derivation of this equation however describes steady laminar flow 
in rigid cylindrical tubes and not the pulsatile flow through elastic vessels as in the body. 
Additionally, Poiseuille’s law is based on the assumption that each liquid particle moves 
at a constant velocity (v) in parallel to the cylinder wall, and that the force opposing this 
motion is proportional to viscosity and to the velocity gradient perpendicular to the 
direction of flow [27]. 
In the vascular system, length of the vessel plays an important role in determining 
the magnitude of resistance to blood flow. The longer the vessel the larger the pressure 
gradient needed to propel the blood further. As the vascular system progresses through 
the body, vessels divide and increase in number forming an in-parallel arrangement 
within each vascular bed. The increasing number of vessels causes each segmental cross-
sectional area for blood/tissue exchange of materials to increase also. However if this 
increase in vessel number and cross-sectional area didn’t occur and each microvascular 
beds were connected end-to-end, an in-series vascular beds or resistance would be 
formed. The total resistance of these in-series resistances equals the sum of the individual 
resistances, which adds up to an enormous resistance against flow. Therefore, such 
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arrangement makes it extremely difficult for the cardiovascular system to function given 
the large pressure needed to drive blood flow through, even for resting condition, let 
alone under stressful condition (e.g. exercise) [15, 27]. However, typically multiple 
vascular beds are created from one vessel forming in-parallel resistance (figure 3-10). In 
this situation, the total resistance equals the sum of the reciprocals of the individual 
resistances, which is obviously far less than in-series resistance [6]. 
 
Figure LR3.10. Vascular resistance in-series and in-parallel circuits.  
Taken from [18]. 
 
According to Poiseuille’s law, a slight change in vessel diameter causes a 
tremendous change in flow due to the fourth power and is attributed to the physical 
characteristics of blood flow [27]. In laminar flow, blood velocity is minimum in the 
layer adjacent to the vessel wall and progressively increases until it reaches maximum at 
the center of the lamina. In a narrow vessel, where a lot of the blood is very close to the 
vessel wall and minimum volume of blood is flowing centrally blood would be flowing 
slowly. In contrast vessels with larger diameter where more blood is flowing centrally, 
average blood flow would be faster (figure 3-12).  
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Figure LR3.11.  A; Relationship between blood flow and vessel diameter. B; 
Velocities of different concentric layers of blood flow, layers in the center are the 
fastest.  
Taken from [3]. 
 
For example when a pressure gradient of 100 mmHg is applied to drive blood 
through three separate blood vessels with diameters of 1, 2 and 4, blood flow will be in 
these three perspective vessels 1 ml/min, 16 ml/min and 256 ml/min, respectively (figure 
3-12) [3]. One third of peripheral resistance is in the small arterioles, which have internal 
diameter that ranges between 8 to 30 µm with a tremendous capability of changing their 
diameter by about 4 folds. A 4-fold increase in vessel diameter could increase the flow by 
as much as 256 folds. This phenomenon allows arterioles to have an important role in 
vascular resistance and to be very effective in changing blood flow to tissues as a result 
of central nervous system or local neurohumoral signals [3].  
Viscosity of blood also contributes to total vascular resistance. Percent of blood 
cells and solid matters in blood vessels are called hematocrit and determines viscosity of 
blood [6]. Hematocrit level usually averages about 40% of blood plasma, which is about 
3 times as great as viscosity of water. However an increase in hematocrit to 60 or 70% 
form a viscosity as great as 10 times of water [3]. Concentration of hematocrit in plasma 
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depends on gender, disease status, degree of bodily activity and altitude at which a person 
reside.  Higher blood viscosity generates greater friction created by dragging blood cells 
and matters against adjacent cells and vessel wall. This friction is the source of resistance 
created by viscosity of blood to flow across the circulation [27].  
3.5. VENOUS HEMODYNAMICS 
According to the Frank-Starling theory of contraction, the heart can pump only what 
passively fills it during diastole. The venous system operates as a collecting reservoir for 
blood and controls the quantity of blood returning back to the right atrium. Consequently 
cardiac output is primary regulated by venous return and the resultant end-diastolic 
volume by a simple mechanism of filling and stretching the left ventricular muscle fibers 
[32]. The Frank-Starling law involving the end-diastolic volume however is not the only 
factor influences cardiac output. Cardiac contractility, heart rate, and arterial pressure are 
also important factors [33].  
Low intra-vascular pressure, large volume present, intermittent nature of the flow, 
gravitational effect, venous valves, and the collapsible nature of the venous wall add 
complicity to flow in the venous cavity. Therefore, there are supplementary factors 
assisting the flow of blood in within the venous tree [20].  
Flow of blood runs with no resistance in large veins when they are distended 
however as veins enter the thorax and abdominal cavities flow is impeded. Most veins are 
compressed at many points by the surrounding tissues and the intra-thorax and abdominal 
pressures, which obstructs flow of blood to the heart chambers [27]. Pressure in the right 
atrium also hinders blood returning back to the heart from the systemic circulation. 
Pressure in the right atrium might sometimes increase above 0 mm Hg (e.g. heart failure), 
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causing blood to backup [32]. However pressure in the venous system doesn’t increase 
until all collapsed segments between peripheral veins and large veins have opened, which 
doesn’t occur until right arterial pressure reaches 4-6 mm Hg.  A further increase in right 
atrial pressure would reflect a progressive pressure increase in large veins [33, 34]. 
However, pressure elevation in the right atrium doesn’t usually occur except under acute 
circumstances, such as exercise and heart failure [35].      
During quiet standing, gravitational effects cause the drainage of thorax blood to 
the lower parts. Instantly skeletal muscles surrounding the veins start contracting and 
pushing against the veins to propel blood toward the heart [2, 15]. Meanwhile, the veins 
refill during muscle relaxation. In this case skeletal muscle is acting as a pump, which is 
clearly demonstrated during exercise as it plays a more effective role in driving blood 
toward the heart during exercise. While exercising, larger cardiac output is indeed 
required for tissue metabolic needs. This is facilitated in part by increasing skeletal 
muscle contraction force to enhance venous blood flow to the heart thereby increasing 
end-diastolic volume and cardiac output. However increased venous return and filling 
capacity is offset due to increased heart rate during exercise [15]. 
The contraction of the venous smooth muscle also plays a role in driving blood 
toward the heart, however its contraction depends on the intra-vascular pressure. The 
venous wall movement is mainly passive at low pressure, however when venous pressure 
increases above 5 mmHg wall tension increases providing an active role of the venous 
tone. Venous tone is controlled mainly by central and local neurohumoral signals [2, 27]. 
While the skeletal muscle pump and venous tone is important to propel blood 
forward, the venous valves prevent retrograded flow. Following skeletal muscle 
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contraction and propelling blood forward, the valve cusps close and the veins refill 
rapidly, which allow for unidirectional flow [13, 20]. However in some venous disorders 
(e. g. inflammation of the vein or congenital defects), venous valves become 
incompetent. As a result of this venous deficiency valves don’t close properly allowing 
for blood to back flow, which tends to increase venous congestion and venous pressure. 
Consequently venous return is reduced causing fatigue associated with painful sensation 
in the congested areas of the venous system [36].  
The intra-thorax pressure varies during quiet breathing from –2 to –4 mm Hg 
during expiration to about –5 to –7 during inspiration. The intra-abdominal pressure 
decreases when intra-thorax pressure increases, which facilitates venous return form the 
intra-thorax veins thereby increase thoracic vena cavae flow of blood and venous return. 
The resultant changes in flow inside the veins cause ±25% changes in cardiac output 
during respiration. This change in cardiac output is even more pronounced during 











SECTION 4. CONTROL OF VASCULAR FUNCTION 
Changes in blood vessel diameters are the underlying factor that control blood flows in 
the arterial and venous systems throughout the circulation. These changes in vessel 
diameter are the result of contraction and relaxation of vascular smooth muscle. The 
strategic location and the unique arrangement of the vascular smooth muscle throughout 
the peripheral circulation allow for phenomenal modulation of the vascular system and 
subsequently blood flow modifications to and from body tissues (figure 4-1).  
The smooth muscle cells wrapped around the vessels of the circulatory system are 
small, mononucleate, and spindle shaped. They are generally arranged in helical or 
circular layers around the larger blood vessels and in a single circular layer around 
arterioles [7, 37]. The vascular smooth muscle cells contain small numbers of thick 
myosin filaments and large number of thin actin filaments forming sarcomeres with non-
visible striations. These filaments are aligned in the long axis of the cell and the sliding 
filament mechanism operates by means of phosphorylation of cross-bridges to regulate 
their rate of cycling [3, 7]. Parts of the endothelial cells project into the vascular smooth 
muscle layer forming myoendothelial junctions at various points along the vessels. These 
junctions are used for functional communication between endothelium and adjacent 
vascular smooth muscle (figure 4-1) [7].  
In contrast to skeletal muscles, vascular smooth muscles contract very slowly, 
develops high forces, maintains force for long periods with low adenosine triphosphate 
(ATP) utilization, and operates over a considerable range of lengths under physiologic 
conditions. On the other hand similar to cardiac muscles, cell-to-cell signal conduction is 
responsible for synergistic contraction smooth muscle [3]. As in skeletal and cardiac 
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muscles, contraction caused by cross-bridge formation is controlled by myoplasmic Ca+2 
concentration [38], however the Ca+2 mechanism of action for regulating contraction is 
slightly different in vascular smooth. Contraction is elicited by the increase in 
myoplasmic Ca+2 that come via voltage-gated calcium channels, through receptor-
mediated calcium channels in the sarcolemma, and by the release from the sarcoplasmic 
reticulum. Several neurohormonal and metabolic pharmacologic stimuli have been 
proposed to be involved in modulating intracellular Ca+2 level including catecholamines 
[39, 40], angiotensin II [41], vasopressin [41, 42], histamine [40], serotonin [43], 
adenosine [44], CO2 [45], K+ [46], H+ [47], nitric oxide [48], and prostaglandins [49]. 
 
Figure LR4.1. Typical elastic artery. Shown different segments of a vessel.  





Figure LR3.2. Schematic diagram of signal transudation involved in vascular 
smooth muscle modulation.  
PKC; protein kinase C, PLC; phospholipase C, G; guanine nucletide binding 
protein, PIP2; phosphatidyl inositol bisphophate, DAG; diacylglycerol, IP3; 
inositol triphosphate, Ca+2; Calcium ions, CaM; calmodulin, MLCK; myosin 
light chain kinase. Taken from [50]. 
 
The binding of agonists to vascular smooth muscle membrane receptors activates 
phospholipase C (PLC) in a reaction coupled with guanine nucletide binding proteins (G 
protein). Phospholipase C hydrolyzes phosphatidyl inositol bisphophate (PIP2) in the 
membrane to yield diacylglycerol (DAG) and inositol triphosphate (IP3). Diacylglycerol 
and IP3 increase Ca+2 by activating voltage-gated calcium channels and releasing Ca+2 
sarcoplasmic reticulum, respectively. Calcium ions bind to calmodulin, which in turn 
binds to myosin light chain kinase. This activated Ca+2-calmodulin-myosin kinase 
complex phosphorylates the light chains (20,000 daltons) of myosin. The phophorylated 
myosin ATPase is then activated by actin, and the resulting cross-bridge cycling initiates 
contraction (figure 4-2). Relaxation on the other hand occurs when the myosin light chain 
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phosphatases dephosphorylate the light chains of myosin and the cytosolic Ca+2 is 
lowered by sarcoplasmic reticulum uptake and by Ca+2 extrusion by the Ca pump and Na-
Ca exchanger [51, 52].  
Vascular smooth muscle is normally tonically contracted and physiological 
responses of increased and decreased contraction are a function of the integrated signals 
from autonomic nerves, circulating and local hormones, endothelium tissue and local 
metabolites [7, 53]. The endothelium, for example, regulates vascular smooth muscle 
function by releasing a variety of vasoactive factors [54]. Endothelial cell calcium 
regulates the activities of nitric oxide synthase, which metabolizes L-arginine to nitric 
oxide, the most important endothelium-derived relaxing factor [55, 56]. After diffusing to 
smooth muscle cell nitric oxide exerts its effects by negatively influencing calcium 
release from the sarcoplasmic reticulum and its entry through calcium channels, as well 
as by inhibiting calcium activated contractile process itself [57, 58]. Endothelin-1 is 
another endothelial-borne molecule however promotes vasoconstriction by sustaining 
elevated levels of Ca+2 and activating muscle cell contractile process [56, 59].   
Most of the body arteries and veins are supplied to different degrees by autonomic 
nervous system fibers that exert a tonic effect on the blood vessels. Activation of the 
sympathetic nerves either directly or reflexly causes smooth muscle contraction or 
enhances vascular resistance by increasing cytoplasmic Ca+2 levels. In contrast, the 
parasympathetic nerves tend to decrease vascular resistance, but they innervate smaller 
number of the body blood vessels. Moreover, changes in the local environment alter the 
contractile state of vascular smooth muscle, and alterations such as increased temperature 
or increased carbon dioxide levels induce relaxation of this tissue [60, 61]. This section 
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will provide an overview of the mechanisms involved in vascular function modulation 
under normal conditions. Since vasoregulation is a complex process and include systemic 
and local factors, the regulatory effect of each factor will be discussed.      
4.1. SYSTEMIC CONTROL OF THE VASCULAR SYSTEM 
Systemic modulation is maintained by homestatic reflex mechanisms that receive 
mechanical and chemical signals from peripheral sensors within the circulation causing 
either a local reaction or activation of the central nervous system [3, 15, 62]. The signals 
sent to the central nervous system are processed then forwarded to the command centers 
to take appropriate action in the periphery. These command centers send signals to either 
the autonomic nervous system or glands around the body. Signals from both arms of the 
systemic vascular control are reflected on total peripheral resistance, blood pressure and 
blood flow [3, 62].  
4.1.1. Nervous Regulation of the Circulation 
Neural control of the cardiovascular system affects mainly global functions such as blood 
redistribution (blood shunting), cardiac output, metabolic adjustments and particularly 
important for maintaining constant pressure within the circulation [15]. This control is 
inflicted on the vascular system entirely by the autonomic nervous system. Both branches 
of the autonomic nervous system innervate the heart however the vasculature has 
extensive sympathetic network whereas the parasympathetic innervation is minimum. 
Thus the sympathetic nervous system is very important in the control of the heart and 
vasculature whereas the parasympathetic system is particularly essential for the 
regulation of the heart and cardiac output with some control to the vasculature (figures 4-
3 and 4-4) [3, 32, 62]. 
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Figure LR4.3. Functional anatomy of the sympathetic nervous control of the 
circulation.  
Taken from [3]. 
 
The most remarkable characteristic of the autonomic nervous system is probably 
the ability to modify heart rate, vascular resistance and blood pressure within few 
seconds. For example the sympathetic nervous system double heart rate within 3-5 
seconds whereas blood pressure is increased to double normal within 15 seconds [15, 63]. 
This exceptional capability is due to the sophisticated and extensive neural network that 
connects the central nervous system to the heart and almost all segments of the 
vasculature  (figures 3-3 and 3-4) [61, 64]. The innervation of the small arteries and 
arterioles allows the sympathetic stimulation to increase vascular resistance, blood 
pressure and blood flow to areas where needed. Whereas the innervation of the large 
vessels, particularly the veins, assists in propelling blood from these vessels to the heart 
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thus generating larger cardiac output [20]. Additionally sympathetic activities are 
especially important to increase heart rate and contractility force [61, 64]. Although, due 
to minimum vascular intervention, the parasympathetic stimulation is not particularly 
important for vasoregulation it plays a crucial role in the reduction of heart rate and 




Figure LR4.4. Sympathetic innervation of the systemic circulation.  
Taken from [3]. 
 
The sympathetic vasomotor nerves project their fibers from almost all the thoracic 
and two lumbar spinal nerves. These fibers connect to the heart and its vessels and to the 
peripheral vessels (figures 4-3 and 4-4). Additionally a sympathetic nerve fiber branches 
of the intermediolateral horn cells of the spinal cord passing through the sympathetic 
chains and the splanchnic nerves directly into the adrenal medulla, which is responsible 
for the secretion of epinephrine and norepinephrine into the blood stream [8, 66]. The 
signals transmitted via the sympathetic fibers are initiated in the vasomotor center located 
in the pons and medulla (figure 4-5). The vasomotor center is controlled by locations 
within the central nerves system including the hypothalamus and cerebral cortex [8].  
Within the vasomotor center there are areas responsible for initiating vasoconstriction 
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whereas others initiate vasodilation. Generally however increased sympathetic nervous 
system activities induce strong vasoconstriction throughout the circulation except in the 
heart and skeletal muscle vasoconstriction is less pronounced [15, 67, 68]. In addition to 
vasoconstriction and vasodilation signaling the vasomotor center is also responsible for 
receiving and coordinating reflexes from the sensory receptors around the circulation 
(e.g. barareceptors and chemoreceptors). This particular function orchestrates a rather 
sophisticated feedback loop between the periphery and the central nerves system [65, 69]. 
The vasoconstrictor area, within the vasomotor center, fires vasoconstriction impulses to 
vessels around the circulation to form a sympathetic vasoconstrictor tone. These signals 
are to maintain a vasomotor tone that is important to preserve adequate blood pressure 
and flow. At rest this tone allows for partial state of contraction of blood vessels however 
during stress the firing of vasoconstriction impulses increases causing a corresponding 
increase in blood pressure (figure 4-5) [15].  
The sympathetic terminal nerve endings are called adrenergic nerve fibers 
because they secrete the neurotransmitter norepinephrine. The manufacturing of 
norepinephrine is initiated in the axoplasm of the terminal nerve endings of adrenergic 
nerve fibers but is completed inside the vesicles [66, 69]. Once released norepinephrine 
binds to cellular membrane receptors called alpha (α) and beta (β) adrenergic. These 
receptors are highly specific, located in the vascular smooth muscle cell and penetrate 
through the cell membrane [8]. Upon norepinephrine binding to the receptor it cause 
conformational changes to the penetrating receptor thereby triggering cellular activities 
within the vascular smooth muscle cell by either increasing membrane permeability to 
ions or activate/deactivating enzymatic reaction (s) [3, 66]. In general α-adrenergic 
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receptors cause vasoconstriction β2 receptors cause vasodilation whereas β1 cause 
increase in heart rate and contractility. The skin and internal organs vasculature has 
mostly α receptors, skeletal muscle and splanchnic vasculature contains both α and β2 
receptors however α are more abundant and dominant than β2 whereas the heart muscle 
contains β1 and the heart vessels contain α and β2 receptors [3, 63]. The action of β2 
receptors has probably been most confusing since it induces vasodilation. When 
norepinephrine infused into tissues contain α and β2 receptors it activates only α 
receptors, whereas β2 receptors are activated only when α receptors are blocked.  
However norepinephrine released from nerve endings does not activate β2 receptors even 
if α receptors are blocked. [15]. Therefore increase sympathetic nervous system activities 
increase heart rate and contractility, heart and skeletal muscle vasoconstriction and strong 
skin and internal organ vasoconstriction [70]. Although some reports indicated β2 
receptors’ action might contribute to initial vasodilation observed at onset of exercise, 
skeletal muscle vasodilation is sustained by local mechanisms [15]. Since the autonomic 
nervous system is responsible for the flight-or-fight response, these cardiovascular 
adjustments are particularly important for the initial increase in blood delivery to the 
skeletal muscles during times of physical stress such as exercise [15, 70]. Dilation of the 
eye pupils, increased activities of the sweating glands, and increased metabolism are also 
implicated in the flight-or-fight response and stimulated by the sympathetic nervous 




Figure LR4.5. Systemic circulation regulatory areas within the brain.  
Taken from [3]. 
 
The removal of norepinephrine is accomplished by either reuptake by the nerve 
endings, diffuse to the circulation or destroyed by the enzyme monoamine oxidase or one 
of its derivatives. The reuptake mechanism accounts for 50-80% of the unused 
norepinephrine whereas norepinephrine diffuses to the blood accounts for most of the 
reminder. Finally norepinephrine destroyed by monoamine oxidase accounts for only a 
small fraction of the reminder [3, 69]. Norepinephrine released directly into the tissue 
stays active for only few seconds before its removal by one of the mechanisms. However 
norepinephrine released into the blood stream by the adrenal medulla or escaped from the 
nerve terminal stays active for 10-30 seconds until it diffuses into some tissue (e.g. liver) 
where its destroyed by monoamine oxidase [3, 15].   
The parasympathetic nervous system projects its nerve fibers to the heart through 
the vagus nerve (cranial nerve X). The nerve endings at the heart release the 
neurotransmitter acetylcholine, which binds to cholinergic receptors, located mostly at 
the atria [66]. This system serves a double purpose, as it is particularly important when 
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the heart is excited and functioning under great workload. Activation of cholinergic 
receptors of the heart decreases heart rate and contractility within a few seconds [1]. In 
fact a strong parasympathetic stimulus can stop heart pumping for a few seconds and 
reduce the strength of the heart contraction by 20-30% [3]. The parasympathetic 
contribution to the control of the vasculature is very limited and confined to a few tissue 
beds including the brain, heart, erectile tissue of the genitalia, some glands and, to a 
lesser extend, the kidney [72]. 
The activities of both branches of the autonomic nerves system are in constant 
fluctuation mainly to defend blood pressure within a narrow range however this 
maintenance of blood pressure is intended only for short term whereas other mechanisms 
have to be activated for long-term blood pressure maintenance [27]. The slightest change 
in blood pressure is normally sensed by the baroreceptors and chemoreceptors within the 
circulation, subsequently they send informative singles to the vasomotor center to unleash 
a reflex to restore blood pressure back to normal [6]. This reflex usually includes a 
withdrawal and/or activation of either of the autonomic nervous system branches. For 
example in the case of elevated blood pressure, the autonomic nervous system deceases 
sympathetic activities and increase parasympathetic activities to elicit a decrease in blood 
pressure to normal [3].       
4.1.2. Systemic Hormonal Control of the Circulation 
Systemic hormones are released into the bloodstream by the major endocrine glands and 
bind to receptors located on the vascular smooth muscle. These hormones include 
catecholamines, rennin-angiotensin-system hormones and arginine vasopressin [1, 73]. 
Hormonal agents released into the blood stream act directly on vascular smooth muscle 
causing either dilation or constriction [73]. However hormones might also inflect their 
 141
effects on vascular tone indirectly vie modulating neural control or other hormonal 
mechanistic [62]. For example angiotensin II binds to the neuronal membrane and 
modulate the release of norepinephrine [74]. As well, angiotensin II controls blood 
pressure by modulating salt and water levels in the body thereby plasma volume [75]. 
Therefore considering the constant communication between the periphery and central 
nervous system in addition to the interaction between hormonal and neural control, the 
action of hormones in the body is often multifaceted and highly complex [62].  
Catecholamines 
Due to a lot of similarities the adrenal medulla serves as an extension to the sympathetic 
nerves system. In addition the sympathetic nerves system activities at the adrenal 
medullae stimulate the release of large quantities of epinephrine and norepinephrine into 
the blood stream. However catecholamines effects last 5 to 10 times longer as a result of 
slower removal of the hormones [3]. Similar to the sympathetic nerves activities, 
circulating catecholamines increase when the body is stressed mentally or by hunger, 
exercise, or hypothermia. In addition they contribute to the fight-or-flight response as 
they have profound and rapid effect on the heart, vascular system, and metabolism [15]. 
Both catecholamines hormones are derivatives of the amino acid tyrosine, have the same 
production procedures, and similar structure [18]. In addition at the same sites both 
epinephrine and norepinephrine have the same effect however mole for mole epinephrine 
is several times more powerful than norepinephrine. On average 80-90% of the adrenal 
medulla secretion is epinephrine whereas 10-20% is norepinephrine. Both catecholamines 
are extremely important in blood shunting and maintenance of adequate blood pressure 
thereby assuring sufficient blood delivery and removal during times of rest and stress 
(e.g. exercise) [3, 76]. 
 142
Epinephrine acts on the peripheral arteries by activation of α and β2 adrenal 
receptors throughout the body. Alpha-receptors cause vasoconstriction whereas β2-
receptors induce vasodilatation. The concentration of these receptors is more abundant 
and dominant in areas than others. For example α is more abundant and predominant than 
β2 receptors in the skeletal muscle and splanchnic arteries whereas β2 don’t exist in the 
skin and internal organs arteries [3]. Alpha-receptors on the other hand are highly 
concentrated in the skin and internal organs. Therefore increase in circulating 
epinephrine, such as during exercise, results strong vasoconstriction throughout the body 
except the skeletal muscle vasoconstriction is moderate [3, 76]. Increase in epinephrine to 
concentrations of 100 pg ml-1 induces elevation in heart rate and systolic blood pressure 
increases at concentrations of 125 pm ml-1. Activation of β2 causes vasodilatation 
followed by a drop in diastolic blood pressure in skeletal muscle however this drop 
doesn’t occur until epinephrine reaches 200 pg ml-1 which is ~ 135 pm ml-1 higher than 
basal levels [76].  
In the venous side of the circulation existence and action of β2 and α adrenal 
receptors are not clear yet in human. However splanchnic and cutaneous veins contain α 
adrenal receptors and were found to induce venoconstriction. On the other hand the 
action of β adrenal receptors in veins is not known yet in human [77].  
Norepinephrine is considered a neurotransmitter since most of it is derived from 
the sympathetic nerve terminals in the body [76]. However as a result of high 
sympathetic nervous activities its blood concentration might reaches four or five times 
above normal values (~1.8 ng ml-1) [15]. At these high levels norepinephrine acts as α 
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adrenal receptor hormone and induces vasoconstriction. In areas where α and β2 adrenal 
receptors present vasoconstriction occur since β2 has low affinity to norepinephrine [3]. 
Angiotensin II 
The action of angiotensin has been revealed in the 1950s as the agent responsible for the 
pressor responses observed following intravenous injection of renal extracts [62]. 
However aside from its capability to control arterial pressure through changes in vascular 
tone, angiotensin inflect its effect on blood pressure by several mechanisms involves 
controlling fluid volumes and interaction with the central and peripheral nerves systems, 
thus its essential for long-term pressure control [78].  
The production of angiotensin II is triggered by peripheral signals initiated by 
reduction in blood pressure [67]. This reduction in blood pressure provoke the conversion 
of prorenin to renin within the juxtaglomerular cells in the walls of the afferent arterioles 
immediately proximal to the glomeruli in the kidney [79]. Following its release into the 
blood stream the enzyme renin converts angiotensinogen to angiotensin I, a mild 
vasoconstrictor with minimum effect in circulatory function. Renin persists in the blood 
stream for 30 to 60 minutes as it continues forming angiotensin I [79, 80]. After few 
seconds of producing angiotensin I, angiotensin-converting enzyme (ACE) converts it to 
angiotensin II in the small vessels of the lungs. Angiotensin II persists in the blood for 
only one or two minutes, then it gets converted to the inactive form by the enzyme 
angiotensinase [80].  
Angiotensin II powerful vasoconstriction capability is probably the main 
mechanism by which it effect vascular resistance and blood pressure [81]. 
Vasoconstriction occurs mainly in the arterial side and to a lesser extends in the venous 
side. Contraction of the arterial smooth muscle cells generates increase in vascular 
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resistance and blood pressure, whereas the mild contraction of the venous smooth muscle 
cells causes increase in venous return and cardiac output to help the heart pump against 
the angiotensin II-induced increase in blood pressure [15, 81]. 
Angiotensin II is not held to its vasoconstriction capability but also affects blood 
pressure by changing plasma volume. Angiotensin II acts directly on the kidney causing 
retention of salt and water and indirectly by inducing aldosterone secretion from the 
adrenal glands [62]. The effect of angiotensin II on fluid volume is particularly important 
for long-term control of arterial blood pressure [64]. High concentration of angiotensin II 
constricts the renal blood vessels thereby diminishing blood flow through the kidneys as 
a result, less fluid filters thorough the glomeruli into the tubules. Additionally the reduced 
blood flow into the peritubular capillaries reduces pressure causing rapid osmotic 
reabsorption of fluid from the tubules [3]. Angiotensin II also directly affects the tubular 
by increasing reabsorption of salt and water. The combined effect of these three 
mechanisms result in decreasing urinary output as much as four- to six-fold.  
The reduction in kidney blood flow causes the release of aldosterone. Aldosterone 
increases sodium reabsorption by the kidney tubules, which increases the extracellular 
fluid sodium thereby increase in fluid retention. The total effect of direct and indirect 
mechanisms of fluid control is crucial for long-term control of arterial blood pressure. 
However to the opposite of the popular belief, angiotensin II-induced retention of fluid by 
the direct-effect mechanism is probably three or more times as potent as the indirect 
effect [3].  
Angiotensin II presser response vie vascular and fluid control has been confirmed 
for decades. However research have also revealed that angiotensin II facilitate the release 
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of sympathetic nerves system neurotransmitters in the periphery and adrenal medullary 
catecholamines in addition to its possible influence on the central nervous system [62]. 
The first observation of the central effect of angiotensin II was observed when a dog head 
was isolated from its circulation and connected to another animal while the brain 
remained connected to the body only by the spinal cord. Following angiotensin II 
infusion in the donor animal arterial pressure was increased in both animals. This presser 
effect was inhibited by blocking the sympathetic activities, which indicate the effect was 
mediated by sympathetic nerves system [82]. Arterial pressure increased also in rabbits 
following vertebral arterial infusion of angiotensin II and failed to rise following systemic 
infusion confirming the central role of angiotensin II [83]. However the angiotensin II-
induced augmentation of blood pressure in greyhounds was greatly hampered by atropine 
(parasympathetic antagonist) or vagotomy indicating parasympathetically mediated 
response [84]. This difference might be due to species differences given the autonomic 
nerves system in greyhounds is predominantly vagal. The central site for angiotensin II 
effect is not clearly determined. However since angiotensin II doesn’t cross the blood 
brain barrier the site of action must be reachable from the circulation. Several 
investigations have found traces of angiotensin at varies location within the 
circumventricular organs including postrema area of the hind brain, the subfornical organ 
in the forebrain and the organum vasculosum of the lamina terminalis [85, 86].     
The high level of interaction of these mechanisms demonstrates the multiple and 
complex action of angiotensin II in the control of blood pressure. Discovering the 
interaction of angiotensin II with several body systems have propelled the research 
related to hypertension and therapy pertain to (e.g. ACE inhibitors).  
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Arginine vasopressin (antidiuretic hormone) 
Arginine vasopressin is a nonapeptide hormone released by the posterior lobe of the 
pituitary gland. Increased osmolality (increased plasma concentration) stimulates 
osmoreceptors near the hypothalamus, which send singles to posterior pituitary to release 
arginine vasopressin into the circulation [87]. However reduction in central blood volume 
as a result of fall in blood volume (hemorrhage) [88], orthostatic and/or positive pressure 
breathing, are also potent stimuli of arginine vasopressin [89, 90]. Whereas mechanisms 
by which either osmolality is decreased or central blood volume is increased inhibit the 
production of the nonapeptide [91]. 
Arginine vasopressin receptors are located on the peritubular surface of the cells 
of the distal convoluted tubules and medullary collecting ducts in the kidney. The binding 
of the hormone to these receptors stimulates adenylyl cyclase activity and form cAMP 
[92]. Thereafter cAMP initiates protein kinase activity and a phosphorylation cascade 
resulting in the insertion of the protein, aquaporin, in the luminal membrane causing 
antidiuretic action, the main effect of the hormone. Vasopressin inflicts its effect on the 
kidney by increasing fluid permeability of the collecting ducts and tubules allowing water 
to be reabsorbed back to the body [64].  
In rats arginine vasopressin is several folds more potent vasoconstrictor than 
angiotensin II, on a mole-for-mole basis [64, 93]. However the vasoconstrictor effects of 
arginine vasopressin in human appear to be pathological rather than physiological as 
vasopressin plasma levels are unlikely to reach those levels required to achieve 
vasoconstriction [94]. At lower concentration of arginine vasopressin the contractile and 
pressor responses to adrenergic and neural stimuli appear to be augmented [95]. 
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Vasopressin once released remains in the plasma for as little as 2-3 minutes before 
removed by the kidney and liver.      
4.2. THE REFLEX CONTROL  
The circulation is a mechanical feedback system thus any alteration in pumping or 
peripheral vascular tone will influencethe intravascular pressures in various sections of 
the circulation [96]. Continuous information about the state of the circulation is 
transmitted from different sensory receptors strategically located around the circulation. 
Any disturbances has direct effects on the heart and blood vessels which will tend to alter 
cardiac output and tissue blood flow through local regulatory mechanisms [97]. These 
peripheral sensory receptors are the baroreceptors and chemoreceptors.  
4.2.1. Baroreceptors 
Baroreceptors are found in almost every large artery in the thoracic and neck areas 
however they are found in abundant in the carotid artery and aortic arc. These sensors are 
stimulated when these arteries are stretched [98]. Signals from the carotid receptors are 
transmitted vie the Hering’s nerve that connects to the glossopharyngeal nerve, then to 
the tractus solitarius in the medullary area, whereas the aortic baroreceptors connect with 
the tractus solitarius by the vagus nerves (figure 4-6) [3, 9, 65].  
The baroreceptors appear to have pressure-dose-response [3, 9]. The aortic 
baroreceptors are stimulated at pressures around 30 mmHg whereas the carotid ones start 
sending signals to the brain when pressure decrease below 60 mmHg and their activities 
progressively intensify as they reach maximum at 180 mmHg. However the normal 
operating pressure is around 100 mmHg and a slight change in pressure calls for the 
autonomic nervous system for adjustments. The remarkable characteristic of the 
baroreceptors is the extremely rapid respond to changes in blood pressures. Additionally 
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constantly and rapidly increasing blood pressure triggers baroreceptors’ response far 
more rapidly than stationary pressure [3, 99]. For example a progressively increasing 
blood pressure of 150 mmHg cause twice as much increase in the baroreceptors’ firing 
rate as a stationary blood pressure of 150 mmHg. Whereas a falling pressure cause one 
quarter firing rate of that for the stationary pressure [3, 100]. Once the signals are 
received in the vasomotor center the sympathetic vasoconstrictor tone is inhibited and the 
vagus tone is activated (figure 4-5). This would decrease cardiac output and vascular 
resistance followed by blood pressure decrease. Additionally the baroreceptors firing rate 
increases during systolic and decreases during diastolic phases of the cardiac cycle [3, 
15]. The magnitude of sympathetic tone inhibition depends on the firing rate from the 
arterial baroreceptors where higher firing rate cause more inhibition. Therefore a decrease 
in the firing rate, such as during a fall in blood pressure, cause an increase in sympathetic 
tone thereby elevation in blood pressure. This is apparent when blood pressure in the 
head and upper portion of the body falls upon standing up after laying down the 
baroreceptors elicit a reflex that triggers a strong and immediate sympathetic discharge 
result in rapid restoration of normal blood pressure [15, 68]. The baroreceptors serve as a 
short-term mechanism to defend blood pressure within a narrow range. However for 
long-term regulation of blood pressure other control systems, such as antidiuretic and 
associated hormonal systems, have to get involved [9, 98]. 
4.2.2. Chemoreceptors 
The chemoreceptors are highly vascularized, extremely sensitive to changes in blood gas 
proportion, and easily accessible by the blood [68]. The bifurcation of the common 
carotid artery and the aorta are the host of these really small (1-2 millimeters) organs. 
Each common carotid artery harbor one sensor called carotid bodies whereas several 
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similar receptors, called the aortic bodies, cling to the wall of the aorta (figure 4-6) [9, 
67]. The accessible location of these nerve endings allows for constant sensing of 
changes in blood gas continent, such as lack of oxygen, excess carbon dioxide and excess 
hydrogen ions. Additionally the small nutrient artery runs through these bodies supply 
them with abundant blood flow and keep them with close contact with arterial blood [3, 
101]. Below a critical value fall in blood pressure changes blood flow in the nutrient 
artery, which results in a diminished oxygen and accumulation of carbon dioxide 
contents. Consequently these sensors are stimulated and start firing signals to the 
vasomotor center in the central nervous system [15, 101]. Within the vasomotor center 
these signals are processed and a stimulus is transmitted to the sympathetic nervous 
system to counteract this drop in arterial blood pressure. However these sensors play an 
important role in preventing a fall in blood pressure below 80 mm Hg whereas they are 
not acutely activated during normal blood pressures [3, 9, 101]. 
 
Figure LR3.6. Peripheral baroreceptors.  
Taken from [3]. 
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4.3. LOCAL REGULATION OF VASCULAR TONE 
The cardiovascular system delivers blood throughout the body according to tissue 
demands. This process involves constant adjustment of the heart and the vessel functions 
to assure sufficient blood pressure and volume. However an integral part of this 
adjustment occurs primarily in the capillaries, arterioles, venules, small arteries and small 
veins. This group of vessels is controlled by chemical substances mainly produced in the 
tissues surrounding theses vessels. Additionally these chemical substances are produced 
in accordance with the demands of the metabolic tissues. This mechanism is the local 
regulation of vascular function and involves mainly the contribution of the endothelium 
and metabolic tissues. 
4.3.1. Endothelium-Dependent Regulation of Vascular Tone 
The endothelium is a monolayer of squamous cells located strategically at the interface 
between the blood and vascular muscle cells implying an intimal and direct interaction 
between these three compartments [56, 102, 103]. The endothelium is a very interactive 
tissue capable of responding to numerous mechanical, chemical and cellar stimuli. The 
surface of the vascular endothelium expresses a verity of receptors for potent vasotonic 
agents that have rapid and profound effects on the vascular wall function.  
Recent advances in cardiovascular science have demonstrated the integral role of 
endothelium cell in the cardiovascular function beyond just a passive barrier of the 
vasculature. Since the illustration by Furchgott and Zawadzki of the obligatory role of the 
endothelium in the relaxation to acetylcholine in the isolated aorta of the rabbit [104], it 
has become obvious that the endothelium modulates the degree of constriction of the 
underlying vascular smooth muscle. It does so by liberating vasoactive substances 
including endothelium-dependant relaxing factors [104, 105], endothelium-dependant 
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hyperpolarizing factors [106-108], and endothelium-dependent constriction factors [59, 
109].  
It is also clear now that the endothelium possesses a variety of modulatory 
functions beyond the control of vascular tone including endothelium-dependent 
modulation of platelet aggregation [110] and endothelium-dependent modulation of 
vascular growth [111]. The endothelium tissue is also involved in vascular function 
alterations associated with the pathogenesis of many cardiovascular diseases [112]. 
Endothelium-dependent relaxation 
Among a number of vasotonic factors, the endothelium lining of the vascular system 
releases relaxing mediators including nitric oxide, prostacyclin, and hyperpolarization 
factors. In addition to smooth muscle level of responsiveness, these vasodilatory agents 
play an integral part in peripheral vasodilation at rest and under various stress conditions. 
In a lot of cases these agents interact together to achieve proper peripheral blood flow. 
However paradoxically Ca+2 ion, the very same agent that promote vasoconstriction, is 
also involved in vascular smooth relaxation. All endothelium-dependent relaxation 
factors are released as a result of increasing Ca+2 concentrations in the endothelial cell. 
This increase is triggered by either agonists (e.g. acetylcholine, histamine, bradykinin, 
arginine vasopressin and ADP) or sheer stress (figure 4-7).  
Nitric oxide 
Nitric oxide is a substance released continuously by the endothelial lining of the vascular 
system and prominently directed to induce vasodilation [48]. Additionally it is currently 
considered as one of the most endothelial function markers as its release believed to 
induce a compensatory relaxing response to a stimulus of a constricting nature [112] and 
prevent platelet aggregation [113]. Due to its gaseous nature, nitric oxide is rapidly 
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produced, metabolized and highly diffusible without even direct contact with vascular 
smooth muscle, which makes it hard to detect it [104]. However using invasive and 
difficult techniques, animal models have allowed researchers to reveal a lot of 
information to help us understand the important role of nitric oxide [55, 114]. 
Furthermore, pharmaceutical infusion of substances to modify molecular markers of 
nitric oxide function have been used as simple and noninvasive method to assess nitric 
oxide production and synthesis in human [115, 116].  
Interestingly the role of nitric oxide was discovered as a result of searching the 
effect of acetylcholine. For a long time the role of acetylcholine in vascular tone was a 
subject of controversy. Some investigators noted acetylcholine effect ranged from slight 
to substantial vasodilatation, [117-119] whereas the majority of the literature reported 
only additional contraction [120].  However the importance of an intact endothelium for 
the acetylcholine-induced vasodilation in rabbit aorta rings was not demonstrated until 
the accidental finding by Furchgott and Zawadzki in 1980 [104]. A failure to follow the 
standard procedures for the effect of drugs on vascular smooth muscle tone resulted in 
preserving the intimal surface (endothelium tissue) of the vascular smooth muscle and 
subsequent muscle relaxation to acetylcholine. These unexpected results were followed 
by another experiment in which extra care was taken during vascular smooth muscle 
preparations to avoid rubbing the endothelium tissue. In this experiment a transverse strip 
of rabbit aorta with endothelium removed was mounted between spring-clips with a 
longitudinal strip of the same length and width but with endothelial cells present, intimal 
surface against intimal surface. In this so-called “sandwich” preparation, the 
endothelium-free transverse strip, which alone did not relax in response to acetylcholine, 
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exhibited good relaxation. This relaxation was attributed, at the time, to the release of 
substance(s) from the endothelial cells of the longitudinal strip, and called endothelium-
dependent relaxation factor [104]. Independently Ignarro and coworkers in their 
continued study of nitrovasodilator action discovered that nitric oxide could relax 
vascular smooth muscle through stimulation of soluble guanylate cyclase [121]. 
Afterward the findings of these two groups were matched to conclude that the 
endothelium-dependent relaxation factor was indeed nitric oxide [122, 123].  
Like the rest of endothelium-dependent relaxation factors, production of nitric 
oxide is initiated as a result of increasing Ca+2 ions concentration in the endothelium cell. 
Epinephrine, arachodonic acid, acetylcholine, ADP, ATP, arginine vasopressin, 
bradykinin (AVP), endothelin, histamine, serotonin, thrombin, in addition to sheer stress 
are factors responsible for this increase in Ca+2 ions.  
The binding of one of these agents or the physical pressure of sheer stress trigger 
intracellular signals (e.g. cyclin adenosin monophosphate, phospholipase C, inositol 
triphosphate and diacylglycerol) causing an increase Ca+2 ions within the cell. This 
increase in Ca+2 activates nitric oxide synthase, which reduces L-arginine to nitric oxide 
and L-citrulline [125-127]. 
Following the release of nitric oxide from the endothelium cell, it easily diffuses 
to the adjacent vascular smooth muscle cell and produces vasodilation. This vascular 
relaxation occur as a result of nitric oxide binding to the heme portion of guanylyl 
cyclase in muscle cells and increase production of cyclic guanosine monophosphate 
(cGMP) from guanosine triphosphate. The accumulation of cGMP activates cGMP-
dependent protein kinase, which phosphorylates myosin light chain kinase and regulates 
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activity of action-myosin ATPase (figure 4-8). Phosphorylation of myosin light chain 
kinase lowers its affinity for the calcium-calmodulin complex, thus decreasing 
phosphorylation of myosin light chain and promoting the formation of comparatively less 
active, dephosphorylated form of myosin. Activation of cGMP-dependent protein kinases 
can also result in the phosphorylation of calcium transporters, complexing intracellular 
calcium and allowing relaxation of vascular smooth muscle [128]. However other 
investigators have suggested that cGMP-mediated relaxation might involve other 
mechanisms. These mechanisms include inhibition of a sarcolemmal calcium channel to 





Figure LR4.7. Agents cause the release of endothelium-derived relaxing factors.   
NO; nitric oxide, PGI2; prostacyclin, AVP; arginine vasopressin, NA; 






Figure LR4.8. Effect of endothelium-derived relaxing factors.  
 NO; nitric oxide, PGI2; prostacyclin, R; receptor, cGMP; cyclic guanosine 
monophosphate, cAMP; cyclic adenosine monophosphate.  Taken from [124]. 
 
Nitric oxide is also involved in deactivation of platelets aggregation. This process 
is mediated by increasing intercellular levels of cGMP [58]. However the effect of nitric 
oxide is strongly synergistic with that of prostacyclin. Thus the combined secretion of 
nitric oxide and prostacyclin by the endothelin cells at the interface with the blood must 
constitute a powerful antiaggregatory barrier (figure 4-8) [131].  
Nitric oxide-independent relaxation maybe reduced by hemoglobin or methylene 
blue, which antagonize the rise in cGMP either by inhibiting guanylate cyclase or by 
scavenging nitric oxide and preventing its stimulation of the enzyme [54, 56].     
Infusion of 0.8 mg ml-1 of nitrates was enough to produce venodilation but 3-4 mg 
ml-1 was required to produce dilation in the arterial side in pre-constricted vessels [132], 
whereas nitroglycerin produced venodilation even in unconstricted veins [133]. The 
effect of nitric oxide however varies in different segments of the venous system. In a 
study to compare the effect of nitric oxide in different veins found that acetylcholine 
produced significant dilation in the external jugular, superior vena cava, brachiocephalic 
veins and two portions of the inferior caval vein. Whereas the azygos, pulmonary, 
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splenic, renal, femoral and lateral saphenous veins exhibited 10-20% relaxation. On the 
other hand the portal, mesenteric and the third segment of the inferior caval veins showed 
constriction [134]. Similar observations were also found in human [135], as 0.4 of 
nitroglycerine had no effect on superficial hand veins whereas produced dilation in the 
calf and forearm veins. 
Prostacyclin  
Physiologically, prostacyclin is locally produced and serves a double purpose as it causes 
vascular smooth muscle relaxation and prevents platelets aggregation. In addition it is 
responsible for metabolizing cholesterol esters in smooth muscle cell, prevent the 
accumulation of cholesterol esters and suppress the release of vascular smooth muscle 
growth factors [105, 136]. Arachidonic acid is a membrane-bound fatty acid processed by 
cyclooxygenase into endoperoxides then to prostacyclin by prostacyclin synthase. This 
process is initiated by the break down of cell phospholipids by phospholipase A2 within 
the endothelium cell then degraded to 6-keto-PGF1α, a biologically inactive form of 
prostaglandin [137]. Amongst several substances proposed, bradykinin and choline esters 
seem to be the strongest candidates to stimulate prostacyclin formation and release in 
endothelium cells of human and animals [138, 139]. Angiotensin I and II also participate 
in the production process, however they don’t seem to be as potent generators as 
bradykinin and choline esters [139]. Nicotinic acid derivatives and the sheer stress of 
blood on vessel walls have also been suggested to mediate the release of prostacyclin in 
human and animal endothelium cells [140-142]. Moreover histamine, arginine 
vasopressin, platelet activating factor, interleukin-1, leukotrienes and thrombin are 
believed to be involved in the production of prostacyclin [31]. However regardless of the 
external stimulus, prostacyclin biosynthesis is triggered by activating membrane G-
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protein and increasing cytoplasmic Ca2+. This increase in [Ca2+] activates phospholipase 
A2, the initial rate-limiting enzyme in prostacyclin production pathway (figure 4-8) [105].  
Glucocorticosteroids and lipcortin inhibit the production of prostacyclin via 
inhibiting phospholipase A2 [143, 144]. Whereas low-density lipoproteins [145] and 
vitamin K [146] inhibit prostacyclin biosynthesis by interfering with prostacyclin 
synthase function because they produce oxygen free radicals. On the other hand aspirin 
and aspirin-like drugs affect prostacyclin production by blocking the activities of 
cyclooxygenase thereby inhibiting the conversion of arachidonic acid to endoperoxides 
[147]. 
Following binding to the receptors prostacyclin induces relaxation and prevents 
platelet aggregation by increasing cAMP activities in vascular smooth muscle and in 
platelets [105]. However some investigators suggest the contribution of prostacyclin in 
vascular function is not as significant as nitric oxide and might be considered negligible 
[148].   
 The effect of prostacyclin on venous smooth muscle is a disperse, mainly due to 
minimum information available. Sinzinger and Fitscha questioned venodilation to 
prostacyclin as they found venoconstriction in human saphenous veins [149].  In general 
however prostacyclin was found to produce venous smooth muscle relaxation [150, 151]. 
For example in a study by Hiremath et al. prostacyclin produced dose-dependent 
relaxation [150] confirming previous observations by Robinson and colleagues [152].  
Endothelium-dependent hyperpolarization factor 
In 1978 Kuriyama and Suzuki reported hyperpolarization of the cell membrane of smooth 
muscle when exposed to acetylcholine [153]. Bolton et al. verified this finding in 1984 
while hyperpolarization was converted to depolarization as a result endothelial tissue 
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removal suggesting the involvement of the endothelium tissue [154]. Bioassay 
experiments thereafter revealed that the endothelium indeed releases highly diffusible 
substance(s) causing hyperpolarization followed by smooth muscle relaxation [107]. 
Despite infusing endothelium-dependent relaxant inhibitors (e.g. methylene blue and 
hemoglobin) [155, 156] or exposing the endothelium tissue to substances don’t cause the 
release of nitric oxide or proctacyclin (e.g. substance P and oxotremorine) [106, 157] 
hyperpolarization-induced relaxation was maintained indicating additional endothelium-
dependent relaxation mechanism other than nitric oxide and prostacyclin.  
Several substances have been identified to cause the release of endothelium-
dependent hyperpolarization factor. These substances include acetylcholine, the primary 
smooth vessel dilator, in addition to histamine [155] bradykinin [158, 159], substance P 
[160] [107], calcitonin gene-related peptide [161], ADP [162], endothelin [163-165] and 
vasoactive intestinal polypeptide [160]. As nitric oxide, endothelium-dependent 
hyperpolarization factor is released as a result of an increase in free [Ca+2] within the 
endothelium cell. The initial response to a stimulus can be attributed to the release of 
intercellular endothelial calcium stores, whereas the entry of extracellular calcium into 
the cell prolongs the response to acetylcholine or bradykinin [166, 167]. Additionally 
endothelium-dependent hyperpolarization apparently involves calcium calmodulin, as 
inhibitors of this enzyme decrease hyperpolarization in porcine coronary artery to 
bradykinin  (figure 4-8)[168, 169].      
Endothelium-dependent hyperpolarization of smooth muscle is induced by an 
increase in K+ conductance of the cell membrane, which leads to relaxation by increasing 
the membrane potential of the muscle cell [154]. This has been evident as membrane 
 159
conductance of K+ in smooth muscle is increased during hyperpolarization [153, 154, 
170], the magnitude of hyperpolarization is inversely related to [K] [170], radioactive 
rubidium (marker of K+ activities) efflux is increased during hyperpolarization [171, 
172], hyperpolarization has been inhibited by K+-channels blockers [173], acetylcholine 
produces a transient increase in the K+ efflux, associated with the transient 
hyperpolarization of the membrane [171] and K+-channels openers have caused 
hyperpolarization-induced relaxation [170]. Potassium channels have been proposed to 
account for most of the potassium trafficking across the smooth muscle membrane 
because resting membrane potential relay mostly on the membrane potassium gradient.  
This has been more evident in large conduits than small ones [174].  Moreover, several 
investigations have demonstrated that endothelium-dependant hyperpolarization is 
insensitive to ATP-sensitive potassium channel inhibitors, blocked by small conductance 
calcium-activated potassium channel and voltage-dependent potassium channel inhibitors 
but not affected by large conductance calcium-activated potassium channels inhibitors 
[175]. However other mechanisms might be involved in inducing hyperpolarization. For 
example Busse et al, demonstrated that the increase in intracellular free Ca+2 might be the 
preliminary event leading to the secondary membrane hyperpolarization [176]. 
Several characteristics have been identified for the hyperpolarization mediator 
including high solubility and transferability, and ability to produce hyperpolarization-
induced relaxation [107, 177]. Additionally the hyperpolarization of the smooth muscle 
usually is more transient than the accompanying relaxation induced by endothelium-
dependent vasodilators [155, 170, 171, 178]. The exact nature of the endothelium-
dependent hyperpolarization factor however has not been identified as several substances 
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have been proposed to cause hyperpolarization in smooth muscle cell. Prostacyclin, nitric 
oxide, and products of cytochrome P450 have been reported to cause smooth muscle 
hyperpolarization in different species at various locations in the vascular system. Fore 
example prostacyclin and nitric oxide have been reported to increase potassium 
trafficking across the smooth muscle membrane by activating ATP-sensitive [179] and 
calcium-activated channels [180]. Moreover, experiments performed mainly in bovine 
and porcine coronary arteries show that smooth muscle hyperpolarization is inhibited by 
inhibitors of cytochrome P450 monooxygenases and associated with the release from 
endothelial cells of epoxyeicosatrienoic acid (EET) (substance produces 
hyperpolarization of vascular smooth muscle) [181, 182]. Alternatively, 
hyperpolarization of endothelial cell causes accumulation of potassium ions in the 
intercellular space between endothelial and smooth cells. This increase potassium 
concentration can provoke the hyperpolarization of vascular smooth muscle cell by 
activating the inwardly rectifying potassium conductance [183] and Na/K pump [184]. 
Considering all these dynamics, potassium could also be regarded as an endothelium-
dependent hyperpolarization factor. However these facts, about the nature of 
endothelium-independent hyperpolarization factor, are not true in all blood vessels of 
different species. For example in blood vessels of the pig as well as in various arteries 
from human, chemically unrelated inhibitors of cytochrome P450 do not produce an 
inhibition of hyperpolarization-responses [185-187]. Additionally these proposed factors 
might all be responsible for hyperpolarization-responses in the smooth muscle cell of 
vessels as they all contribute at different stages and to various degrees to the 
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hyperpolarization process. Therefore, more research is needed to further identify the 
nature of this factor(s) in different metabolic tissues of different species.  
Resent investigations have shown the importance of endothelium-dependent 
hyperpolarization factor increases as the vessel size decreases in rat mesenteric as well as 
in human gastroepiploic arteries [186, 188]. Additionally endothelium-independent 
hyperpolarization factor is impaired in aging and hypercholesterolemic human and 
animals [186, 189, 190] and in hypertensive and diabetic animals [189, 191].     
Endothelium-dependent contraction 
It was as early as 1982 when the vasoconstrictory role of the endothelium was 
demonstrated as arachidonic acid augmented smooth muscle contraction evoked by 
norepinephrine in the canine systemic and pulmonary veins [192]. This augmentation 
disappeared when the endothelium tissue was mechanically removed suggesting that the 
endothelial cell can be a source of vasoconstrictor signals [192]. Endothelium-dependent 
smooth muscle contraction has been described in a verity of blood vessels under various 
conditions and plays a role in maintaining proper vascular tone without implying 
endothelium dysfunction [56, 193].  
Endothelin 
The existence of a contractile factor released by the endothelium cell was demonstrated 
as early as 1985 with the presence of extracellular calcium and independent of the 
adrenergic, cholinergic, serotoninergic, or hitaminergic systems [195, 196].  This factor 
was then characterized and named endothelin, as it was isolated from the endothelial cells 
of pig aorta in 1988 by Yanagisawa et al. Endothelial was described as a peptide made up 
of 21 amino acids with a N-terminal domain provided a very strong affinity to the 
receptor [59]. Subsequently three isoforms of the peptide were identified and named 
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endothelin-1, endothelin-2 and endothelin-3. All subtypes are present in all mammalian 
species, however endothelin-1 is the only one made in the endothelial cell [197]. 
Endothelin-1 is ten times more potent vasoconstrictor then angiotensin II and induces a 
very long lasting hypertensive action [198]. However endothelin-2 is the most potent 
among all of them and has longer duration of action on blood pressure whereas 
endothelin-3 has 1/20th of the vasoconstrictor activity of endothelin-1 [59]. 
 
Figure LR4.9. Agents cause the release of endothelium-derived contracting 
factors.  
EDCF1; endothelium-derived contracting factor, PO2; partial pressure of 
oxygen, AI&II; angiotensin I & II, AA; arachidonic acid, SP; substance P, 5-HT; 
5-hydroxytryptamine, PGH2; prostaglandin H2, TXA2; thromboxane A2, AVP; 
arginine vasopressin, TGFα; transforming growth factor beta, ACE; angiotensin 
converting enzyme. Taken from [194].  
 
The secretion of endothelin-1 is regulated at the level of peptide synthesis due to the lack 
of dense secretary granules where it can be stored then released as needed. The 
expression and release of endothelin-1 is induced by several factors including adrenaline, 
thrombin, vasopressin, angiotensin II, insulin, cytokines, growth factors and physical 
stimuli (figure 4-9).  The production of endothelin-1 involves the increase in intracellular 
calcium and protein kinase C activity, which is induced by many of these agents [199]. 
 163
On the other hand nitric oxide [200], prostacyclin [201], natriuretic peptides [202], 
heparin [203] and protein kinase C inhibitors reduce endothelin-1 expression and release 
[199]. 
Two types of endothelin receptors were identified and termed ETA and ETB 
receptors.  The affinity of the three isopeptide to ETA is endothelin-1 > endothelin-2 >> 
endothelin-3, where the affinity of endothelin-1 in man is 1000-fold more than 
endothelin-3 [204]. However the ETB receptors show no selectivity for any of the 
endothelin isoforms [205]. The vasoconstrictor response is produced by stimulation of 
ETA receptors present in vascular smooth muscle and relaxing response by stimulation of 
ETB receptors in the endothelium. However studies reported the existence of ETB in 
vascular smooth muscle and produces vasoconstriction [206, 207].  
Administration of endothelin-1 induces an initial reduction in arterial blood 
pressure followed by prolonged increase. This reduction is transient and most noticed 
during elevations in resting blood pressures however have been attributed to the release 
of vasodilator substances including prostacyclin and nitric oxide from the vascular 
endothelium [126, 208, 209]. Similar to other vasoconstrictors, endothelin induces 
smooth muscle contraction by increasing intracellular C+2. The initial phase of this 
contraction is achieved by activating IP3 system thereby mobilizing intracellular C+2 
stores. The prolonged phase of the contraction is maintained by stimulating the entrance 
of extracellular C+2. However the mechanism by which the entrance of extracellular C+2 
is achieved is not clear yet. Several investigations have suggested that the formation of 
inositol tetrakis phosphate (IP4) might trigger the entrance of C+2 [210-212].  
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In addition to its vasodilator and vasoconstrictor effects endothelin-1 promotes 
proliferation of vascular endothelium and smooth muscle cells and fibroblasts, which 
results in structural changes to the vascular wall. The mitogenic effect of endothelin-1 is 
attributed to stimulation of tyrosine residues phosphorylation and activation of two other 
mitogen-activated protein kinases in the vascular smooth muscle [213, 214]. 
Numerous reports have been published regarding the possible role of endothelin 
in a variety of phathophysiological conditions involving several body systems. These 
systems include the renal system, pulmonary system, heart and vasculature. This 
involvement in a wide range of diseases and conditions is due mainly to the endothelin 
capacity to induce constriction and cell proliferation. In the vascular system, endothelin 
increases vascular tone, vascular resistance thereby blood pressure. It is also believed to 
be involved in the atherosclerotic process and vascular structure alterations. Endothelin is 
also involved in increasing the production of other vasoconstrictor including rennin, 
angiotensin II, epinephrine, and aldosterone as well as increasing sympathetic activity. 
Besides its vasoconstrictor and pressor effect, endothelin has positive inotropic properties 
that increase the contractility of vascular smooth muscle [215, 216]. 
Veins appear to be super sensitive to endothelin as it was 5- to 10-fold more 
potent constrictor in isolated large veins than isolated large arteries from dog coronary, 
mesenteric, femoral, renal, and internal mammary vessels [217, 218]. Similar 
observations were also noted in human as endothelin produced greater contraction in 
human saphenuos vein then the gastroepiploic artery [219].  Endothelin effect in human 
is described as slow onset venoconstriction. This constriction was maintained even 
following the administration of Ca+2-blockers [220, 221]. On the other hand 
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venoconstriction was reversed when nitric oxide was administrated but to a lesser extent 
than as observed in the arteries [219]. Additionally infusion of potassium channels opener 
drugs and calcium channels antagonists prior to endothelin administration prevented 
endothelin-induced constriction [222]. In a comparison of the constrictor effect in human 
superficial hand veins, endothelin-1 was 26 times and enodhtlin-3 was 3 times more 
potent than sympathomimetic drug (phenylephrine) [223, 224].  
Activation of voltage-dependent channels [59, 225], closure of ATP-sensitive 
potassium channels [222], and most importantly mobilization of Ca+2 from internal 
sources [226] are the mechanisms by which endothelin increase Ca+2 levels and 
consequent venoconstriction. 
4.4. METABOLIC VASOREGULATION 
The metabolic theory of vascular control is characterized as changes in the concentration 
of dilator substances(s) alter the excitation-contraction coupling of vascular smooth 
muscle cells. Increased vascular resistance and decreased blood flow to metabolic tissues 
causes increased vasoactive metabolic substance concentrations in the interstitial space 
[97, 227]. This theory indicate that imbalanced blood demand/supply induce the 
production and accumulation of vasoregulation mediators. These mediators interact with 
the vascular smooth muscle of the resistance vessels inducing alterations in vascular tone 
thereby changes in local tissue blood flow [228].  
Hypoxia has been implicated as a vasomediator since oxygen might be a limiting 
factor in aerobic ATP production. This hypothesis indicate that reduction in cellular 
[ATP] during muscle exertion induces vasodilation [229]. However studies suggested 
that respiratory chain function and ATP production wouldn’t be affected until 
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mitochondrial PO2 reaches ~0.05 mmHg [230, 231]. This drop in PO2 can’t be found in 
normal situation even under hypoxic conditions experienced during exercise [232, 233].  
Hypoxia-induced smooth muscle contractions in isolated peripheral, coronary and 
cerebral arteries of the dog however have been documented. This response was attributed 
to an unknown substance produced from the endothelium to the smooth muscle [234-
236]. Endothelium-dependent vasoconstriction to hypoxia appears to be dependent on 
activation of voltage-dependent calcium channels in smooth muscle because the 
contraction was blocked by calcium antagonists [237].  
Upon the discovery of endothelin, as a vasoconstrictor, it has become an attractive 
candidate especially it produces a contractile effect sensitive to inhibition with calcium 
antagonists and does not require the activity of cyclooxygenase in animal models.  
However further analysis of the characteristics of the substance(s) released by hypoxia 
indicated that endothelin is not responsible for the response [238]. In addition contractile 
respond to endothelin is slow and sustained whereas hypoxia-induced contraction was 
fast and transient [239]. On the contrary, hypoxia-induced contraction can be blocked 
when activity of nitric oxide is reduced by either methylene blue or inhibition of nitric 
oxide synthesis. Thus endothelium-dependent contractions to hypoxia might be due to the 
reduced activities of nitric oxide caused by hypoxia rather than the release of a diffusible 
contracting factor(s) [240, 241]. In human internal mammary artery hypoxia-induced 
contractions can be attenuated by indomethacin or inhibition of nitric oxide synthesis and 
are abolished by a combination of both. Therefore in human endothelium, two 
contracting components might be involved during hypoxia; a product of cyclooxygenase 
and the reduced activity of nitric oxide [242]. Interestingly in re-perfused canine coronary 
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arteries, the hypoxia-dependent contraction is augmented indicating the response may 
contribute to myocardial ischemia in coronary artery disease [193].  
On the other hand endothelium-dependent hypoxic contractions are not observed 
in peripheral veins [192]. This lack of response however might be due less sensitivity of 
the venous smooth muscle to the contracting effect as coronary arterial smooth muscle 
“sandwiched” with venous endothelium exhibits hypoxic contraction [235].  
Since carbon dioxide production is coupled with oxygen consumption and ATP 
production [243-245] it might be an attractive candidate as a vasoregulator. Assuming 
venous PCO2 is representative of tissue PCO2 investigators have found a direct 
relationship between venous PCO2 and vasoactivity in both direction constriction and 
dilation [45, 246, 247]. However since these investigations where not designed 
particularly to distinguish between the effect of CO2 and H+, changes in pH might also 
play a role in vasodilation. 
Potassium is constantly floating around during metabolism and muscle 
contraction as it plays an integral role in cell membrane depolarization and repolarization. 
The progressive increase in interstitial [K+] noticed following increased metabolism is 
associated with a vasodilator effect [248]. However this vasodilator effect continues as 
the rise in [K+] disappears indicating transitory, complimentary or negligible role of 
potassium in the vasodilation attributed to metabolic out-products [249, 250]. A moderate 
increase in [K+] has minimum effect on smooth muscles of venous wall in animals [251, 
252]. However, higher concentrations (above 12-20 meq/liter) seem to potentiate the 
venoconstrictor effects of catecholamines and directly caused vasoconstriction of isolated 
veins [253-255]. These venoconstrictor effects of K+ ions have been attributed to 
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membrane depolarization and consequent influx of extracellular Ca+2 [256]. 
Concentrations above 30 meq/liter induce indirect venoconstrictor effect of K+ by 
stimulating norepinephrine from the nerve endings [257, 258]. Additionally 
concentrations of 10 or 15 meq/liter seem to inhibit the neuronal uptake of 
catecholamines. This inhibition was related to the Na+/K+ ATPase of the cell membrane 
[257]. This venoconstrictor effect of potassium is appears not significant as compared to 
the effect to sympathetic or norepinephrine activities.   
The relaxing role of adenosine appears to be significant during the early phase of 
vasodilation [259, 260]. This adenosine-induced vascular relaxation is activated by 
specific receptors located on the vascular smooth muscle and inhibited by 
methylxanthines [261, 262]. However the inhibition of adenosine activities didn’t prevent 
vasodilation to other factors including myogenic [228, 263] and acidosis [264]. 
Adenosine appears to promote dilation and to inhibit the effect of venoconstrictors, such 
as norepinephrine, in the venous side of the circulation in dogs [265, 266]. Similar 
observations were also found in human veins as adenosine promotes venodilation in a 
concentration-dependent manner [267]. In vivo, human hand veins precontracted with 
phenylephrine (a sympathomimetic) are relaxed by infusion of adenosine, showing no 
effect of aging on the venous respond to adenosine [268]. Venous relaxation in respond 
to adenosine or adenosine products was observed in several other tissue beds including 
erectile [269], portal [270] and jugular [271] veins of different species.      
It appears that several metabolic out-product are involved concurrently in the 
control of the vascular function. However, it’s not known which of these substances is the 
sole mediator of metabolic regulation. Evidence from experiments that perturb a steady 
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state suggests that vascular function don’t depend on a single metabolite. Rather the 
regulation of resistance vessels may reflect the combined influences of several 
vasodilators and the most likely candidates seem to be CO2/H+, K+, and adenosine [228].  
Identifying the attribution of each mediator individually requires a series of 
straightforward experiments designed to study the effect of each metabolic out-product in 
isolation from the rest of out-products. In addition this relationship has to be established 
under all physiological as well as pathological conditions [272]. However such a 
designed is not easy to accomplish and requires complex preparations. 
4.5. THE MYOGENIC VASOREGULATION  
Blood vessels respond to elevation in transmural pressure with constriction and to 
pressure reduction with dilation. These changes in the vessel diameter are induced 
independent from neural, hormonal, or metabolic influence and attributed to the 
autoregulations of the myogenic response. This behavior is most observed in the 
arterioles however it has been demonstrated in arteries, venules, veins, and lymphatics 
[97, 273, 274].  
Jones et al. reported the myogenic response as early as 1852 [275], and followed 
by similar observations by Ostroumoff et al. in 1868  [276], and Gaskell in 1881 [277]. 
However in 1902 William Bayliss was the one who clearly attributed a considerable 
contribution of vascular control to changes in transmural pressure. Bayliss concluded that 
changes in transmural pressure induce changes in the diameter of the vessels too rapid to 
be mediated by metabolic accumulation and is similar to isolated arteries constriction 
observed following sudden distension [278]. These findings were a matter of debate for a 
long time until 1949 Folkow demonstrated that denervated vessel preparations developed 
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pressure-dependant vascular tone [279] and autoregulation of blood flow was attributed 
in part to pressure-dependent mechanism [280]. These findings were followed by 
intensive investigations resulted in developing sophisticated techniques to study whole 
organ circulation [34, 281] and quantify the myogenic responses in the microcirculation 
[282, 283]. These investigations confirmed previous reports and concluded that the 
vascular responses to changes in transmural pressure are rapid [284] and induce 
considerable changes in vascular resistance [34, 281]. Development of isolated vessel 
techniques [285] has also allowed for more accurate quantification of myogenic 
mechanism in small arteries [286, 287] and arterioles [288, 289] where the effects of 
pressure could be clearly distinguished form flow, metabolic, neural and endothelial 
influences. 
The magnitude of the myogenic respond is inversely related to vessel size among 
arterioles of a given vascular network [14, 290]. However the magnitude of the myogenic 
respond of similar size vessels varies in different vascular beds. For example the rat small 
mesenteric vessels have weak myogenic respond whereas it is strong in similar sized 
cerebral [291] and skeletal muscle [292] vessels. These differences in the response were 
also observed between vessels with similar diameter in the same vascular bed [289]. 
Therefore the existence of the myogenic response is well documented however its 
strength varies between vessels even in vessels of similar diameter.  
Several studies, performed in isolated and in vivo vessel preparations, have 
attributed part of the basal vascular tone to the myogenic respond [14, 293]. In these 
studies increase in vascular transmural pressure resulted in vasoconstriction and increased 
vascular resistance independent of other controlling factors [294]. The myogenic 
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response is also postulated to play an important role in maintaining constant blood flow 
and capillary hydrostatic pressure during variations in systemic arterial pressure [97]. 
Whole organ data suggested that changes in arterial inflow and venous outflow pressures 
produced changes in arterial resistance that would serve to minimize changes in capillary 
hydrostatic pressure. Mellander et al. have reported constant cat hand-limp volume 
during wide range changes in systemic pressure [294]. Given the tissue volume is a 
reflection of capillary hydrostatic pressure, it was assumed that constant capillary 
hydrostatic pressure was achieved by the autoregulation of the myogenic respond [295]. 
However these assumptions have disregarded the role of Frank-Starling law and other 
local regulatory mechanisms. The myogenic response might be involved in maintaining 
blood flow and capillary hydrostatic pressure, however other regulatory mechanisms 
might play a more important role [14]. 
Vascular smooth muscle contraction and relaxation associated with the myogenic 
response is thought to be the results of vascular smooth muscle membrane depolarization 
and increased calcium ions permeability [296, 297]. However recently researchers have 
found that myogenic contraction is initiated by depolarization of the vascular smooth 
muscle, which modulate calcium ions entry to the cell through voltage-gated calcium 
channels [298]. Data from cat cerebral artery showed graded (by –20m) vascular smooth 
muscle depolarization occurred as pressure was changed from 0 to 160 mmHg [299]. 
Similar observations were recorded in pig coronary [300], bladder myocytes [301] and 
mesenteric artery myocytes following longitudinal stretch [302]. This depolarization was 
associated with activation of voltage-gated calcium channels and subsequent myogenic 
behavior [14]. 
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SECTION 5. ACUTE VASCULAR RESPONSES TO EXERCISE 
Greater blood flow to skeletal muscles during exercise is a combination of increased 
cardiac output, increased inactive tissue vascular resistance and decreased skeletal muscle 
vascular resistance. Certainly this increase is in accordance with active muscle metabolic 
demands [303] and the result of the integration of central and peripheral mechanisms 
[15]. Cardiac output increases as a result of greater venous return and stroke volume, 
additionally increased sympathetic activities and parasympathetic withdrawal strengthen 
contractility and accelerates heart rate, thereby larger cardiac output [304].  
Vascular adjustments to exercise however are controlled centrally and 
peripherally. The large sympathetic discharge and increased hormonal activities cause 
total body vasoconstriction thereby increased vascular resistance. This “global” 
vasoconstriction is in favor of active muscle blood flow as local vasodilatory mechanisms 
are activated causing vascular smooth muscle relaxation during exercise [305]. This 
dynamic behavior of the vasculature, systemic vasoconstriction and local vasodilation, 
causes blood redistribution. Since blood is more needed in the contracting muscles the 
majority of cardiac output is redistributed or shunted toward the active muscles while 
blood flow to most of the inactive tissues is reduced [306]. 
 Vascular adjustments are often regulated by different mechanisms during 
different phases of exercise as none of these mechanisms could alone explain the 
integrated control of blood flow to the active muscles [307]. While vascular control 
during exercise is complex this chapter will try to explain the mechanisms responsible for 
increasing blood flow to the active muscles. The systemic control of vascular function 
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will be briefly discussed whereas the peripheral vasoregulatory mechanisms will receive 
greater attention.    
5.1. SYSTEMIC VASOREGULATION DURING EXERCISE 
Muscle contractions stimulate the vasomotor center to increase sympathetic 
activities and to cause parasympathetic attenuation [308]. The mechanism (s) by which 
the vasomotor center is stimulated during physical activities is still a mater of debate. 
Since heart rate and ventilation at onset of exercise increase almost immediately whereas 
electrically induced exercise (central command inoperative) developed a slower 
tachycardic response some researchers have suggested a centrally mediated sympathetic 
control of the cardiovascular function. Freyschuss et al. reported that static contraction 
increased heart rate and blood pressure with or without neuromuscular blockade, however 
this increase was one-half greater without blockade [309]. Therefore the supporters of 
this theory propose that motor outflow from the cerebral cortex interacts with the central 
neuron pools that regulate the cardiovascular responses to exercise. On the other hand, 
others reported electrically induced contraction caused an increase in heart rate and blood 
pressure indicating an activation of the sympathetic nervous system without central 
command involvement [310-312]. Additionally this increase in sympathetic nervous 
activities was intensity related [313, 314]. The supporters of this theory indicate that 
peripheral mechanical and chemical receptors are responsible for increased sympathetic 
activities associated with exercise. They further explain that reflexes from the contracting 
muscles seam to be the primary mechanism that activates the vasomotor center to initiate 
a sympathetic drive [315]. It seems muscle mechanoreceptors are the main source of 
peripheral reflexes during initial phase of exercise (0-15 sec.) whereas vascular 
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baroreceptors, carotid bodies, thermoreceptors and muscle chemoreceptors are activated 
next (15 sec.-2 or 3 min.) by exercise. Peripheral reflexes during steady-state (3 min. 
onwards) seems to be derived from the activation of all peripheral mechanisms [316]. 
However both sides of the argument have ignored the integration of central and 
peripheral mechanisms to provoke sympathetic activities. In a recent study, Wichester et 
al., [317] demonstrated the importance of both mechanisms to evoke sympathetic 
discharge during exercise as demonstrated in patients with Brown-Sequard syndrome. 
The spinal cord in these patients is hemisectioned leaving one side of the body with 
sensory loss and normal motor function and the other side with normal sensation and 
reduced motor function. Voluntary and electrically stimulated static knee extension of 
either legs (with either deficit) elicited increases in heart rate and blood pressure, except 
during electrical stimulation of the leg with sensory deficit heart rate and blood pressure 
didn’t increase. In summary, neural mechanisms of cardiovascular control is redundant 
[318] additionally modifications in autonomic nervous system activity could always find 
a strategy for stimulating the cardiovascular system stressing the plasticity of the neural 
network [317].    
Regardless of the mechanism (s) responsible for activating the vasomotor center, 
exercise appears to initiate sympathetic release that is rapidly propagated to the heart and 
most vascular networks. Probably the most remarkable characteristic of the autonomic 
nervous system is to elicit cardiovascular adjustments within few seconds. For example 
the sympathetic nervous system double heart rate within 3-5 seconds whereas blood 
pressure is increased to double normal within 15 seconds [15, 63]. This exceptional 
capability is due to the sophisticated and extensive neural network that connects the 
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central nervous system to the heart and almost all segments of the vasculature [61, 64]. 
Increased sympathetic activities during exercise to small arteries and arterioles increase 
vascular resistance, blood pressure and blood flow to areas of need. Whereas the 
sympathetic innervation to the large vessels, particularly the veins, assists in propelling 
blood from these vessels to the heart thus generating larger venous return, stroke volume 
and cardiac output [20]. For example the sympathetic stimulation increases arteriolar 
resistance by ~eight-folds and can expel approximately 40% of the blood in the 
capacitance vessels [319].  
Although sympathetic outflow help increasing blood flow to the contracting 
muscles by triggering systematic vasoconstriction, substantial increase in sympathetic 
drive as a result of engaging in near maximal exercises involving large number of muscle 
groups might induce skeletal muscle vasoconstriction [320, 321]. In a study by Clausen et 
al., exercising upper and lower body at near maximal intensity resulted in decrease in 
lower body blood flow. This could be an active reflex redistribution of cardiac output and 
would indicate that all sympathetic efferent activity is not locally blocked or attenuated 
[322]. This increase vascular resistance might be essential to maintain sufficient blood 
pressure with the circulation [314, 323]. However vasoactive agents resulting from the 
contracting muscles usually override skeletal muscle vasoconstriction by reducing 
sensitivity to [324] and maybe even inhibit the release of norepinephrine [102, 325, 326] 
thereby maintaining sufficient blood flow. Actually norepinephrine might stimulate the 
release of some of these agents thereby induce vascular smooth muscle relaxation and 
increase active muscle blood flow [327]. 
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Cardiovascular responses to dynamic upper body exercise are different from 
lower body exercise. Due to the lack of lower body musculature involvement during 
upper body exercise a large vasculature remains undilated providing resistance to 
peripheral circulation [328]. This larger peripheral resistance induces substantially higher 
blood pressure at a given exercise intensity. Additionally at a given submaximal steady 
state oxygen consumption, heart rate during upper body exercise is higher. Due to less 
musculature involvement in upper body exercise venous return and stroke volume are 
lower. Therefore, since cardiac output is similar for upper and lower body exercises 
higher heart rate compensate for the reduced stroke volume [329, 330]. 
The complete parasympathetic withdrawal is achieved at heart rate of ~100 b/min. 
This withdrawal causes an increase in cardiac output however it has minimum effect on 
the vasculature since they have very few vagal receptors [72]. Therefore as far as neural 
control, the sympathetic nervous system plays a greater role in controlling the vascular 
during exercise [65].  
Increased sympathetic drive, during exercise, activates the medullary portion of 
the adrenal glands to release relatively large quantities of epinephrine and a smaller 
amount of norepinephrine. Essentially both adrenal hormones activate adrenergic 
receptors of the cardiovascular system causing increased cardiac output and generalized 
vasoconstriction. Hormonal control however seems to play a relatively minor role in 
regional blood flow during exercise compared with the more direct, rapid and potent 
sympathetic neural control. Furthermore it is more essential during stead-state exercise as 
it support the neural activities to maintain appropriate cardiovascular respond. 
Additionally other physiological requirements, including thermoregulation, fluid 
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homeostasis and metabolic activities, compete for the adrenal medulla hormones [316, 
331]. 
5.2. PERIPHERAL VASOREGULATION DURING EXERCISE 
Increased blood flow and oxygen delivery to the contracting muscles are essential in 
order for exercise to continue. The first few seconds of exercise are associated with 
substantial increase in muscle blood flow, perfusion and oxygen extraction while these 
elements remain elevated as long as muscles are contracting [305]. In fact peak muscle 
blood flow during exercise is estimated to increase ~20 folds and to peak at 300-400 
ml/min/100 g [306]. Certainly this increase is in accordance to muscle metabolic 
demands and related to muscle oxygen consumption [332], muscle contracting frequency 
[333, 334], and running speed [335, 336]. Additionally within the active muscle group 
the recruited muscle fibers appear to receive most of muscle blood flow [334, 336].  
Sympathetic vasoconstriction is induced during exercise throughout the body 
except in the contracting skeletal muscles. In a study by Johnson and Rowell blood flow 
to forearm decreased whereas it increased to the leg muscles during prolonged lower 
body exercise [337]. In fact blood flow was observed to increase to red portions and 
decrease to white portions of the same muscle during low-intensity exercise [338, 339]. 
The increased sympathetic vasoconstriction and decreased blood flow to inactive tissues 
while blood flow to the contracting remains elevated is achieved by functional 
sympatholysis. This process involves deactivating sympathetically induced 
vasoconstriction during exercise [325].  
5.2.1. Local Mechanisms Contribute to Vasoregulation  
Various mechanisms have been proposed to contribute to locally induced increase in 
muscle blood flow, as none of these mechanisms can be solely held accountable for this 
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substantial increase. Muscle pump, metabolic factors, myogenic response, and 
endothelial-derived relaxing factors have been implicated as vasoregulatory mechanisms 
responsible for the increased blood flow during exercise. These mechanisms are a 
reflection of the contracting muscle activities and primarily to offset the vascular 
responses to systematically induced vasoconstriction [254, 340-342]. 
Metabolic Mechanisms 
The oldest mechanism have been considered to contribute to hyperemic response 
associated with exercise is metabolic vasodilation. As previously discussed, contracting 
muscle metabolic byproducts are one of the mechanisms involved in peripheral reflexes 
that initiate sympathetic vasoconstriction. Ironically however these metabolites also 
appear to be involved in local muscle vasodilation during exercise. The byproducts of 
metabolism accumulate in the interstitial fluid surrounding resistance vessels, thereby 
establishing a local mechanism that is capable of matching oxygen delivery to the level of 
contractile activity. The mechanism(s) by which the sympathetic vasoconstriction in the 
active muscle is deactivated varies however the metabolic byproducts generally compete 
with the sympathetic vascular regulation causing vascular smooth muscle to be less 
sensitive to catecholamines [325]. For example Dodd and Johnson reported that the 
metabolic byproducts reduced vasoconstriction mediated by post-junction α1-
adrenorecepoters but not by circulating catecholamines [343]. There is also a differential 
sensitivity of α1- and α2-adrenoceptor constriction to metabolic inhibition during skeletal 
muscle contraction as metabolic release of dilator substances attenuated α2-adrenoceptor 
constriction 10-folds more than α1-adrenoceptor constriction [327]. 
Anyway the apparent relationship between muscle metabolism and muscle blood 
flow during exercise indicates a factor related to muscle metabolism might contribute to 
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vascular tone regulation. This relationship becomes evident when vasodilation was 
observed in resting recipient muscle upon the infusion of venous blood from a 
contracting muscle [344, 345]. It appears metabolites produced by the contracting 
muscles diffuse to the resistance vessels causing vasodilation and increased capillary 
recruitments. Adenosine, magnesium, potassium, calcium, oxygen and overall osmolarity 
are among the vasoactive factors associated with skeletal muscle metabolism and have 
been implicated in elevation of muscle blood flow during exercise [325]. Isolating the 
vasoactivity of each factor is a challenge however some studies have successfully 
observed the action of some of these factors.  
Adenosine appears to accumulate in the vicinity of the contracting muscles [346]. 
The source of adenosine could be muscle tissue [347], endothelium tissue [348, 349], or a 
property of nervous activities [350]. However the muscle seem to be the major source of 
adenosine during contraction as electrically stimulated muscle produced adenosine 
without the present of nerve and endothelial cells [347]. 
Regardless of the source during contraction adenosine seems to induce 
vasodilation associated with increased muscle blood flow [15]. Arterial infusion of 
adenosine has been shown to produce vasodilation in most vascular beds including in 
human forearm and leg muscles [351] [352]. The magnitude of this vasodilation is 
comparable to the one observed during peak effort and greater than induced by 
acetylcholine [353].  
Adenosine blockade seems to show the importance of adenosine vasodilatory role 
as exercise hyperemia is reduced in animals. During electrically induced muscle 
contraction exercise hyperemic response was reduced in cat [354], dog [355] and rabbit 
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[356] when adenosine receptors were blocked. Additionally peak and average arteriolar 
diameter and volume flow in hamster was reduced [357]. Data from human exercise 
investigations are however insufficient to form a conclusion. Systemic infusion of 
nonspecific adenosine receptor blockers in human reduced total reactive hyperemia after 
5-10 min. of forearm occlusion [352]. However minimum information available 
regarding adenosine receptor blockade on exercise-induced hyperemia in human skeletal 
muscle. Additionally since the only drug used in human trials to block adenosine 
receptors is nonselective therefore other vasodilator mechanisms might be inhibited or 
activated and mask the blockade effect [358].  
Muscle fiber type and intensity of exercise might play a role in the vasodilatory 
effect of adenosine. In a study by Schwartz and McKenzie the administration of 
adenosine deaminase (promotes the degradation of vasoactive adenosine) reduced muscle 
blood flow by ~40% during high intensity contractions of highly oxidative slow-twitch 
cat soleus muscle followed by reduction in muscle oxygen consumption and force 
production. Whereas the same variables in the same muscle were not effected by 
adenosine deaminase during low-intensity contraction. Moreover adenosine deaminase 
had no effect on these variables during neither low- or high-intensity contraction of fast-
twitch cat gracilis muscle [359]. These data indicate that the vasodilatory effect of 
adenosine appears to be most evident during high-intensity contraction of highly 
oxidative slow-twitch muscles. This might be related to adenosine formation from AMP, 
which is proportional to oxidative capacity of the tissue, which greatest in slow oxidative 
muscle fibers during high intensity contraction. [359]. 
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Since potassium is one of the byproducts of skeletal muscle it has been implicated 
as one of the contributors to the vasodilation associated with exercise [341, 345]. Several 
studies have illustrated the relation of accumulated potassium to reduced vascular 
resistance [333, 360] and increased muscle blood flow during exercise [345]. The 
vasodilatory effect of potassium however seems to be transient. The increase in venous 
potassium [361] as well as potassium infusion [345] were found to be effective for a short 
period of time indicating involvement in the initial phase but not in the maintenance of 
functional vasodilation. Additionally resting blood flow or the relationship between 
oxygen consumption and tissue blood during contraction were not changed as a result of 
potassium infusion [362]. Therefore potassium has been rolled out as a primary 
vasodilator during steady-state exercise [362, 363]. However the increase in systemic 
potassium observed during large mass muscle maximal contraction might be sufficient to 
induce vasodilation in other vascular beds [363]. 
While changes in hydrogen and subsequent reduction in pH during exercise are 
well established [345] no relationship was found between venous blood concentration of 
hydrogen ions and vascular resistance [360]. Additionally vasodilation observed during 
exercise was not associated with increased arteriolar hydorogen ions nor superfusion with 
highly acidic mixture resulted in significant vasodilation [364]. Therefore alterations in 
local pH don’t seem to play a role in increasing blood flow to contracting muscle. 
Since ions and metabolic byproducts increase in the venous blood the subsequent 
increased in osmolarity [341, 345, 365] might be presumed as a vasodilator agent during 
muscle contraction. Although raise in osmolarity can result in relative increase in skeletal 
muscle vasodilation [366], elevated venous blood osmolarity during contraction is not 
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related to the magnitude of the decrease in vascular resistance [333, 360] and observed 
dilation is transient [345, 365]. Additionally artificially increasing osmolarity in the 
venous blood of resting muscle does not result in vasodilation similar to the one observed 
in exercising muscles [365] nor alters the relationship between blood flow and tissue 
oxygen consumption [362]. Moreover blood flow remained elevated while osmolality 
returned to control values during long-lasting muscle contraction [367], whereas blood 
flow returned to control values as osmolality in venous blood remained high during close 
arterial infusion of hyperosmotic solution [368].  Therefore local osmolarity might play 
minor role in the vasodilation observed during exercise other factors associated with 
exercise seem to have greater influence. 
As important as each metabolite in vasodilation associated with muscle 
contraction simultaneous alterations of multiple chemical factors have a synergistic effect 
on vascular function. In a study by Skinner and Costin, simultaneous manipulations of 
oxygen content, potassium concentration, and osmolarity of arterial blood could produce 
vasodilation comparable to that seen during contraction while manipulation of single 
chemical factor resulted in weak vasodilation [341]. Similarly correcting venous blood 
PO2 and pH completely abolished the vasodilator effect of venous blood from the 
contracting muscle [361]. Additionally Mohrman and Regal found the combined effect 
insufficient PO2 and PCO2 is profound and may account for most the metabolic 
vasodilation observed during contraction [332]. These and other studies confirm the 
importance of each muscle metabolic byproduct during contraction however they also 
emphasize the importance of the combined effect of these byproducts. They also suggest 
that a variety of chemical combinations can result in profound increases in skeletal 
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muscle blood flow, which might differ according to muscle fiber, contraction speed, 
stimulation parameters, species or other factors associated with muscle properties during 
exercise. 
As much as the metabolic theory is accepted, it doesn’t not explain all the 
hyperemia observed during exercise. Additionally the vasodilation generated by 
metabolic factors (e.g. potassium, PO2, adenosine, osmolarity) seem to be sufficient to 
initiate exercise hyperemia however don’t persist as exercise hyperemia continues. This 
indicate that they are either are not responsible for exercise vasodilation or are 
superseded as exercise continue [250, 363]. Additionally vasodilation occurs at location 
not within the metabolic vasodilatory factor reach. Therefore other mechanism(s) should 
be involved in vasodilation observed during exercise especially after the initial phase of 
exercise hyperemia and in locations away from interstitial fluid [369].          
Mechanical Mechanisms 
Skeletal muscle during contraction undergoes a cycle of shortening and lengthening 
causing the muscle contracts and relaxes, respectively. The contracted muscle produces 
mechanical tension that reduces and, in some occasions, pauses blood flow to the active 
tissue even during maximal vasodilation [344, 370]. Any reduction in blood flow during 
contraction is rapidly compensated for by an overshoot during the relaxation phase. 
Additionally muscle force development during rhythmic contraction fell sharply with 
small reduction in perfusion pressure and blood flow [371]. In the venous system, the 
muscle pump propels blood toward the heart as well as maintains venous pressure. 
During quiet standing, gravitational effects cause the drainage of thorax blood to the 
lower parts. Instantly skeletal muscles surrounding the veins start contracting and pushing 
against the veins to propel blood toward the heart [2, 15]. Meanwhile with the help of the 
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venous valves the veins refill during muscle relaxation. In this case skeletal muscle is 
acting as a pump, which is clearly demonstrated during exercise as it plays a more 
effective role in driving blood toward the heart during exercise.   
Transmural pressure is the pressure gradient across the vessel wall and calculated 
as the difference between internal pressure and external pressure. Elevation in transmural 
pressure causes vasodilation whereas reduction causes vasoconstriction. These changes in 
the vessel diameter are induced independent from neural, hormonal, or metabolic 
influence and attributed to the autoregulations of the myogenic response. This behavior is 
most observed in the arterioles however it has been demonstrated in arteries, venules, 
veins, and lymphatics [97, 273, 274].  Due to increase in byproducts within the muscle 
tissue pressure increases during exercise causing a decrease in transmural pressure 
thereby vasodilation. The reduction in transmural pressure and subsequent increase in 
vasodilation and blood flow can even occur at intensities as low as 15-30% of MVC [372, 
373]. In fact Mohrman and Sparks reported that vascular myogenic respond accounts for 
~50% dilation observed following 1 sec tetanic contractions in the dog gastrocnemius 
muscle [374]. Myogenic vasoconstriction, caused by rapid increased in intravascular 
pressure, seems to be very potent and can’t be overridden by local vasodilators at rest and 
during contraction. In a study by Meininger et al., the myogenic vasoconstriction is 
maintained in the presence of extremely low tissue PO2 in resting skeletal muscle [375]. 
Moreover Lash and Shoukas reported reduction in functional vasodilation by 60-70% as a 
result myogenic vasoconstriction during rest and exercise [376].  
Increased vascular resistance and cardiac output associated with exercise result in 
systematic increase in blood pressure, which is also another mechanical factor contributes 
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to vascular control. Elevated mean arterial blood pressure increases perfusion pressure 
across the vascular bed thereby increasing muscle blood flow [377, 378]. 
Endothelial Mechanisms 
While metabolites with vasodilator properties have been considered to amply contribute 
to vasodilation it doesn’t fully explain the magnitude, persistence and the sites of 
hyperemia observed during exercise. For example the vasodilatory effect of metabolites 
seems to diminish after the initial stage of exercise (~ 1st 3 minutes)  [250, 325, 363] as 
well as hyperemia observed during exercise is more than the maximum possible 
hyperemic respond can be produced by metabolic byproducts [305, 369]. Additionally 
although it is generally assumed that small arterioles are the major resistance vessels 
recent investigations revealed that 40-55% of the total vascular resistance reside in large 
arterioles and small arteries. Metabolic byproducts can’t account for the vasodilation 
detected in the larger upstream vessels, which are not bathed with interstitial fluid or 
subjected to skeletal muscle metabolic factors [369, 379]. These observations indicate the 
involvements of and have commenced the search for other mechanisms to explain all 
aspects of the tremendous increase in skeletal muscle blood flow during exercise. 
The involvement of the endothelium tissue in the regulation of blood flow has 
been suggested first by Furchgott and Zawadzki [104] and has provided further 
explanations to aspects associated with exercise hyperemia. Pharmacological agents such 
norepinephrine, acetylcholine and bradykinin as well as physical factors such as shear 
stress have been proposed to cause the release of nitric oxide. Both of these stimuli are 
augmented during exercise [380, 381] and increase intracellular level of Ca2+, which 
triggers nitric oxide synthase activities and subsequent nitric oxide production.  
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Indirect evidence, from pharmacological studies of large conduits, strongly 
suggests that α2-adrenergic receptors are present on vascular endothelial cells [382, 383]. 
Since catecholamines increase during exercise, it would be justifiably predicted that they 
might induce the release of nitric oxide. Additionally nitric oxide released has been 
observed to diminish contraction induced by α1- and/or α2-adrenergic receptors located on 
the vascular smooth muscle cell [102, 383]. These data imply stimulation of α2-
adrenergic receptors might be involved in the release of endothelial nitric oxide. 
Flow-mediated dilation or shear stress-induced vasodilation is another function of 
the endothelial cell. During exercise, increased blood flow velocity within the vascular 
lumin causes an increase in the blood drag force against the vascular walls creating a 
shear stress. The increased stress of blood shearing against the vessels is a signal that 
causes vasodilation to reduce stress against the vascular wall.  However, intact functional 
endothelium is obligatory for optimal regulation of shear stress [384, 385]. Stress of 
blood sheering against the endothelium layer produces vasodilatory factors, including 
nitric oxide, from the endothelium tissue resulting in vasodilation of the proximal smooth 
muscle cells [305]. Once released nitric oxide diffuse to the underlying vascular smooth 
muscle cells, which activates guanylate cyclase to convert GTP to cGMP, thereby 
vasodilation occurs [126]. 
Skeletal muscle blood flow at rest is estimated to be 2-4 ml/100g/minute whereas 
it might exceeds 50-80 ml/100g/minute and values as high as 500 ml/100g/minute have 
been reported during strenuous exercise [306, 386]. This tremendous increase in muscle 
blood flow is highly associated with the metabolic demands of skeletal muscle. Although 
terminal arterioles and small arterioles regulate blood flow to the capillaries and 
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contribute largely to vascular resistance large arterioles and small arteries control the 
amount of blood received by the terminal arterioles and account for 40-55% of vascular 
resistance [369]. Since they are within the influence of the muscle metabolic signals, the 
diameter of the smaller vessels change according to the muscle metabolic demands. 
However upstream feed arteries are not within reach of the metabolic influence yet their 
vasoreactivity are still in accordance to the contracting muscle metabolic demands [305]. 
Moreover smaller vessels are mainly controlled by changes in local metabolites thus they 
regulate intra-organ blood flow whereas neural and endothelium regulation is 
concentrated on the larger arteries which are better placed to regulate the organ perfusion 
and systemic blood pressure [305]. Smaller vessel dilation is capable of increasing blood 
flow by a factor of only 2-3 times more than resting levels, which is simply not adequate 
to attain increase in flow of blood observed during exercise. Additionally without a 
decrease in feed artery resistance, increased perfusion pressure through the microvessels 
would be prohibited, thereby limiting the driving force for flow. Therefore concomitant 
and coordinated dilation of the feed arteries located upstream seems detrimental to meet 
the metabolic demands of the exercising muscle [305, 369]. 
Consequently it is clear, in order to match blood flow with muscle metabolic 
requirements, the vasodilatory response to exercise has to be controlled by coupling 
microvessel dilation with that of upstream arteries. This could be achieved by ascending 
signals from the downstream vasculature to that of the upstream to induce feed artery 
dilation [305]. These signals could be a functional vasoactive respond that propagates 
vasodilation by direct cell-to-cell conduction along the vascular wall vie gap junctions of 
either the endothelium tissue [387] or the smooth muscle cell [388]. Recent work 
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suggests that the signal might be a depolarization propagation triggered by acetylcholine 
along the endothelial cell layer ascending dilation along the arterial network [387, 389], 
however more research is needed to verify these findings. Therefore functional 
hyperemia seems to be originated in the smallest pre-capillary arterioles, which are 
generally presumed to be the most sensitive to vasodilator metabolites and spreads 
towards the lager arteries. 
With flow-mediated dilation mechanism, sheer stress causes the release of 
endothelium-relaxing factor(s), which relaxes adjacent smooth muscle cells. Through this 
mechanism, the initial dilation of downstream vessels will increase flow through 
upstream vessels, inducing dilation of the upstream vessels [379, 390]. In fact cell-to-cell 
communication during exercise has also been reported to be influenced by venous 
factors. Venular endothelial cells can also release factors that relax adjacent arterioles and 
thereby contribute to functional hyperemia, without the present of arterial endothelium 
[391]. 
Nitric oxide is clearly essential for the vasodilatory respond to exercise, recent 
evident however suggest the contribution of endothelin-1 in the increased blood flow to 
the contracting muscle. Maeda et al., demonstrated increased circulating endothelin-1 
following 30-minute exercises at 90 and 130% of ventilatory threshold of young healthy 
volunteers. The concentration of endothelin-1 was the greatest after 30 minutes of 
exercise cessation and was greater following the higher intensity [392]. In a follow-up 
study, Maede et al. showed that circulating endothelin-1 increased in femoral artery of 
the noncontracting muscle and decreased in the contracting muscle during strenuous 30-
minitues-leg exercise [393]. The authors of these studies concluded that endothelin-1 
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increase during exercise is intensity dependent and contribute to the distribution of 
increased cardiac output during exercising.        
5.3. SUMMARY 
Muscle contraction triggers systemic and local mechanisms involved in vascular control. 
Systemic factors, including neural and hormonal, appear to maintain the homeostasis of 
all aspects of the cardiovascular system including the heart, vessels and blood 
distribution. The raised sympathetic drive increases cardiac output, total vascular 
resistance and direct blood toward the working muscle. The shift of the increased cardiac 
output toward the active muscles is also facilitated by the vasodilatory factors produced 
at the site of contraction by overriding the vasoconstrictory effect induced by the 
sympathetic discharge. These factors include metabolic, endothelium and mechanical 
factors. Metabolic vasodilators tend to influence the arteries within the interstitial space, 
which includes capillaries, terminal and small arterioles. Whereas endothelium-induced 
vasodilation seems to be involved in flow-mediated dilation, which occurs mainly in the 
large arterioles and small arteries and triggered mainly by the dilation in the distal vessels 
and sheer stress. However these factors jointly increase the diameter of the vessels 
thereby blood delivery to meet the metabolic demands of the muscle. The relative 
importance of each of these factors to the vasodilatory response is not well understood, 
however each factor seems to play a role and to contribute to increased blood flow to the 
contracting muscle either throughout the exercise period or limited to only initiation of 
the blood increase. Moreover some factors appear to be more important than others 
depending on the muscle fibers involved in contraction. It seems, as might make sense, 
muscle blood flow increase in oxidative fibers more than nonoxidative. Finally systemic 
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and local factors compete to takeover the control of the vessels however it appears as 
long as the muscle is contracting, factors produced locally usually claim “victory”. 
5.4. VENOUS RESPONSES TO EXERCISE 
According to the Frank-Starling theory of contraction, the heart can pump only what 
passively fills it during diastole. The venous system operates as a collecting reservoir for 
blood and controls the quantity of blood returning back to the right atrium. The increase 
in the amount of blood mobilized in the veins and propelled back to the heart during 
exercise is well established. This increase in venous return is essential to accommodate 
the required increase in cardiac output [32]. While the controlling mechanisms of blood 
flow in the arterial vasculature during muscle contraction are complex and interrelated 
more controlling mechanisms are even involved in the venous system. Low intra-vascular 
pressure, large volume present, intermittent nature of the flow, gravitational effect, 
venous valves, cardiac pressure, and the collapsible nature of the venous wall add 
complicity to flow in the venous cavity as all these factors interact with each other during 
exercise to achieve blood return to the heart [20].  
Flow of blood runs with no resistance in large veins when they are distended 
however as veins enter the thorax and abdominal cavities flow is impeded. Most veins are 
compressed at many points by the surrounding tissues as a result of the intra-thorax and 
abdominal pressures, which obstructs flow of blood to the heart chambers [27]. Due to 
the increase in intercostals muscle contractions during exercise the physical pressor in the 
intra-thorax cavity increases causing further obstruction of blood in the veins. 
Pressure in the right atrium might also hinder blood returning back to the heart 
from the systemic circulation. The increase in speed and force of cardiac contraction 
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during exercise causes elevation in cardiac pressure including pressure in the right atrium 
resulting in venous return blood to backup [32, 35]. However pressure against flow of 
blood in the venous system doesn’t increase until all collapsed segments between 
peripheral veins and large veins have opened, which doesn’t occur until right atrial 
pressure reaches 4-6 mmHg.  A further increase in right atrial pressure would reflect a 
progressive pressure increase in large veins [33, 34].  
Upon presuming standing position, gravitational effects cause the drainage of 
thorax blood to the lower parts. Instantly skeletal muscles surrounding the veins start 
contracting and pushing against the veins to propel blood toward the heart meanwhile, the 
veins refill during muscle relaxation [2, 15]. In this case skeletal muscle is acting as a 
pump, which is clearly demonstrated during exercise as it plays a more effective role in 
driving blood toward the heart. The efficacy of this pump is intensity dependent and 
certainly enhances venous blood flow [15]. 
The contraction of the venous smooth muscle also plays a role in driving blood 
toward the heart, however its contraction depends on the intra-vascular pressure. The 
venous wall movement is mainly passive at low pressure, however when venous pressure 
increases above 5 mmHg wall tension increases providing an active role of the venous 
tone. Venous tone is controlled mainly by central and local neurohumoral signals [2, 27]. 
While the skeletal muscle pump and venous tone is important to propel blood 
forward, the venous valves prevent flow regurgitation. Following skeletal muscle 
contraction and propelling blood forward, the valve cusps close and the veins refill 
rapidly allowing unidirectional flow only [13, 20].  
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The intra-thorax pressure varies during quiet breathing from –2 to –4 mm Hg 
during expiration to about –5 to –7 during inspiration. The intra-abdominal pressure 
decreases when intra-thorax pressure increases facilitate venous return form the intra-
thorax veins thereby increase thoracic vena cavae flow of blood and venous return. The 
resultant changes in flow inside the veins cause ±25% changes in cardiac output during 
respiration. This change in cardiac output is even more pronounced during exercise due 
to the increase in the rate and force of perspiration [27]. 
In a series of studies by Bevegard and colleagues venous function was examined 
during and following exercise. Forearm and calf venous capacitance decreased and 
pressure increased during leg exercise and combined leg and handgrip exercises. 
Additionally forearm and hand venous capacitance decreased in accordance to leg 
exercise intensity throughout the experiment. The authors attributed these changes to 
increased venous tone induced by sympathetic venoconstriction and with minimum 
contribution of the muscle pump especially since venous tone remained elevated even 
following cessation of exercise [394, 395]. In subsequent studies, Bevegard reported 
increase in forearm blood inflow without concomitant increase in venous capacitance 
following cessation of exercise indicating that local vasodilators contributed to arterial 
dilation but didn’t change venous tone confirming previous observations [396]. Similarly 
Seaman and colleagues investigated forearm venous function during handgrip exercise at 
20, 30 and 40 % of most voluntary contraction. Venous filling decreased and venous 
pressure increased indicating greater venous wall tension during exercise. The authors 
concluded that this increase was intensity dependent and is a reflection of 
venoconstriction essential to increase venous emptying and right atrial and ventricle 
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fillings [397]. In 1968 Robinson and Wilson examined the effect of exercise on venous 
function of nonworking muscle with and without propranolol (β-blocker) administration 
in young healthy males. Forearm venous compliance decreased during exercise than it 
had been at rest. Moreover despite reduction in heart rate, an indictor of cardiac 
performance, propranolol administration didn’t cause changes in forearm venous 
compliance however forearm blood flow and vascular resistance decreased and increased 
respectively. The authors concluded that venous compliance in the nonworking muscle is 
decreased during exercise however its not affected by reductions in cardiac output 
whereas the arterial system is affected by changes in cardiac performance [398]. Detry et 
al. investigated the effect of exercise on the venular blood volume of nonworking 
muscles with and without nitroglycerine, a potent vasodilator, in normal young men. 
Forearm venous volume decreased by 25% during moderate-intensity leg exercise 
however this volume increased following nitroglycerine administration indicating volume 
changes might be due to venoreactivity. The authors concluded that the venous system in 
the nonworking muscle constricts during exercise however nitroglycerine administration 
causes venodilation. Additionally the effect of exercise on venous distensibility is 
essential to increase venous return however the effect of nitroglycerine caused venous 
relaxation and pooling thereby reducing preload which might partially explain the reason 
nitroglycerine is helpful for individuals with angina patients [399]. In order to determine 
variations in venous function hemodynamics during the course of the day, changes in 
valvular function, calf muscle pump and ambulatory venous pressures were examined 
during performing daily activities in the early morning and late after noon. These 
functions were examined during standing up from supine position and after tiptoe 
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exercises in males and females. Indexes of valvular venous function in males and females 
were lower in the afternoon than in the early morning whereas calf muscle pump and 
ambulatory venous pressure indexes remained the same. These data indicate that venous 
function is not affected by either daily circadian rhythm or gender, with the exception of 
the effect of daily circadian rhythm on venous valvular function [400]. 
In the contrary other investigations have reported venous dilation. The increase in 
sympathetic activity associated with exercise causes systemic arterial and venous 
constriction. However infusion of vasodilator substances as well as applying heat resulted 
in significant dilation in the arterial vessels but did not change venous tone [401-403]. 
These results indicate the involvement of other factors. Marshall and Tandon investigated 
venous function during exercise using direct measurements. The internal diameter of 
individual arterioles and venules of rat spinotrapezius were measured immediately after a 
period of electrical stimulation. The arteries as well as veins similarly dilated within the 
region of muscle contraction. Venodilation was faster and larger in magnitude in the 
smallest vessels as well as in individual venous and was contraction frequency dependant 
indicating metabolic vasodilation. The authors concluded that venodilation results from 
factors associated with muscle contraction and may play a role in outward capillary 
filtration and preventing edema formation following exercise [404]. Other investigators 
reported endothelium involvement in venodilation. Administration of nitric oxide 
inhibitor in rats resulted in a dose-dependent increase and decrease in venous tone and 
capacitance, respectively. The authors concluded that endothelium tissue contributes to 
venodilation observed in animals [405]. Inhibition of nitric oxide was also found to 
elevate venous tone and reduce return and cardiac filling, confirming the involvement of 
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endothelium-derived nitric oxide in the modulation of venous function [406]. Koller and 
collogues examined the effect of shear stress on the walls of isolated venous diameter and 
reported increased nitric oxide and prostaglandin release and venodilation. The authors 
concluded that shear stress, as observed in the arteries, induces endothelium-derived 
nitric oxide and prostaglandin release, which contribute to the regulation of venous 
function. Additionally, since shear stress increases during exercise, the authors expected 
that endothelium is also involved in venous regulation during muscle contraction [407]. 
There is a general certainty that venous emptying increases during exercise to 
suffice the demanded increase in cardiac output however the mechanism by which 
venous emptying increases is still a debate. Contrary to that of the resistance vessels 
some investigators indicate sympathetically-induced increases in venous tone is not 
abolished by local vasodilators. Additionally this increase in venous tone propels blood 
toward the heart [304, 408]. Whereas other studies suggest the involvement of local 
vasodilators, including metabolic and endothelial, result in increased venous relaxation 
and venous diameter [404, 406, 407]. The mechanisms, suggested by both sides of the 
debate panel, seem to contribute to blood return to the heart during exercise.  However 
there is a clear lack of well-designed studies and conflicting results, which limits our 
understanding of the role of venous function during exercise. Additionally the control of 
the venous system under resting conditions is complex and involves several mechanisms, 
let alone during exercise. Therefore there is a tremendous need for more investigations 
that examine each mechanism separately to have an integrative understanding of venous 
function and overall cardiovascular physiology.   
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SECTION 6. CHRONIC CIRCULATORY ADAPTATIONS TO EXERCISE 
TRAINING 
Repeatedly challenging the body systems with exercise will result in adaptations of all 
body systems to assure maximum performance. While increased exercise tolerance is an 
obvious feature of the adaptations to exercise training a wide range of cellular, 
mechanical, chemical, structural, and regulatory changes associated with this increase. 
These changes occur in a verity of systems and body parts including, cardiovascular, 
skeletal muscles, nervous and hormonal systems and depend largely on the type of 
exercise chosen for training. Changes in these systems are eventually integrated to 
achieve increase in exercise tolerance [409, 410].  
Generally, exercise training involves rhythmic contractions of large muscle 
groups for a long period of time improves oxygen consumption. This improvement, first 
and foremost, corresponds to and is to meet the changes in the metabolic characteristics 
of the skeletal muscle involved and, for the most part, achieved by improvements in the 
cardiovascular system capacity to deliver oxygen and nutrients and remove carbon 
dioxide and byproducts. Essentially the delivery and removal aspects of the 
cardiovascular system become more efficient and result in reduced the workload placed 
on all components of the cardiovascular system at any given intensity, including resting. 
This decrease in workload allows the cardiovascular system to function efficiently for 
longer period of time, which results in increased exercise tolerance [322, 411].  
A variety of physiological changes occur in the cardiovascular system following 
long-term exercise training. These changes involve each aspect of the system including 
the heart, vessels and blood and all directly influence each other. For example decreased 
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heart rate following exercise training is attributed to increased stroke volume, which 
attributed to changes in cardiac structure and increased blood volume. Moreover exercise 
training results in increased vessel capabilities to deliver and remove blood to and from 
skeletal muscles. This increase is due to the contribution of all aspects of the 
cardiovascular system, however studies examining the effect of localized small muscle 
group reported increase in blood flow without the involvement of the heart and blood 
[322, 412-414]. Since the cardiovascular system is a continuum and its components 
directly interact with each other changes in the heart and blood will be briefly and 
generally described. However this chapter will mainly focus on the vasoregulatory 
mechanism adaptations associated with exercise training.    
6.1. CENTRAL CIRCULATORY ADAPTATIONS TO EXERCISE TRAINING 
6.1.1. Changes in the Heart and Blood Constituents 
Repeated bouts of exercise place the cardiovascular system under stress and induce 
physiological adaptations. Maximum oxygen consumption has been the most useful to 
quantify the results of exercise training. Values of oxygen consumption range from 30 
ml-1●kg-1●min-1 in young sedentary, to 85 ml-1●kg-1●min-1 in elite athletes, and values of 
45-50 ml-1●kg-1●min-1 have been observed in young active individuals [322]. Meanwhile 
2 to 3 months of exercise training resulted in increases ranging between 15 and 30%, 
depending on the initial level of fitness [413]. Oxygen consumption increases is 
attributed to increase in maximal cardiac output and muscle tissue capabilities to extract 
oxygen (A-Vd). Exercise training for 2-3 months resulted in 16% increase in oxygen 
consumption as a consequence of 8% increase in cardiac output and 8% increase in A-
Vd. The increase in cardiac output has been attributed completely to increases in stroke 
volume whereas maximum heart rate doesn’t change, if anything, it might slightly 
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decrease following exercise [322, 412, 413]. Whereas the increase in A-Vd might be due 
to several reasons including increased muscular vascular density, vasoreactivity and 
muscle oxidative capacity [415].   
Reduced heart rate in athletes and in individuals following exercise training is 
well documented. The decrease in resting and sub-maximal heart rate might results from 
structural, neural and hormonal changes [412, 416] including alterations in 
sympathetic/parasympathetic balance toward greater dominance of the parasympathetic 
component [417, 418]. However the reduction in heart rate has been reported to decrease 
during 7-weeks training program without concomitant reduction in plasma 
catecholamines indicating the involvement of other factors [419]. The reduction in resting 
heart rate might also results from changes in stroke volume, which might result from 
changes in cardiac structure and blood volume. Cross-sectional date indicate that cardiac 
dimensions and end-diastolic volume are larger in endurance athletes than athletes 
involved in activities of a short durations, such as resistance training (figure 6-1) [420]. 
These observations were also reported following training at 85-90% of maximum oxygen 
consumption for 7-weeks in sedentary individuals [421]. In fact increase in heart 
dimensions were observed following only 1 week of exercise training [422]. In addition 
to cardiac structure, Gillen et al. reported 10% increase in blood volume within 24 hours 
following only one bout of ergometry-cycling at 85% of maximum oxygen consumption 
[423]. Additionally one-half of the difference in stroke volume normally observed 
between untrained and highly endurance-trained men during upright exercise is due to a 
suboptimal blood volume in the untrained men [424]. Coyle EF et al., concluded that the 
reduction in cardiovascular function following detraining is due, in large, to the decline in 
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blood volume [425].  Therefore increased cardiac dimensions and blood volume result in 
increased stroke volumes and subsequent reduction in heart rate.  
 
Figure LR6.1. Cardiac mass index in elite athletes.  
Taken from [18]. 
 
Training-induced increase in blood volume and myocardial hypertrophy 
contributes also to reduced heart rate during submaximal exercise. However heart rate 
reductions might not exclusively due to central adaptations. In a study by Saltin et al., 
heart rate responses to one-leg submaximal exercise in the trained leg were lower than in 
the untrained leg [426]. Similarly, heart rate responses to leg exercise were higher than to 
arm exercise following arm exercise training program and vise versa following leg 
exercise [416, 427]. These studies suggest at least part of the fall in heart rate during 
submaximal exercise is induced by peripheral factors and specifically related to the 
trained body part. The relationship between heart rate and the trained muscle group might 
be mainly due to the decrease in sympathetic stimulation [417, 418]. Exercising with 
untrained leg or arm might result in greater feed back reflex induced by greater 
accumulation of metabolic byproducts. Specific nerve fibers within the skeletal muscle of 
most species can be activated by many different metabolic stimuli. Substances including 
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lactate, osmolality, and potassium that trigger these fibers appear in different 
concentrations in the extracellular space of trained and untrained muscle while exercise. 
Actually the magnitude of heart rate increase during exercise in the trained and untrained 
muscles has been related to the concentrations of metabolites produced by the muscle 
[318]. Thus cardiac adaptations to exercise training appear to result from central and 
peripheral changes. These changes include a shift in autonomic nerves system balance, 
structural changes in the cardiac muscle, increased in blood volume and reduced 
metabolic stimuli from the trained muscle.    
6.2. PERIPHERAL VASCULAR ADAPTATIONS TO EXERCISE TRAINING 
Resting muscle blood flow appears not to be affected by exercise training however 
endurance, high-intensity sprint and isometric training have been shown repeatedly to 
increase blood flow under varies conditions, including anticipatory state. These training 
effects might be the results of alterations in vascular smooth muscle and vascular 
endothelium structure and function, however the influence of cardiac and skeletal muscle 
adaptations cannot be totally excluded [428-432].  
One of the early study examined the effect of exercise training on regional 
vascular function reported a decrease in blood flow in humans. In this study male 
subjects jogged 4-5km at 80% of maximum running capacity 5-6X/wk for five weeks. 
Blood flows, measured immediately after maximal and submaximal exercise, were 
lowered following the training program. The authors attributed lowered leg blood flow to 
a more “effective” metabolic process [433]. Bond et al. also reported reduction in 
hyperemic blood flow following a training program consists 6 sets of 15 one-leg maximal 
isokinetic concentric contractions of planter flexion for 4 weeks while the nontrained leg 
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served as control. The authors attributed reductions in trained leg blood flow to an 
increase in muscle cross-sectional area without proportional changes in microvascular 
density [434]. More recently another study reported reduction in leg submaximal blood 
flow following 9-12 wk high intensity lower body endurance training and this decreased 
was coupled with decrease in submaximal oxygen consumption and unchanged cardiac 
output. The authors attributed the decrease to unchanged cardiac output and blunted 
splanchnic vasoconstriction [435].  
Several other investigations however revealed conflicting results. For example 
Klausen and colleagues reported that trained leg blood flow in six young healthy male 
subjects increased during maximal and submaximal exercises following eight week one-
leg exercise training at ~85% of heart rate maximum [436]. The effect of endurance 
training on the regional blood flow response to maximal exercise was also investigated in 
foxhound by Musch et al. Training consisted of 8-12 wk of treadmill running at 80% of 
maximal heart rate 1 h/day for 5 days/wk. Gastrocnemius muscle blood flow increased 
and systemic vascular resistance decreased during maximal exercise following training 
[437]. In another study by Musch et al., regional blood flow adaptations were determined 
for rats after 6 days/wk for 6 wk of high-intensity sprint training or limited cage activity. 
Training consisted of five 1-min bouts of treadmill running at work loads (15% grade, 97 
m/min) in excess of the animals' maximal oxygen uptake interspersed with 90s of rest. 
Blood flow to the different organs of the abdominal region was greatly reduced during 
maximal exercise although. Furthermore blood flow to the entire hindlimb and to several 
individual muscles (soleus, plantaris, gastrocnemius, flexor hallicus longus, vastus 
lateralis, rectus femoris, biceps femoris, and adductor magnus and brevis muscles) was 
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greater in the exercise group during maximal exercise than in the sedentary control rats. 
The authors concluded that increased cardiac output following high-intensity sprint 
training is primarily directed toward the working skeletal muscle and not toward the 
organs found in the abdominal region in rat [438]. Armstrong et al., reported increase 
also in preexercise anticipatory blood flow after running exercise training in rats.  In fact 
this increase was intensity dependent, as the rats were assigned to a low-speed (daily 
treadmill walking up a 12 degree incline at 15 m/min), and high-speed (daily treadmill 
galloping up a 12 degree incline at 50 m/min) training program regimens for 2-4 wk. The 
authors also demonstrated that regional changes in blood flow to long-term endurance 
exercise training that elicits systemic adaptations were more pronounced in red muscles 
whereas short term elicited adaptations in only the white muscles indicating that blood 
flow adaptations are dependent on muscle type and the length the exercise training 
program [431, 439]. Blood flow was also reported to increase at onset of exercise 
following 10 days of cycle ergometer exercise training at 65% of maximal oxygen 
consumption [440]. The results of the above-cited studies are indeed very tempting to 
conclude that exercise training induce vascular adaptations. However the concomitant 
modifications in blood volume, stroke volume, heart rate, cardiac output, blood pressure, 
muscle metabolic capacity, and oxygen consumption demonstrate central cardiovascular 
involvement. Since the exercise training mode selected to examine vascular adaptations 
elicited systemic responses, the observed improvements in regional blood flow might be 
the result of increased blood volume, stroke volume, cardiac output, capillarization, A-Vd 
and oxygen consumption or might be basically due to improved cardiac output shunting 
to the active muscles rather than improved regional vascular function per say. Therefore 
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the question whether exercise training leads to regional vascular changes without central 
influence, remained unanswered. 
TABLE LR6.1. Vascular function adaptations following small muscle group 
conditioning programs 
Study Population Type of training Results 
Yasuda, 83 10 HY HG, 33 & 50% MVC, 6X/wk (6 
wks) 
34 & 26% ⇑ BF, 
respectively.  
Sinoway, 87 6 HY HG, 70% MVC, 4X/wk, 30min (4 
wks) 
⇔ BFrest.  
30% ⇑ RHBF in trained arm 
Green, 94 11 HY HG, 75% MVC, 4X/wk, 30min (4 
wks)  
⇔ BFrest 
23% ⇑ RHBF in trained arm 
Franke, 98 6 HY HG, 70% MVC, (4 wks)  ⇔FVCrest. 
35% ⇑ FVCpeak. 
Bank, 98 
 
11 HY & 7 
CHF  
HG, 70% MVC, 4X/wk, 30min, 
(4-6 wks) 
⇔ in CHF. 
24% ⇑ RHBF in HY. 
Alomari, 01 28 HY HG, 25 & 75% MVC, 5X/wk (4 
wks) 
18, 29% ⇑ RHBF in trained 
arm, respectively. 
BF = Blood flow; RHBF = Reactive hyperemic blood flow; VR = Vascular resistance; FVC = 
Forearm vascular conductance; healthy & young = HY.   
 
In one of the early studies that examined the effect of localized exercise training 
on peripheral vasculature without central influence, Yasuda et al reported improvements 
in hyperemic forearm blood flow. The training program consisted of performing 6X/wk 
isometric handgrip exercise for 6 weeks at 33 and 50% of MVC to fatigue. Both training 
regimens resulted in similar increase in blood flow however adaptations after 6 months 
were greater than 3 months indicating training-period dependency [441]. Sinoway and 
colleagues also showed localized vascular adaptations to small muscle group training 
without systemic influence. In a cross-sectional study forearm blood flow, measured 
following 5-minutes of ischemia and 5-minutes of ischemia coupled with exercise, was 
higher in the dominant arm of tennis players whereas it was similar in both arms of a 
control group of comparable oxygen consumption. Additionally the difference in 
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hyperemic blood flow between 5-minutes ischemia and 5-minutes ischemia coupled with 
exercise in the dominant forearm of the tennis players was greater than the rest of the 
measured arms (nondominate forearm of the tennis players and both forearms of the 
control group) indicating greater vasodilatory reserve in the dominant forearm of the 
tennis players. The experiment populations and protocol allowed viewing the peripheral 
vasculature as an isolated local entity independent of the systemic cardiovascular 
involvements such as cardiac output and mean arterial blood pressure. Although the study 
was not proposed to reveal the mechanisms responsible for these adaptations, the authors 
attributed increase in dominant forearm blood flow of tennis players to peripheral 
vascular phenomena (increased capillarization), but also didn’t totally exclude systemic 
influence such as changes in sympathetic tone [428]. In a longitudinal study, Sinoway et 
al. further demonstrated modifications in regional vascular function following a small 
muscle group exercise-training program without eliciting systemic cardiovascular 
adaptations. The training regimen included four-week isometric handgrip exercise at 70% 
of maximum workload (workload was determined as the maximum amount of work the 
subjects could perform while maintaining 30 contractions/min for 3 minutes). The 
subjects exercised 4 times a week for 30 minutes and intensity was progressively 
increased as needed. The authors reported increase in forearm blood flow and reduction 
in forearm vascular resistance, measured immediately after ischemia and ischemia 
coupled with exercise, in the trained arm while oxygen consumption and vascular 
function in the untrained arm remained unchanged. The authors concluded that regional 
vascular modifications without systemic adaptations are attainable and attributed to 
enhanced intrinsic skeletal muscle vasodilatory capacity [442]. In an attempt to examine 
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the effect of training intensity on vascular function, subjects exercised at 25 and 75% of 
MVC of isometric handgrip in our laboratory. The training program consisted of 
exercising 20 minutes 5X/wk for 4 weeks and both intensities resulted in similar increase 
in forearm blood flow, although the magnitude of increase was greater in the high 
intensity group [443].  
Some investigations however have found that vascular adaptations to localized 
exercise training might be transferable to untrained body parts. Forearm blood flow in the 
ipsi- as well as the contra-lateral arms following 6 weeks were increased in the study of 
Yasuda and colleagues. The authors attributed the improvements to changes in 
neurogenic balance however the metabolic contribution was not totally excluded [441]. 
Silber et al. also reported a 50% increase in forearm blood flow following leg cycle 
ergometer exercise however these adaptations might be the results of systemic 
adaptations rather than localized vascular adaptations as changes in oxygen consumption 
and heart rate were reported [444]. Therefore these studies have certainly demonstrated 
that peripheral muscle blood flow adaptation to exercise training program is a local entity 
independent of systemic cardiovascular modifications. However all the above studies 
were not designed to explain the mechanism(s) involved in peripheral vasculature 
adaptations although speculations attributed the observed blood flow adaptations to 
unclear local phenomena.   
Hashimoto was the first to examine the effect of exercise training on endothelium-
induced dilation [445]. The investigator reported no effect of exercise training on 
endothelium-dependent modulation (vasoconstriction or vasodilation) following 1-
hour/day treadmill exercise training for 12 weeks in young (16wks) and old (98wks) rats. 
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However no documentations were provided to quantify the effect of exercise training 
although it did induce lipoprotein profile changes (↑HDL- and ↓LDL-cholesterol). On the 
other hand several other investigators reported different results. In well-designed 
sequence of studies, Delp and colleagues repeatedly demonstrated training-induced 
improvements in endothelium-dependent vasodilatory capacity. In one particular study 
male rats ran on a treadmill at 30 m/min with 15O incline for 1 h/day 5 days/wk for 10-12 
wk. Maximal vasodilator responses induced by acetylcholine were greater in vessel rings 
from trained rats whereas dilatory responses by sodium nitroprusside were not different 
following training, indicating that the augmented acetylcholine-induced dilatory response 
resulted from endothelium adaptation. Additionally blockade of nitric oxide synthase 
activity, by L-NMMA, diminished acetylcholine-induced vasodilation by 100 and 79% in 
trained and nontrained rats, respectively [446]. Similar exercise training protocol was 
used to examine the effect of exercise training in hyperthyroid rats. Vasodilatory 
responses to acetylcholine and sodium nitroprusside were enhanced and not altered, 
respectively, in rat abdominal aortas following the exercise program [447]. Vascular 
smooth muscle dilation is mediated by increasing cellular cyclic monophosphate, which 
is stimulated by activating guanylate cyclase. Acetylcholine indirectly increases the 
levels of cyclic monophosphate by stimulating endothelium-derived nitric oxide release, 
which activates smooth muscle guanylate cyclase whereas sodium nitroprusside increase 
the levels of cyclic monophosphate by directly activating smooth muscle guanylate 
cyclase. Thus the unaltered vessel response to sodium nitroprusside in the trained animals 
indicates that adaptations might be independent of cyclic monophosphate and related to 
the endothelium tissue. Additionally inhibiting nitric oxide activities, by L-NMMA, 
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completely obliterated the acetylcholine-induced vascular relaxation, which further 
demonstrated the involvement of endothelium tissue and nitric oxide pathway.  
Similar observations were reported by Chen and Li following only eight weeks of 
treadmill exercise training. Acetylcholine- and sodium nitroprusside-induced relaxations 
were enhanced and unaltered, respectively, in thoracic aortae and pulmonary arteries, but 
not in carotid arteries from rabbits [448]. Vascular endothelium adaptations were reported 
following even shorter exercise program. Sun et al. found that vasodilatory responses to 
acetylcholine and L-NMMA were augmented in gracilis muscle of rats following 
treadmill exercise training as short as 2-4wks [449]. Therefore in an attempt to determine 
the time course of improvements in vasodilatory capacity in rats, Delp and et al. 
examined training-induced adaptation of vascular endothelium at different times of a 10-
wk exercise-training program in rats. The exercise group was further subdivided into 
postexercise, 1-day, 1-wk, 2-wk, 4-wk, and 10-wk groups, whereas another group of 
animals didn’t exercise and served as control. The exercise program was similar to the 
previous studies [446, 447] and resulted in enhanced maximal vasodilation to 
acetylcholine and expression of endothelium nitric oxide synthase protein in aortas from 
4-wk and 10-wk rats. These data indicate that the enhanced endothelium-dependent 
vasodilation of the rat aorta is present by 4 wk of endurance exercise training. 
Additionally adaptations appear to be mediated primarily through the nitric oxide 
synthase pathway and are associated with an increased expression of endothelium nitric 
oxide synthase protein [450]. These studies clearly indicate that exercise training 
enhances vascular sensitivity and vasomotor function through adaptations of the 
endothelium as well as smooth muscle in animals. Additionally training-induced increase 
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in blood flow observed following exercise training could be partially allocated to greater 
vasodilatory capacity of nitric oxide. However thus far, the effect of exercise training on 
vascular endothelium function is not as clear in human as in animals therefore these 
findings still need to be confirmed in humans.  
In a series of studies, Green et al. reported that enhanced peak blood flow 
following small muscle group exercise training is not endothelium-dependent. As 
previously reported [442, 443] Green and colleagues found increase in peak forearm 
blood flow following handgrip training program however with no changes in the 
vasodilatory capacity of nitric oxide [430]. Similarly they reported enhanced peak blood 
flow in the dominant forearm of tennis players however no evidence of difference were 
found in vascular endothelium function in the nondominant forearm of the tennis players 
and both forearms of the control group [451]. In fact the same group reported that 
forearm blood flow responses to L-NMMA and norepinephrine remained unchanged 
following 6 weeks of detraining, induced by forearm casting, indicating no detraining 
effect on nitric oxide pathway, despite evidence of physical deconditioning [452]. The 
authors attributed changes in blood flow to changes in vascular structure and vascular 
responsiveness without alterations in capillarization. Additionally they concluded that the 
lack of nitric oxide adaptations to exercise training (or detraining) as shown in animals, 
might be due to training protocol or species differences however didn’t exclude the 
contribution of other vasodilator pathways. 
In contrast Kingwell and his group repeatedly observed improvements in nitric-
oxide-mediated vasodilation following physical conditioning among humans. In a cross-
sectional study they reported that endurance-trained athletes had greater vasodilatory 
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response to acetylcholine, greater vasoconstrictor response to norepinephrine, angiotensin 
II, and L-NMMA, and similar response to sodium nitroprusside as compared to sedentary 
control group. Nevertheless these differences were linked to the level of serum 
cholesterol indicating that training-induced changes in endothelium function might be the 
result of reduction in cholesterol level [453]. The same research group substantiated these 
results in a longitudinal study as the subjects engaged in a 4-week cycle exercise-training 
program. Training increased maximal work-load and maximal oxygen consumption, and 
blood pressure was reduced. Additionally L-NMMA caused a greater vasoconstriction 
after training whereas there was no difference in vascular response to acetylcholine or 
sodium nitroprusside between pre and post training. The authors concluded that the 
improvements in vascular endothelium tissue are due to elevated shear stress resulting 
from increased blood flow and blood viscosity after cycle training [454]. More recently 
the same research group reported endothelium changes following home-based exercise 
training program for 4 weeks in hypercholesterolemic volunteers. The training program 
consisted of cycling 3X/wk for 3 minutes at 65% of maximum oxygen consumption and 
resulted in greater oxygen consumption, blood flow, vasoconstriction response to L-
NMMA along with improvement in lipid/lipoprotein profiles whereas vascular responses 
to acetylcholine and sodium nitroprusside didn’t change before and after training [455]. 
Endurance training was also found to improve nitric-oxide-mediated blood flow by 
several other investigations in young [456], older [457] heart failure [458], and 
hypertension [459, 460] participants. However the involvement of other vasodilatory 
pathways shouldn’t be denied since nitric oxide inhibition was found to have modest 
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effect on peak vasodilation during reactive hyperemia whereas prostaglandins appeared 
to play greater role [461]. 
Despite the overwhelming evidence of nitric-oxide-induced vasodilation 
improvements following exercise training the current discrepancy found between 
different studies need to be resolved.  This discrepancy might be due to differences in 
training stimulus and/or experimental measurements and protocol. For example Bank et 
al. was the only one to report improvement in nitric-oxide-dependent vasodilation and 
peak hyperemic forearm blood flow in normal subjects but not in patients with heart 
failure following handgrip exercise training [462]. Otherwise all the studies reported 
changes in nitric oxide production used large muscle group exercises (e.g. running or 
cycling) whereas Green et al. examined vascular function following small muscle group 
exercise training (e.g. forearm handgrip or tennis playing). Additionally these 
improvements were reported in muscle beds that were not involved directly in exercise 
training (e.g. measuring forearm vascular function following leg exercise training), which 
indicate that improvements might be due to systemic adaptations. Therefore the search 
for other mechanism(s) that might be involved in vascular adaptations observed during 
exercise training is still warranted. 
Increased blood flow observed following exercise training might also be due to 
reduction in vasoconstrictor control. Wiegman et al. reported reduction in 
norepinephrine-mediated vasoconstriction due to the reduction in the sensitivity to 
norepinephrine following 6wk-swim-training program in rats [463]. However the study 
was not design to determine whether the alterations in norepinephrine function are related 
to the endothelium or smooth muscle. Delp and colleagues found that endurance training 
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reduced vascular sensitivity to norepinephrine, in rat aortic rings, only when the 
endothelium tissue was intact suggesting endothelium involvement [446]. Since α2-
adrengeric receptors are found on the endothelium tissue and mediate the release of nitric 
oxide or other endothelium-derived relaxing factors [382], binding of norepinephrine to 
the receptors on vascular endothelial cells from trained animals may induce greater 
released of endothelium-derive factor(s), which could blunt norepinephrine-mediated 
vasoconstriction. Additionally evidence indicates that endothelium tissue might inhibit 
the release of norepinephrine from adrenergic nerves [326] therefore exercise training 
might alter the endothelium-induced inhibition of norepinephrine release. 
Despite the minimum knowledge of endothelin-1 function during exercise 
evidence shows that its production in the working muscles decreases while it increases 
and causes vasoconstriction in the nonworking muscles. Additionally this increase is 
exercise intensity- and time-dependent, contributes to norepinephrine-induced 
vasoconstrictions and plays a role in blood redistribution during exercise [392, 393, 464]. 
However, very few studies have examined the effect of exercise training on the 
endothelin-1 function and these studies are certainly far from conclusive. For example 
Jones et al. found endothelin-1 adaptations to exercise training in miniature swine is 
gender dependent. The exercise program included treadmill running for 12 wks and 
resulted in reduction of coronary artery sensitivity to endothline-1 of male swine but not 
of the female [465]. From the same laboratory, Laughlin and coworkers also reported 
gender-dependent adaptations however exercise training was found to reduce porcine, 
femoral and brachial artery sensitivities to endothelin-1 in female swine but not in the 
male [466]. In an effort to examine the effect of exercise training on endothelin-1 
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function in human, Maeda et al. examined plasma concentration of endothelin-1 
following 8 wks of 1 hour cycling, 3-4 days/wk, at 70% of oxygen consumption. 
Enduthline-1 plasma concentration were reduced and negatively correlated with 
increased plasma concentration of nitric oxide. The observed alterations in endothelin-1 
and nitric oxide concentrations were maintained for 4 weeks and didn’t return to basil 
level until the 8th week after cassation of exercise training [467]. These studies suggest 
that exercise training might has some effect on endothelin-1 function however more 
research is definitely needed to expand our knowledge in the role of endothline-1-
mediated modulation of the vascular function.  
Therefore exercise training seems to modify the peripheral effect of 
vasoconstrictor factors however the mechanism by which this function is modified is not 
known. Additionally more studies are needed to examine the effect of exercise training 
modality, intensity, duration, frequency as well as training period length on the function 
of vasoconstrictor factors in different segments of the vasculature of various species, 
particularly human. 
6.3. VENOUS SYSTEM ADAPTATIONS TO EXERCISE TRAINING  
Improved venous return is probably the most recognized feature of the venous system 
that improves following exercise training. However since the effect of training on the 
heart, arterial system as well as blood contents have been extensively investigated, 
increased venous return has primarily been attributed to alterations in these aspects of the 
cardiovascular system, with minimum considerations given to the venous system. For 
example cardiac contractility and blood volume thereby stroke volume have been 
repeatedly found to increase following exercise training. Additionally vascular resistance, 
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vasoactivity, muscle vascular density, muscle perfusion, muscle blood flow and muscle 
blood volume have also been reported to be favorably altered. Since the cardiovascular 
system is a closed circuit, the combined exercise training-alterations within the system 
would certainly induce venous return changes. However recognized the venous system is 
a reservoir for ~65% of the total body blood and repeatedly challenged during exercise, it 
must be affected by exercise training. However very few studies examined the effect of 
exercise training on venous hemodynamics, therefore conclusions regarding the 
vasculature performance have for the most part ignored the contribution of the venous 
system adaptations to physical conditioning [32, 322, 413]. 
 The available studies investigated sporadic aspects of the venous system. For 
example Suzuki and colleagues examined the effect of exercise training on venous 
density. Soleus muscle arteriolar and venular capillary densities in young (3 wks) and 
middle-age (54 wks) Wistar rats were evaluated before and after 6-wk exercise training 
program. The exercise protocols for the young training group were: 10-22.5 m/ min 60 
min/day for 6 days a week, on 7O incline during the final 2 weeks; for the middle-aged 
training group, the protocols were: 10-20 m/min. 50 min/day for 6 days a week. Although 
it was greater in the younger group, arteriolar capillary density increased similarly in both 
training groups whereas the venular portion didn’t [468]. The same group of researchers 
examined time-course changes in soleus muscle arteriolar and venular capillary densities 
of young female Wisters. Running exercise training started at the age of 5 weeks and 
lasted for 5 weeks at 25 m/min on a 25O incline, 10-60 min/day, 5 days/week. 
Morphological findings were obtained from the soleus and deep portions of the medial 
gastrocnemius muscles. In soleus, training resulted in increased capillary-to-fiber ratio, 
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total capillary density, and density of venular capillaries at Week 1. However values for 
total capillary and arteriolar and venular capillaries were significantly decreased after 4 
weeks of training. In gastrocnemius muscles, training significantly increased the 
capillary-to-fiber ratio at Week 1 and from Week 3 onwards whereas total capillary 
density values showed no difference between control and training groups at all points of 
time. These findings suggest that exercise training in Wister rats results in greater 
arteriolar and venular capillarization, mainly in highly oxidative muscles, as early as 1 
week.  However the conflicting result between the two studies might indicate that 
training-induced adaptations might be time-, age- or gender-dependent. Additionally the 
reduction in capillary growth observed after the 4th week might suggest that other 
mechanisms, including vascular modulator adaptations, might be involved during a 
delayed phase of the exercise program. However since neither study have examined 
arterial or venous hemodynamics or any vascular function indicators a complete 
conclusion cannot be made. Finally the changes in venular capillary densities might 
explain the growth pattern of the capillary network associated with endurance training 
[469]. 
Kenney and Armstrong investigated venous pooling following 40 mints, 3d/wk 
for 8-wk running exercise training program. Venous pooling was measured in the foot as 
volume drainage following “Trendeleburg” maneuver (VT). The “Trendeleburg” 
maneuver consisted of 45o leg elevation for 15 seconds while the subjects is laying down 
followed by setting up to a position of 90o flexion with the legs lower than the body. The 
investigators assisted the subject throughout the maneuver to avoid muscle contraction. 
Moreover, to take the muscle pump contribution into account, volume drainage was 
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evaluated following 15soconds of dorsi-flexion/planter exercise while the foot is lower 
than the body (VE) then subtracted from volume drainage following the Trendeleburg 
maneuver (VT - VE). Exercise training resulted in increased VT, VT - VE, oxygen 
consumption without changes in VE. Therefore the authors concluded that increased 
venous pooling is the result of hypervolemia associated while ignoring structural or 
functional changes in the venous system [470]. 
Hypervolemia, associated with exercise training, was also linked to changes in 
central venous pressures. Exercise program consisted of 10 wk of cycle exercise for 30 
min/day, 4 days/wk at 75-80% of maximal O2 uptake and resulted in 20% increase in 
maximal O2 uptake, decreased resting heart rate, 9% increase in blood volume and 
increased central venous pressure. The increase in central blood pressure was associated 
with the increase in blood volume without changes in total effective venous capacitance, 
thus the authors attributed changes to blood volume but not to alterations in venous 
structure or function [471]. Louisy and coworkers also attributed changes in venous 
hemodynamics to hypervolemia. Leg-filling volumes during 30 head-up tilt (FV), half-
emptying time (T1/2) and venous output at the 6th second of emptying during return to 
horizontal position (VO6) were examined in endurance trained, strength trained and 
sedentary subjects. Results showed higher values for FV and VO6 in endurance trained 
subjects than strength trained and sedentary subjects. Whereas no significant differences 
were observed between groups in T1/2. Therefore the authors concluded that endurance 
training seems to increase lower limb venous distensibility. Additionally since venous 
emptying and venous return from the lower limbs were not affected increased venous 
distensibility is probably a physical response to hypervolemia consecutive to chronic 
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aerobic training rather than alterations of the visco-elastic properties of deep vein walls 
[472]. 
However other investigations reported venular structural and functional changes 
following exercise training. In a cross-sectional study, Wecht et al examined the 
difference in venous hemodynamic indices between individuals with spinal cords injury, 
sedentary and active individuals. Venous tone, venous capacitance, venous compliance, 
total venous outflow but not venous emptying rate were higher in the active group. The 
authors concluded that endurance exercise training enhance vascular function [473]. 
Miyachi et al. examined venous diameter following 6 wk one-legged cycle training at 
80% peak oxygen consumption, 40 min/day for 4 days/wk followed by 6 wk of 
detraining. Arterial and venous cross-sectional areas increased by 16% and 46%, 
respectively and correlated with increase in one-leg peak oxygen consumption. These 
changes returned to baseline during detraining. The authors attributed part of the changes 
in oxygen consumption to arterial adaptations and improved blood delivery [474]. 
Involuntarily detraining also might affect venous function such as in morbidity 
diseases. Ikenouchi and colleagues found that venous distensibility is reduced and related 
to the severity of the disease in patients with heart failure [433, 475].  Our laboratory 
found that reduced venous distensibility and outflow in heart failure were related to 
exercise tolerance indicating inactivity influence confirming the effect of heart failure on 
venous function [476]. While venous changes might be a direct effect of heart failure, 
inactivity associated with the disease might indirectly alter venous function.  
The effect of exercise training on venous function seems to be ignored despite 
evidences of the importance of the venous system in cardiovascular function. Therefore 
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more studies are certainly needed to examine the effect of exercise training modality, 
intensity, duration, frequency as well as training period length on different segments of 









































SECTION 7. VASCULAR PATHOPHYSIOLOGY 
The vessel diameter is modulated by cellular calcium ion level. Calcium ions increase in 
vascular smooth cell as a result of a cascade of chemical reactions initiated by an agonist 
(e.g. norepinephrine or endothelin-1) binding to a receptor located on the cell membrane. 
The binding of agonists to vascular smooth muscle membrane receptors activates 
phospholipase C (PLC) in a reaction coupled with guanine nucletide binding proteins (G 
protein). Membrane Phospholipase C hydrolyzes phosphatidyl inositol bisphophate 
(PIP2) to yield diacylglycerol (DAG) and inositol triphosphate (IP3). Diacylglycerol and 
IP3 increase Ca+2 by activating voltage-gated calcium channels and releasing Ca+2 from 
the sarcoplasmic reticulum, respectively. Thereafter, Ca+2 ions bind to calmodulin, which 
in turn binds to myosin light chain kinase. This activated Ca+2-calmodulin-myosin kinase 
complex phosphorylates the light chains of myosin. The phophorylated myosin ATPase is 
then activated by actin and the resulting cross-bridge cycling initiates contraction. 
Relaxation on the other hand occurs when the myosin light chain phosphatases 
dephosphorylate the light chains of myosin and the cytosolic Ca+2 is lowered by 
sarcoplasmic reticulum uptake and by Ca+2 extrusion by the Ca pump and Na-Ca 
exchanger [51, 52].  
Agents elicit elevation in smooth muscle calcium ions and vasoconstriction include 
catecholamines [39, 40], angiotensin II [41], arginine vasopressin [41, 42], and 
endothelin-1, whereas metabolic byproduct [228, 477], nitric oxide, prostacyclin, and 
endothelium hyperpolarization factor [54] inhibit the effect of these vasoconstrictors. 
Therefore the endothelium-derived vasodilatory factors counteract the vasoconstrictor 
effect induced mainly by the sympathetic nervous system and circulating hormones. In 
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vascular disease state these mechanisms are altered as such Ca+2 levels are constantly 
elevated resulting in elevated vascular tone. Vascular disease is primarily characterized as 
elevated circulating vasoconstricting agents and endothelium failure to inhibit the 
contraction of smooth muscle cell. Additionally the vasculature undergoes structural 
changes that result blood flow kinetics. The purpose of the section is to discuss the effect 
of a variety of disease state on vascular function.  
7.1. SYSTEMIC NEUROHORMONAL DYSFUNCTION IN DISEASES  
Abnormalities in the neuroendocrine systems have been implicated in a verity of 
cardiovascular and metabolic diseases. These abnormalities include mainly impaired 
sympatho-vagal balance, elevated circulating catecholamines, and hyperactivated renin-
angiotensin-aldosterone hormonal system. Overstimulated neurohormonal systems 
usually result in blood pressure rise followed by cardiac and vascular structural changes. 
The increase in blood pressure is due to increased cardiac output, hypervolemia, and 
increased vascular tone. This segment will focus on changes in the neuroendocrine 
systems observed in heart failure and hypertension. 
7.1.1. Heart failure 
The predominant quandary in heart failure is significant reduction in cardiac output 
resulting in underfilling of the arterial system. This underfilling causes activation of 
neurohormonal reflexes that stimulate multiple system responses. These neurohormonal 
reflexes are initiated by mechanoreceptors located at the high-pressure sides of the 
circulation including the left ventricle, carotid sinus, aortic arch, and renal afferent 
arterioles. Decreased activation of these receptors due to a decrease in arterial blood 
pressure, stroke volume, renal perfusion, or peripheral vascular resistance leads to an 
increase in sympathetic nervous system, activation of the renin-angiotensin-aldosterone 
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system and release of arginine vasopressin as well as stimulation of thirst. The activation 
of these systems results in increased sodium and water retention, greater stroke volume, 
elevated cardiac pressure, fluid intake, and vasoconstriction. These responses are 
compensatory and mainly to maintain sufficient circulatory blood pressure and tissue 
perfusion, however unfortunately they may lead to further deterioration in heart function.  
The activation of the sympathetic nervous system in heart failure causes increased 
cardiac contractility, tachycardia, arterial vasoconstriction thereby increased cardiac 
afterload. Sympathetic nervous system activation also indirectly triggers systemic 
vasoconstriction by stimulating the release of catecholamines from the adrenal medulla. 
Furthermore vasoconstriction induced by increased sympathetic drive and circulating 
catecholamines causes reduction in renal blood flow, which stimulates the proximal 
convoluted tubule to activate the renin-angiotensin-aldosterone hormonal system, which 
also contributes to further vasoconstriction.  
Plasma renin activity is increased and provides prognostic index in heart failure, 
additionally its activity is largely related to the severity of the disease [478]. The 
activated renin-angiotensin-aldosterone hormonal systems serve two compensatory 
purposes in the circulation. Aldosterone increases blood volume by increasing sodium 
and water retention while angiotensin II is a potent vasoconstrictor.  This increase in 
body fluids is to increase the amount of blood pumped out of the left ventricle thereby 
increasing systemic blood pressure and tissue perfusion. Whereas angiotensin II further 
provokes the proximal tubular to increase aldosterone secretion in addition to its potent 
vasoconstrictive effect [479]. Angiotensin II also seems be involved in increased thirst 
sensation observed in heart failure as it may to trigger the central thirst center. However 
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angiotensin II seems to have a deleterious effect on the cardiac muscle as it causes 
cardiac mitogenesis resulting in cardiac remodeling that may lead to a decrease in the size 
of the capillary network thus predisposing the patient to ishcemic injury. Angiotensin-
converting enzyme inhibitors seem attenuates the affects of angiotensin II as they may 
reduce the vasoconstrictor effect, reverse the myocytes proliferation, and inhibit thirst 
sensation [480-482].  
Similar to renin-angiotensin-aldosterone hormonal system vasopressin actions 
include vasoconstriction and decrease in water excretion. The activities of vasopressin are 
elevated in heart failure contributing to the increased vasoconstriction and water 
retention. The stimulus for vasopressin release in heart failure is not completely known 
yet, though angiotensin II, osmolality and fluid volume have been implicated [483, 484]. 
Vasopressin appears to be the least influential vasoregulatory agent activated in heart 
failure though it is a very potent vasoconstrictor. It seems to be the last one activated 
among all of the vasoregulatory systems as its concentrations are related to the severity of 
the disease [485]. According to Creager et al., characterization of the contribution of the 
three vasoconstrictors in heart failure the sympathetic nervous system produce most of 
the vasoconstriction followed by renin-angiotensin system and last the arginine 
vasopressin [486]. Theoretically vasopressin antagonists could be useful drugs to inhibit 
its activities. In animal investigations as well as in healthy volunteers receptor blockers 
have shown promising results [487, 488]. However well controlled trials are still needed 
to verify the efficacy of vasopressin antagonists in heart failure.  
The atrial natriuretic peptide is primarily produced by the atrial and triggered by 
stretching of myocardium cells. This peptide is a vasodilatory hormone but it is main 
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function is to increase sodium and water secretion from the kidney. Thus it counteracts 
the effect of the other activated neurohormonal systems (i.e. sympathetic, renin-
angiotensin-aldosterone and arginine vasopressin systems). Atrial natriuretic peptide 
inhibits renin-angiotensin, suppresses aldosterone and vasopressin release and prevents 
norepinephrine release from neurotransmitter sites [489, 490]. This hormone seems to be 
activated at the initial stages of heart failure as higher levels are evident in asymptomatic 
left ventricular dysfunction patients and before renin-angiotensin-aldosterone system is 
activated. Thus it appears to be essential in helping to maintain a compensated state and 
in inhibiting the progression of the disease at early stage  [491]. Elevated atrial natriuretic 
factor is also found in symptomatic heart failure. In fact its level increases as heart failure 
worsen and is the highest in sever patients [485, 489]. However he beneficial effects of 
the hormone appear to be is attenuated in advanced patients as it is overwhelmed by the 
increased activities of the other neurohormonal systems [492].  
In patients with overt heart failure the compensatory mechanisms that initially 
improve cardiac output are endless and become problematic and counterproductive as 
they contribute to the progression of heart failure. The net result of neurohormonal 
activation is intense vasoconstriction and expanded fluid volume as the balance is tipped 
in favor of vasoconstrictor and antidiuretic agents. Additionally neurohormonal activities 
trigger cardiac and vascular remolding that exacerbate loading conditions on the failing 
left ventricle and contribute to further decrease in myocardial contractility and the 
development of overt and symptomatic failure. Antagonist and inhibitory pharmaceutical 
agents seem to reduce the effect of these neurohormonal activities. Especially α- and β-
blockers and ACE-inhibitors have shown a variety of benefits including decrease 
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morbidity and mortality, improve quality of life and reduce the symptoms associated with 
heart failure [493]. 
7.1.2. Hypertension  
Since a variety of systems are involved, the precise mechanism(s) responsible for 
elevated blood pressure is hard to define (fig. 7-1). However the genesis of hypertension 
includes one or all of the following alterations; abnormal volume expansion, increased 
vascular resistance or greater cardiac output. Each one of these alterations is initiated by 
abnormal neurohormonal activities and cardiovascular structural changes.  
Abnormality in the reflex control of the sympathetic nervous system has been 
reported. Mark et al., studied cardiopulmonary baroreceptors control of forearm vascular 
resistance in nine hypertensive patients (> 150/90 mmHg) and in seven normotensive. 
Sympathetic nervous system activities and vascular resistance were measured while 
reflex activation was provoked by applying negative pressure. The authors found 
attenuation in cardiopulmonary baroreceptor reflexes characterized by increased 
activation of the sympathetic nervous system and vascular resistance [494]. These 
findings were confirmed by another study as abnormal arterial baroreceptor activities in 
hypertensive patients were similar to those normal subjects following administrating 
atropine and propranolol [495]. Impaired peripheral reflexes were also found in salt-
sensitive hypertensive patients and attributed to inadequate cardiopulmonary receptor 
plasticity to increased salt intake [496].  These studies indicate abnormal sympatho-vagal 
balance that contributes to vascular resistance and elevated blood pressure, additionally 
these abnormalities are attributed to impaired peripheral reflexes [497]. Increased 
sympathetic nervous system activation also indirectly triggers systemic vasoconstriction 
by stimulating the release of catecholamines from the adrenal medulla. Furthermore 
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vasoconstriction induced by increased sympathetic drive and circulating catecholamines 
causes reduction in renal blood flow, which stimulates the proximal convoluted tubule to 
activate the renin-angiotensin-aldosterone hormonal system, which also contributes to 
further vasoconstriction and hypervolemia, thereby further elevation in blood pressure. 
Abnormal sympatho-vagal balance also contributes to elevated blood pressure by 
increasing cardiac output. In borderline hypertension, the patients experience elevated 
cardiac output attributed to elevations in heart rate and stroke volume. Since blood 
volume is reduced in borderline patients the increase in stroke volume is attributed to 
alterations in autonomic nervous system balance characterized by increased sympathetic 
and attenuated parasympathetic activities. However with either aging, the disease or both, 
elevations in cardiac output tends to diminish reaching normal levels while vascular 
resistance remains elevated. The normalization of cardiac output appears to be the result 
of reductions in stroke volume secondary to cardiac structural changes. Continual 
elevations in blood pressure cause cardiac hypertrophy and decrease in cardiac 
compliance. Likewise prolonged blood pressure elevation leads to hypertrophy of the 
medial part of the vasculature leading to augmented vasoconstrictive response. The 
changes in vessel wall thickness cause the vessel wall to encroach even more on the 
vessel lumen [498].  
Angiotensin II is a multifaceted hormone that contributes to hypertension in 
several ways. Angiotensin II is a very potent vasoconstrictor, can directly increase renal 
retention of salt and water and indirectly increase fluid retention by stimulating 
aldosterone secretion. Renin-angiotensin-aldosterone system is reportedly hyperactivated 
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in hypertensive patients. This system appears to be activated mainly as a result of 
increased renal vascular resistance attributed to impaired sympatho-vagal balance [499].    
7.2. ENDOTHELIUM DYSFUNCTION IN DISEASES  
Vascular endothelium is a key element in maintaining balanced vasomotor regulation and 
vascular homeostasis. In vascular diseases the endothelium function is compromised 
leading to diminished vascular function. The main futures of endothelium dysfunction are 
reduction in the efficacy of endothelium vasodilatory anticoagulant agents and increased 
in the vasoconstriction capacity of the endothelium [500].     
7.2.1. Atherosclerosis 
Endothelium dependent relaxation is impaired in atherosclerotic pigs and primates [501, 
502], as well as in human coronary arteries [503]. In fact this impairment was related to 
the stage of atherosclerotic development [503]. Moreover Ginsburg et al. found that the 
contractile process of coronary arteries were related to the severity of the atherosclerotic 
lesion not to the degree of the myocardial dysfunction [504]. In another study, 
vasodilation response to nitroglycerin and acetylcholine were reduced in proportion to 
local plaque load while this plaque load was associated with basal vascular tone. These 
results indicate that the vascular wall sensitivity to vasoactive agents is reduced in 
arteries with atherosclerotic lesion. However evident of endothelium dysfunction have 
also been observed in atherosclerosis as production of endothelium derived relaxing 
factor(s) are reduced in atherosclerotic coronary arteries obtained from patients with 
coronary artery disease [505].   
Since atherosclerotic lesion is usually associated with other disorders including 
hypertension, hypercholesterolemia and diabetes mellitus it is difficult to separate the 
effect of atherosclerotic lesion on vascular wall function from the effect of other diseases. 
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It appears however the initial stage of vascular dysfunction in atherosclerosis is the result 
of reduction in nitric oxide production, as this dysfunction appears to be essential for the 
development of the atherosclerotic process. However some authors argue that as the 
artery thickness and stiffness increase, it becomes harder for the endothelium-derived 
relaxing factor(s) to reach the vascular smooth muscle cell. The prolong exposure to 
varies cardiovascular disease risk factors and the mechanical effect of sheer stress 
promote endothelium dysfunction. Subsequently larger and larger sections of the vessel 
wall become disinfected leading to less effective endothelium-derived relaxing factor(s) 
as well as increase in endothelium-vasoconstricting factor release. This process together 
with increased release of growth factors lead to further endothelium damage, wall 
proliferation and lesion formation initiating a vicious cycle of vessel wall deterioration 
[112, 500].    
7.2.2. Hypercholesterolemia/Hyperlipidemia 
Increased serum cholesterol levels appear to be associated with blunted vasoactivity. 
After feeding rabbits 2% cholesterol diet for 13-15 wks, the inhibitory effect of 
endothelium to neurogenic contraction was reduced whereas endothelium-dependent 
relaxation to acetylcholine was similar to normally fed rats [506]. This inhibitory effect 
was further worsen in denuded vessels [507] indicating endothelium-relaxing factor(s) is 
still synthesized, released and has an effect on vascular smooth muscle in 
hypercholesterolemia. However the oxidative stress of low-density protein seems to 
deplete the reservoir of relaxing factors. Increased levels of low-density proteins activate 
macrophages and favors formation and deposition of oxidative low-density protein in the 
vascular wall. Nitric oxide seems to be either naturalized by oxidized low-density 
lipoproteins or scavenged by macrophages [508, 509].  
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Endothelium-dependant relaxation has repeatedly been shown to be blunted 
following dietary-induced hypercholesterolemia. However this endothelium impairment 
is reversible by dietary manipulation. Morphological improvement of the atherosclerotic 
lesion, and restorations of endothelium-dependent relaxation were evident while the 
intima remained thickened after regression of atherosclerosis following dietary program 
aimed at improving lipid-lipoprotein profiles [510].  
7.2.3. Diabetes mellitus 
Alterations in vascular wall are well documented in diabetes mellitus, leading to 
predisposition to other cardiovascular risk factors including hypertension and 
atherosclerosis. Compelling evidence strongly suggest endothelial dysfunction is 
manifested in this metabolic disorder. This dysfunction is characterized as blunting of 
endothelium-derived vasodilator effects and increased generation of vasoconstrictors 
such as angiotensin II, endothelin-1, and arachidonic acid products [511, 512]. Following 
6 weeks of alloxan-induced diabetes mellitus in rabbits, acetylcholine relaxation was 
normal whereas endothelium inhibition of neurogenicaly-contracted vessels was nearly 
absent. Additionally neurogenic contraction in normal denuded vessels was similar to 
those diabetic with endothelium present indicating completely diminished vasodilatory 
effect of endothelium in diabetic rabbits [513]. 
Growth factors and cytokines agents appear to be elevated in diabetes resulting in 
acute increases in vascular tone, increased blood pressure and vascular remodeling that 
contributes to the microvascular, macrovascular, and renal complications in diabetes. 
Superoxide products, overly produced in diabetics, seem to serve as signals that mediate 
many of the cellular biochemical reactions that result in these deleterious effects. 
Diminished endothelium-dependent relaxation in diabetic rats observed in diabetic 
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vessels was significantly suppressed by pretreatment with superoxide dismutase [514]. 
These results indicate augmentations of superoxide products in diabetics and possible 
treatments with antioxidant therapy [512]. 
7.2.4. Hypertension 
Endothelium-dependant relaxation was attenuated in genetically induced hypertensive 
rats [515] as this attenuation progressively increased with age [516, 517]. The 
vasodilatory response to acetylcholine was also altered in hypertensive patients [518], 
independent of sodium intake [519]. Whether this attenuation is due to deficiency in 
synthesis and release of endothelium-dependent relaxing factors or attenuated smooth 
muscle cell responsiveness to these mediators is not clear yet. However both of these 
mechanisms have been observed in human and animals with hypertension [520].  
 
Figure LR7.1. Mechanism involved in vascular dysfunction in hypertension.  
Taken from [124]. 
 
Endothelin-1 may also be a factor contributing to vascular resistance in hypertensive, 
though its role is not clear yet. Plasma endothelin levels seem normal in most patients 
with essential hypertension however blood vessel wall from hypertensive animals are 
more sensitive and contract more profoundly in response to endothelin-1 [521].  
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The endothelium plays an obligatory role in controlling vascular function as it 
produces varies vasodilatory agents. It is essential to counterbalancing vasoconstriction 
induced by vasotonic agents released by either the autonomic nervous system or the 
endothelium cell. Vascular wall dysfunction observed in patients with cardiovascular risk 
factors is due to a decline in the inhibitory effect of the endothelium tissue. This decline 
might be due to either reduction in endothelium release of vasodilatory agents or failure 
of the vascular smooth muscle to respond appropriately to these agents, or a combination 
of both [522, 523] (fig 7-1).    
7.3. SUMMARY  
A Wide rage of changes occurs to the vascular system of patients with cardiovascular 
diseases including alterations in systemic and local neurohormonal stimulation, vascular 
responsiveness and vascular structure. The net result of these alterations usually is 
impaired blood flow kinetics in these patients and associated with increased fatigue and 
morbidity and reduced quality of life. Medications seem improve quality of life and 
reduce mortality and morbidity caused by the disease, however patients still experience 









SECTION 8. VASCULAR FUNCTION ASSESSMENTS 
Cardiac output distribution to body parts varies during different conditions and strongly 
influence whole-body hemodynamics and homeostasis. Since skeletal muscle shares a 
large portion of this distribution, especially during exercise, its essential to measure 
skeletal muscle blood flow under various conditions for experimental and clinical 
understanding. Therefore invasive and noninvasive techniques have been developed to 
examine various vascular functions including arterial inflow, vascular resistance, venous 
filling capacity, venous emptying rate, vessel diameter, vessel density, and volume 
changes. While there are advantages and disadvantages for each technique, testing 
environment, financial feasibility, staffing and purpose of testing are all deciding factors 
to which of the techniques would be used. The purpose of this section is to provide an 
overview of the common techniques available for examining vascular function.  
8.1. PLETHYSMOGRAPHY 
8.1.1. Principles 
The physiological base of venous occlusion plethysmography is measuring the changes in 
limb volume following manipulations of the arterial and/or venous systems pressures. 
Arterial inflow, vascular resistance, blood pressure, venous reflux, venous capacitance, 
and venous outflow rate are some the vascular functions that can be measured using this 
technique. For example arterial inflow is measured by calculating the rate of change in 
limb blood volume following venous occlusion. Whereas the change in limb blood 
volume following maintaining venous occlusion for a period of time (2-10 minutes) 
allows for estimating maximum venous filling capacity and venous emptying rate can be 




Various modalities of this technique have been adapted to measure vascular function 
including air-filled, water-filled and strain-gauge plethysmography. However while all 
these modalities have provided equally sufficient estimations of various vascular 
functions, recently due to its precision, simple operative procedures and small size, 
strain-gauge plethysmography has gained a lot of popularity. The strain-gauge is a sensor 
placed around the widest part of the limb which converts the limb volume change to 
change in voltage. Mercury-in-silastic strain-gauge sensor has been most used among all 
sensors [524]. 
Plethysmography can be used to measure vascular function in the forearm, calf, 
finger and penis however forearm and calf are generally the most used model. 
Measurements are usually obtained while the subject in supine position, although 
standing, sitting and exercise are conditions that have been used, with a rest period (20-30 
minutes) prior to evaluation of vascular functions. Vascular function can be measured in 
the dominant and/or nondominant limb depending on the purpose of the study. When the 
forearm vascular functions are measured using mercury-in-silastic sensor, cuffs are 
strategically positioned around the participant’s upper arm and wrist, and the strain gauge 
sensor is placed around the forearm approximately 10 cm distal to the olecranon process.  
The forearm would be extended and slightly supinated and supported by a styrofoam 
block. The wrist cuff is usually used to exclude the hand circulation for the forearm 
measurements whereas the upper arm cuff is used to occlude the venous or/and arterial 
vessels. Currently suprasystole (180-240 mmHg) pressures are used to exclude the hand 
and occlude the arterial system, and infradiastole (30-80 mmHg) pressure is used to 
occlude the venous system [443, 476, 525-528].  
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Manipulations in the pressures of the upper and wrist cuffs allows examination of 
the rate of change of limb volume thought to reflect vascular function measurements, 
including arterial inflow, venous capacitance and venous outflow. These changes in limb 
volume are depicted as volume graphs on the plethysmograph recorder. Forearm blood 
inflow rate is derived from the change in the slope drawn on the forearm-volume graph 
following the first 3-5 seconds of venous occlusion. Forearm venous capacitance is 
calculated as the vertical distance (mm) representing the change in forearm-volume graph 
following the completion of venous filling (2-10 minutes). Whereas forearm venous 
outflow rate is derived from the change in the slope drawn on the forearm-volume graph 
between at 0.5 and 2 second following the release of venous occlusion.  Forearm vascular 
resistance is calculated using the following equation:  
Vascular indices are usually expressed in ml•100ml tissue-1•min-1. Forearm 
vasoreactivity can be examined following 5-10 minutes of forearm arterial occlusion 
achieved by inflating the cuff on the upper arm to 240mmHg [443, 476, 526-528]. 
8.1.3. Advantages and Disadvantages  
Low cost and noninvasive simple operative procedures are the advantages of venous 
occlusion plethysmography. This technique has usually been used to measure vascular 
function at rest, after the cessation of exercise, and during pharmaceutical intervention. 
However heighten sensitivity to subject’s movements has traditionally been problematic 
and required the subject to be immobilized. While this technique has been refined and 
improved since the original model was introduced, vascular function assessment during 
exercise using plethysmography is still practically impossible although some researchers 
Vascular resistance = Mean arterial pressure/Blood inflow. 
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have reported arterial inflow during exercise [395, 396]. Additionally applying sufficient 
pressure to occlude the venous system without altering the arterial kinetics is the original 
fundamental assumption has to be fulfilled. However occlusion pressures (30-80 mmHg) 
used in various studies is arbitrary and lack physiological basis. Additionally venous 
occlusion time required for maximum venous filling, in order to measure the venous 
function, is not clear resulting in inaccurate interpretations of the current studies. 
Therefore studies are needed to address methodological issues of the technique to provide 
more accurate vascular function measurements [524, 525].   
8.2. ULTRASOUND 
8.2.1. Principle  
The images created by ultrasonic flowmetery are based on stipulations made upon high 
frequency sound (ultrasound) waves reflection off blood flowing in blood vessels. These 
waves are usually transmitted in a beam form by a crystal transducer to an artery or vein 
to record blood particle movements. Especially with advancements in Doppler ultrasound 
technology the main estimates made of the reflecting waves are the velocity and direction 
of flow in the vessel. Ultrasound Doppler technology allows for continues beat-to-beat 
estimation of blood flow profile [529-532].    
8.2.2. Technicalities 
Doppler echocardiography is among the most advanced modalities available currently 
however M-mode, two-dimensional and contrast echocardiography are other modalities 
can also provide valuable information. Doppler ultrasound technology was introduced 
during the 1950’s however a lot of improvements have been made in order to provide 
sufficient information, especially regarding exercise. Properly equipped Doppler probe 
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can provide continuous estimations of blood velocity and direction and compile a flow 
profile while the subject is performing physical movements [532]. 
The angle between the direction of blood flow and the ultrasonic beam determines 
the kind of information obtained from Doppler sonagrphy. Insonation angles below 60o 
while using pulsed-wave mode seem to provide accurate parabolic velocity profiles at the 
specific depth required. However perpendicular insonation angle is essential for diameter 
measurements. The direction of flow is estimated such that the sound frequency 
reflection is depicted positively on the computer monitor when blood is moving toward 
the transducer and vise versa when blood is moving away. Whereas blood flow is a 
function of volume and time (L/min.) and derived from estimating blood velocity and 
vessel cross-sectional. The following standard Doppler equations are used to calculate 
blood velocity and direction: [529-532]. The diameter of the vessel increases with each 
pulsation and retreat during diastolic, therefore diameter measurements are related to the 
systolic (1/3) and diastolic (2/3) time periods of the cardiac cycle. 
8.2.3. Advantages and Disadvantages  
While the measurements performed noninvasively with fairly easy procedures, 
continuous blood flow profile estimation with high resolution are useful attributes of 
ultrasound Doppler. Rapid changes in blood flow as a result of exercise, metabolic stress, 
orthostatic modifications and pharmacological infusion, are currently easily detected, 
V=(Fr-Fo)*(c/2Fo)*(cosθ) 
Where V=velocity, θ= the angle of intonation, Fr=frequency of reflected sound
beam, Fo= frequency of transmitted sound beam, c=speed of sound (1540).  
 
BF=6*104*Vmean*A 
Where A=cross-sectional of the vessel, Vmean=weighted mean blood velocity (m/s),
constant 6*104=convert m/s to L/min.   
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especially with the recent technological Doppler advancements [533-535]. These 
measurements are considered highly stable and have sufficient within-day and between-
days reproducibility [536, 537]. However since maintaining appropriate and consistent 
insonation angle is essential for accurate measurements, the measured limb and the vessel 
being measured have to be in fixed position [532]. 
Relatively steady laminar flow is essential for accurate blood flow measurements, 
when ultrasound is used. However blood streams through different sizes and shapes of 
vessels and is in constant friction against the vessel walls, thus flow is described as 
parabolic profile. Flow in large vessel is flatter than in small vessel. Additionally when 
blood enters a vessel the flow profile is fairly flat however as it propels for long distance 
the profile becomes more parabolic. When blood departs a narrow vessel into a larger 
vessel, blood flow tends to changes from laminar to a turbulent, which might result in 
inaccurate blood flow measurements. Due to friction against the walls blood would flow 
faster in the outside of a curvy vessel, resulting in change of profile with the vessel. 
Friction between blood and vessel wall also causes blood velocity in the center, of even a 
straight vessel lumen, to be slower than near the edges of the wall, thereby flow profile 
also differs. These physiological concerns are largely avoided by using anatomical 
landmarks within the vasculature when measurements are obtained. Therefore major 
conduits in the body including brachial, femoral, aortic, carotid and pulmonary arteries 
have been used as models to examine vascular function [529-531].   
Due to higher resolution, accurate estimations and easier assessments, 
measurements are usually obtained in larger conduits. Blood flow regulation and 
responses to various physiological, physical and pharmacological perturbations are 
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different in large, medium and small vessels. Therefore current ultrasonic studies should 
be interpreted cautiously and maybe limited to only large vessels. 
8.3. ISOTOPE CLEARANCE 
8.3.1. Principle  
This method is based on locally tracing the clearance of an infused molecule into the 
circulation while assuming clearance is flow-dependent. Obviously this molecule is 
usually easily diffusible and radio-labeled [529-531].  
8.3.2. Technicalities 
The tracer is injected intramuscularly to the area of interest and its clearance for that area 
is externally observed. The rate of clearance is depicted as curves and assumed to 
correspond to blood flow in vessels. Thus tracer is cleared faster during exercise than 
during rest since blood flow is also faster. Usually catheter(s) is inserted into the muscle 
to inject and measure drainage rate of the tracer mixture. Since they are not toxic and 
easily diffuse, Thermodilution and 133xenon are the two most common tracers used in 
humans [529-531]. 
8.3.3. Advantages and Disadvantages 
The potential of measuring blood flow during exercise is an extremely important and 
intriguing attribute of isotope clearance rate method. However its invasive nature and the 
trauma associated with the measurement requires medical training and might actually 
hinder exercise performance. Additionally in some cases isotope does not mix properly 
with the blood, thus results might be erroneously interpreted. Adequately mixed isotope 
and positioned catheter helps ensuring proper isotope/blood mixing and minimize errors 
[529-531].    
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8.4. MAGNETIC RESONANCE IMAGING ANGIOGRAPHY 
8.4.1. Principle 
It is a relatively recently adapted technique to measure blood flow and based on phase-
contrast magnetic resonance velocity imaging of hydrogen nuclei in blood moving 
through a magnetic-filed accumulate a phase shift proportional to their velocity. Moving 
protons are phase-shifted in proportion to their velocity the circulation whereas stationary 
protons do not change their phase [529, 530]. 
8.4.2. Technicalities 
Similar to Doppler ultrasound, blood velocity and vessel cross-sectional area are 
measured to calculate blood flow. The following equation is used to calculate blood flow; 
 
Deep vessels blood flow as well as local number of vessels can be evaluated using this 
technique with extremely high quality images. The images can be obtained during the 
entire cardiac cycle which provide information on the nature of the pulsatile flow. The 
technique is usually used during rest and hyperemic conditions since its very sensitive to 
movement. Magnetic resonance imaging has been validated and used to measure vascular 
function in disease population and to detect vascular pathology [529, 530, 538].  
8.4.3. Advantages and disadvantages 
High quality images and the noninvasive procedures are the most recognized advantages 
of this technique. Blood flow can be measured in deep small individual vessels in human 
as well as animals. Additionally this technique does not require infusing tracing elements 
or determining the insonation angle, unlike isotope tracing or ultrasound respectively. 
However a high price is tagged to each vascular evaluation additionally since it is a 
Blood flow (ml/min)Vmean * A * 60 
Where Vmean (cm/s) is the mean velocity and A (cm2) is the cross-sectional area.  
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magnetic procedure patients with any metal medical aids, such as pacemaker or 
orthopedic metal rods are excluded [529, 530].  
Many direct as well as indirect techniques are available to measure blood flow 
including electromagnetic flowmetery, microdialysis ethanol outflow, near spectroscopy, 
positron emission tomography and laser Doppler. However since it is not expensive, 
simple to operate and measure blood flow during a variety of conditions, venous 
occlusion plethysmography is probably still considered the “gold standard” for blood 
flow measurements [530], however Doppler ultrasound has recently gained tremendous 
popularity. With recent advancements, relatively simple measurement procedures, and 
ability to measure blood flow even while the body is moving, Doppler ultrasound has 
become a favorite measurement tool of vascular function [529-531]. 
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CHAPTER 1.  INTRODUCTION 
1.1. SPECIFIC AIMS 
Selye’s theory of stress-response-adaptation (3) suggests an exercise stress, when applied 
to the vascular system, results in an increased delivery of blood flow to active skeletal 
muscle, and if the stress is repeated over time contributes to a series of vascular 
adaptations. These vascular changes are aimed at increasing vascular conductance and 
oxygen and nutrient delivery to working skeletal muscle during subsequent exercise 
bouts (7, 10, 13, 16, 31, 33). In contrast to the extensive literature describing the 
structural and functional changes in the arterial system following training, training-
induced alterations in the venous system are less clear. Given the importance of the 
venous circulation in regards to metabolic waste removal, its enormous potential to act as 
a volume reservoir and its contribution to the end-diastolic volume, changes in this 
segment of the vasculature could have a profound impact on the exercise response. To 
this extent, Louisy et al. (23) reported greater venous distensibility in endurance-trained 
subjects compared to healthy controls and Miyachi et al., (26) reported an increase in 
peripheral (femoral) venous size following one-legged training. Both investigators 
suggested the veno-adaptations could be associated with increases in blood volume 
following endurance training, and that the increased blood volume may be distributed on 
the venous side of the vascular space, since the veins represent a more compliant 
reservoir. Recognizing the potential influence of systemic factors such as blood volume 
in several previous studies, the purpose of this proposal is to examine the effects of 4-
weeks of handgrip exercise training on arterial reactivity and venous function, 
particularly venous capacitance and venous outflow. 
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1.2. HYPOTHESES 
This study will test two specific hypotheses regarding the influence of physical training 
on arterial (Hypothesis I) and veno-dynamics (Hypothesis II). Finally, depending on the 
outcome of the first two hypotheses, the third hypothesis will test the timecourse of the 
expected changes in vascular dynamics. 
Hypothesis I 
Four-weeks of handgrip exercise training will result in an increase in arterial reactivity 
following 5-minutes of arm occlusion; 
Hypothesis II 
Four-weeks of handgrip exercise training will result in an increase in venous capacitance 
and venous outflow at rest and following 5-minutes of arm occlusion; 
1.3. BACKGROUND AND SIGNIFICANCE  
1.3.1. Previous work 
The effects of exercise training on hemodynamic and hematologic factors have been 
extensively investigated. One of the early studies examined the effect of exercise training 
on regional vascular function reported a decrease in blood flow. The authors attributed 
lowered leg blood flow to a more “effective” metabolic process (30). However Sinoway 
and coworkers reported increased vascular reactivity in the dominant arm of tennis 
players (34) and following handgrip exercise training (35). These findings were further 
confirmed in a number of studies and attributed to alterations in vascular smooth muscle 
and/or vascular endothelium structure and function, however the influence of cardiac and 
skeletal muscle adaptations were not totally excluded (3, 17).  
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One of the most predictable hemodynamic changes following “aerobic” training is 
an increase in blood volume. Consequently, venous return is higher and stroke volume is 
elevated at each absolute level of work. Recognizing that the venous system is a reservoir 
for ~65% of total blood volume and is repeatedly challenged during exercise, it is 
reasonable to assume that this system would be affected by exercise training. However 
few studies examined the effect of exercise training on venous function, therefore 
conclusions regarding circulatory adaptations have for the most ignored the possible 
contribution of the venous system (11, 18, 29). The following paragraphs will provide a 
brief review of the available literature regarding venous adaptations following exercise 
training.  
Wecht et al. examined the difference in venous hemodynamics between 
individuals with spinal cords injury, sedentary and active individuals. Venous tone, 
venous capacitance, venous compliance, and total venous outflow were higher in the 
active group, leading the authors to conclude that endurance exercise training enhanced 
venous function (41). Louisy and coworkers examined venous hemodynamics in 
endurance trained, strength trained and sedentary subjects and reported higher values for 
leg-filling volumes and venous emptying in the endurance trained subjects. The authors 
concluded that endurance training increased lower limb venous hemodynamics 
subsequent to hypervolemia rather than alterations of the visco-elastic properties of the 
vein walls (23).  
Miyachi et al. examined venous diameter following 6 weeks of one-legged cycle 
training at 80% peak oxygen consumption, 40 min/day for 4 days/week followed by 6 
weeks of detraining. Arterial and venous cross-sectional areas increased by 16% and 
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46%, respectively and correlated with an increase in one-leg peak oxygen consumption. 
These changes returned to baseline during detraining. The authors attributed part of the 
changes in oxygen consumption to arterial adaptations and improved blood delivery. 
Furthermore, they suggested the veno-adaptations could be associated with increases in 
blood volume following endurance-training, and that the increased blood volume may be 
distributed on the venous side of the vascular space, since the veins represent a more 
compliant reservoir (26). 
Suzuki and colleagues examined the effects of exercise training on venous 
capillary density of young (3 weeks) and middle-age (54 weeks) (37). The 6-week 
exercise-training program resulted in increased arteriolar capillary density in both groups 
without changes in venular density. In a subsequent time-course study by the same group, 
the effect of exercise training on venular density was examined in young female rats (5 
weeks). Vascular density indices (capillary-to-fiber ratio, total capillary density, and 
density of venular capillaries) of soleus and medial gastrocnemius muscles increased 
following only 1 week of training. However values for total capillary, arteriolar, and 
venular capillaries were significantly decreased after 4 weeks of training in the soleus 
muscle and after 3 weeks in the medial gastrocnemius. These results suggest that 1-week 
of exercise training in Wistar rats results in greater arteriolar and venular capillarization, 
mainly in highly oxidative muscles and indicate that training-induced adaptations might 
be time-, age- or gender-dependent. However since neither arterial or venous 
hemodynamics nor any vascular function indicators have not examined, a complete 
conclusion were not made (37, 38). 
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Kenney and Armstrong investigated venous pooling following an 8-week 
exercise-training program (40 min/day, 3day/week). Venous pooling was measured in the 
foot as volume drainage following the “Trendelenburg” maneuver (VT). The 
“Trendelenburg” maneuver consists of 45º leg elevation for 15 seconds with the subjects 
in a supine position, followed by sitting up to a position of 90º flexion with the legs lower 
than the body. The investigators assisted the subject throughout the maneuver to avoid 
muscle contraction. Moreover, to account for the muscle pump contribution, volume 
drainage was evaluated following 15 seconds of dorsi-flexion/plantar exercise while the 
foot is lower than the body (VE) then subtracted from volume drainage following the 
Trendelenburg maneuver (VT-VE). Exercise training resulted in increased VT, VT-VE, 
oxygen consumption without changes in VE. The authors concluded that the increased 
venous pooling was the result of hypervolemia. However, the possible structural and/or 
functional changes in the venous system following exercise training were not addressed 
(21). Hypervolemia associated with exercise training, has also been linked to changes in 
central venous pressures as reported by Convertino et al. Convertino used an exercise 
program consisting of 10 week of cycle exercise for 30 min/day, 4 days/week at 75-80% 
to examine changes in central venous pressure. Training resulted in a 20% increase in 
maximal O2 uptake, decreased resting heart rate, 9% increase in blood volume and 
increased central venous pressure. The increase in central blood pressure was associated 
with the increase in blood volume without changes in total effective venous capacitance, 
thus the authors attributed the observed changes in central venous pressure to an increase 
in blood volume but not to alterations in venous structure or function (12).  
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Detraining has also been shown to induce changes in the venous system (20, 22, 
32, 42). Louisy and Guezennec examined the effect of 30-days head-down bedrest on 
lower-body venous hemodynamics and reported a progressive increase in venous 
compliance. The study was not designed to reveal the mechanisms involved, however 
reduction in the blood volume and subsequent dilation in the venous system and 
decreased pressure in the proximity of the lower veins were stipulated. Involuntarily 
detraining induced by morbidity diseases might also affect venous function (22). 
Ikenouchi and colleagues found that venous distensibility is reduced and related to the 
severity of the disease in patients with heart failure (20, 32). In our laboratory venous 
capacitance and outflow were lowered and related to exercise intolerance in heart failure, 
confirming the relationship between inactivity and venous dysfunction (42). While 
venous changes might be a direct effect of heart failure, inactivity associated with the 
disease might indirectly alter venous function. 
In summary, the aforementioned studies suggest higher levels of fitness and/or 
exercise training may alter venous hemodynamic. The changes in venous hemodynamics 
appears to be directly related to changes in blood volume and associated with changes in 
exercise capacity. In contrast detraining reveres these adaptations, which may be further 
affected by systemic diseases such as heart failure. However, none of the above-
mentioned studies have clearly addressed the issue whether exercise improves measures 
of venous function and the manner in which this relates to muscle performance.  
Barclay et al. demonstrated the importance of metabolite removal to muscle 
fatigue, indicating the essential role of venous hemodynamics to performance. In this 
study, muscle fatigue rate in dogs was measured in 5 experimental groups subjected to 
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different perfusion conditions by manipulating O2 contents and/or muscle blood flow 
with a perfusion pump. The first group served as a control group and breathed room air 
while the muscles were self-perfused (self-perfused). Group 2, breathed 14% O2 while 
increasing blood flow across the muscle bed with the perfusion pump (low O2/ high flow) 
and examined the effect of hyperfusion on muscle fatigue. In group 3, the dogs breathed 
air saturated with 100% O2 while blood flow was at reduced perfusion rate (high O2/low 
flow) and examined the effect of hypofusion on muscle fatigue. In group 4, blood flow 
pump-perfused while perfusion pressure was kept constant at the animal’s blood pressure 
until a steady pressure was attained. This procedure kept the plasma flow constant and 
identified the effect of blood and plasma flows at constant level established by the 
animal’s blood pressure (constant flow). Finally, the 5th group breathed 100% O2 and the 
blood was diluted with a volume-for-volume exchange of dextran solution while 
maintaining constant plasma flow by increasing blood flow with the perfusion pump to 
identify the effect of hyperfusion with a constant plasma flow (diluted/high flow). The 
self-perfused group fatigued the fastest while the pump-perfused groups had slower 
fatigue rate regardless of O2 delivery or plasma flow rates. The authors argued that 
increased blood flow across the muscle bed resulted in changed cellular environment 
and/or metabolic pattern. Additionally they concluded that the attenuated fatigue 
associated with hyperfusion was independent of O2 and/or substrate delivery and is 
attributed to improved metabolite removal out of the muscle bed (8). This suggests that 
venous health is particular important in exercise performance subsequent to ensuring 
adequate metabolite removal.    
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More recently, Tschakovsky and Hughson also examined the importance of 
venous emptying in the vasodilatory capacity and muscle function. Continuous forearm 
venous volume and blood flows were obtained following arm elevation while either 
venous drainage is prevented or allowed (Fig 1.1).  
 
Figure PR1.1. Schematic illustration of the timing of arm position relative to 
heart level during the prolonged and the acute arm elevation protocols.  
This timing was the same for both venous emptying and venous congestion trials. 
Solid bars indicate transition period between arm positions. Taken from (40).  
 
As demonstrated in Fig 1.2, venous emptying protocol resulted in marked 
decreased blood volume associated with transit increase in blood flow during acute arm 
elevation while the opposite was observed during venous occlusion protocol. The 
hyperemic respond was attributed to transit vasodilatory effect consequent to reduced 
forearm venous volume. Additionally, this increase in forearm blood flow was linked to 
venoarteriolar reflex vasoconstriction with reduction in venous volume and was 
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suggested to simulate hyperemic response subsequent to venous emptying during muscle 
contractions (40).  
 
Figure PR1.2. Hemodynamic response to acute forearm elevation.  
Data are means ± with values at 1-s intervals. A: forearm blood flow; B: changes 
in forearm volume from below heart baseline; C: forearm venous pressure 
(antecubital vein). Forearm began below heart (time = 10 s to 0 s). Arm above 
heart from 2 s to 6 s. Venous emptying allowed during arm elevation ( ). Venous 
emptying prevented during arm elevation ( ). Solid bars indicate the 2-s 
transition periods between arm positions; n = 9 except for venous pressure, 
venous emptying allowed n = 4, venous emptying prevented n = 3. Taken from 
(40). 
  
Thus, these above-mentioned studies suggest a critical role of venous outflow in 
exercise performance. Consequently, studies are needed to examine the effects of acute 
and chronic exercise training, as well as the modality, intensity, duration, and frequency 
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of training, on different segments of the venous system. Additionally investigations 
examining the effects of a localized exercise program on venous alterations are certainly 
warranted.  
1.3.2. Progress report / Preliminary studies 
In preparation of this proposal a series of studies have been conducted to develop the 
appropriate methodologies and understand the rationale for this proposal. These studies 
focused on determining the reproducibility of several outcome measures pertinent to this 
study, examined the ability of vascular measures to differentiate between various 
populations, and evaluated the influence of interventions on changing measures of 
vascular function. These projects will be summarized in chronological order in the 
following section.  
The first study examined the effect of 4 weeks of low (25% of MVC) and high 
(75% of MVC) intensity handgrip (HG) exercise training on arterial function. Forearm 
blood flow (Binf) and vascular resistance (VR) were evaluated in twenty-eight young 
men at rest, following forearm occlusion (OCC) and following forearm occlusion 
combined with HG exercise (HGOCC) using mercury strain gauge plethysmography 
(MSGP) (3). The 4-week program consisted of non-dominant HG exercise performed 5 
d/week for 20-min at either low or high intensity. Both training intensities resulted in 
improved vasodilatory responsiveness in the trained arm only with no change in muscular 
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Figure PR1.3. Forearm Binf changes in the low group following HG exercise 
training.  
Values are means ± SD. *p<0.05 vs. rest; §p<0.05 vs. OCC  ‡p<0.05 vs. Pre Non-



















































Figure PR1.4. Forearm Binf changes in the high group following HG exercise 
training.  









Table PR1.1. Dominant and non-dominant forearm VR changes in the low and high 
groups at rest, following OCC and following HGOCC (3). 
  Dominant Non-dominant 
  Pre Post Pre Post 
Low group (15)      
 VRrest 47.85 ± 13 42.2 ± 13.4 42.5 ± 15.4 44.6 ±17.0 
 VROCC 3.3 ± 1* 3.5 ± 0.5* 3.5 ± 0.6* 3.5 ± 0.8* 
 VRHGOCC 2.5 ± 0.5* 2.8 ± 0.4* 3 ± 0.4* 2.9 ± 0.7* 
High group (13)      
 VRrest 44.5 ± 19 45.7 ± 22.7 39.4 ± 15 34.4 ± 8.8 
 VROCC 3.1 ± 0.5∗ 3.1 ± 0.5∗ 3.7 ± 0.6∗ 3.3 ±0.7∗ 
 VRHGOCC 2.7 ± 0.3∗ 2.77 ± 0.4∗ 3.3 ± 0.7∗ 2.5 ± 0.7∗ 
Values are means ± SD. LO, training intensity = 25% of maximum voluntary contraction (MVC); HI, 
training intensity = 75% of MVC; VRrest, forearm vascular resistance at rest; VROCC, vascular resistance 
following five minute of occlusion; VRHGOCC, vascular resistance following OCC coupled with 3-min. of 
HG of exercise. ∗p < 0.05 vs. rest. 
 
Table PR1.2. Independent t-test comparisons between CHF and Control 
groups (42).  
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In a subsequent study forearm Binf, VR, venous capacitance (Vcap) and outflow (Vout) 
and maximum walking distance (MWD) were evaluated in heart failure patients and age-
matched older adults (42). Arterial and venous function indices and MWD were different 
between the groups (table 1.2). Additionally, correlation analyses revealed significant 
associations between vascular indices and exercise tolerance measurements (figures 1.2 
& 1.3), confirming impaired forearm vasoreactivity and indicating that venous function 
















r =0.57; p =001
 
Figure PR1.5. Relationship between forearm venous capacitance and maximum 
walking distance (42). 
 
Interestingly many of the available protocols to examine venous function using 
MSGP have failed to address many physiological and methodological concerns that 
might directly or indirectly affect the precision of the measurements (4, 5). A particular 
important factor to consider is the selection of the pressure and time of venous occlusion. 
For example Hokanson et al. and Cramer et al. have recommended 50mmHg for venous 
occlusion pressure, regardless of the pressure of the arterial system (14, 15, 19). While 
this pressure is arguably sufficient to prevent venous emptying, in some cases it may also 
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change the kinetics of the arterial system. In a more recent study, Wecht et al. used a 
pressure “just below” diastolic blood pressure as a criterion for venous occlusion 
pressure. However the authors did not quantify the precise pressure used to occlude the 

















r =0.67; p =0001
 
Figure PR1.6. Relationship between forearm venous outflow and maximum 
walking distance (42). 
 
Furthermore, the aforementioned studies (14, 15, 19) have also adapted two 
minutes of venous occlusion to evaluate the venous system, however it is not clear 
whether this time is sufficient to achieve maximum venous filling. Thus the next phase 
involved examining the effect of different venous occlusion times and pressures on Vcap 
and Vout. Venous indices were examined this in ten young individuals using two distinct 
protocols. In protocol one venous occlusion pressures of 7, 14, 21, 28 and 35 mmHg 
below resting diastolic blood pressure were used with a fixed occlusion time of four 
minutes.  
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In protocol two venous occlusion times of 5 and 10 minutes were used with a 
fixed venous pressure of 50mmHg. Figures 1.5 and 1.6 depict a stepwise decrease in 
Vcap (p ≤ 0.0001) and Vout (p ≤ 0.0001) with greatest values following venous occlusion 
pressure 7mmHg below diastolic blood pressure. Forearm Vcap ranged between 3.7±0.7 































1 = 07mmHg < DBP 
2 = 14mmHg < DBP
3 = 21mmHg < DBP
4 = 28mmHg < DBP 
5 = 35mmHg < DBP
 
Figure PR1.7. Venous capacitance using different pressures. 
Values are in means ± SD.  ‡p<0.007 vs. 1; *p<0.01 vs. 2; §p<0.03 vs. 3 (36). 
Furthermore, 10 minutes of venous occlusion resulted in greater Vcap (p < 0.001) 
and Vout (p < 0.026) values as compared to 5 minutes (Figure 1.7).  Finally, the effects 
of altering occlusion times and pressures on resting arterial inflow and vascular resistance 
were minimal and not statistically significant. These findings indicate the importance of 
recognizing the possible influence of venous occlusion times and pressures on venous 
capacitance and outflow. Additionally these technical aspects are particularly relevant 



































1 = 07mmHg < DBP 
2 = 14mmHg < DBP
3 = 21mmHg < DBP
4 = 28mmHg < DBP 
5 = 35mmHg < DBP
 
Figure PR1.8. Venous outflow using different pressures.  
Values are in means ± SD.  ‡p<0.02 vs. 1; *p<0.02 vs. 2; §p<0.05 vs. 3;  †p<0.06 





Figure PR1.9. Venous capacitance and outflow following 5 & 10 minute venous 
occlusion 


















































With attempts made to investigate the role of the venous system for understanding 
cardiovascular physiology, it is imperative to have a reliable investigative model for 
venous function. Our laboratory (24) as well as others (28) has reported adequate 
reproducibility and reliability of the plethysmographic technique to measure arterial 
inflow. In contrast, few studies have examined the reproducibility and reliability of 
plethysmography to measure venous function. Thus another aspect of the research 
process involved examination of the reproducibility of venous and arterial indices. 
Forearm Binf, VR, Vcap and Vout were evaluated at rest and following OCC and 
HGOCC on three different occasions within 10 days and expressed in ml•100ml tissue-
1•min-1. As revealed in table 1.3, between-days interclass correlation coefficients for 
arterial and venous indices at rest and following OCC and HGOCC ranged between 0.7 
and 0.97 (2). The values for the resting Binf and VR are well within expected range, 
additionally no significant difference were found between the means values of the three 
visits. However a slight day-to-day difference might result in low statistical 
reproducibility (34, 35).  These results indicate adequate reliability of MSGP technique 
for measuring arterial as well as venous function on different days under controlled 
conditions. 
Table PR1.3. Between-days interclass correlation coefficients for forearm 
arterial and venous indices (2). 
Condition Binf VR Vcap Vout 
Rest 0.29 0.3 0.78 0.94 
OCC 0.81 0.7 0.7 0.91 
HGOCC 0.95 0.95 0.8 0.97 
Binf=Blood inflow, VR=Vascular resistance, Vcap=Venous capacitance, Vout=Venous outflow 
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Finally the effects of functional ability on arterial and venous measures have been 
examined. This is extremely relevant as this research is ultimately trying to help 
clinicians understand why individuals may be intolerant to exercise. Linking a pathologic 
condition to a functional limitation will eventually result in the development of more 
appropriate strategies to preserve function and avoid disability. Consequently, several 
studies have attempted to link performance measures with arterial and venous function. 
Most recently, HG strength on venous function, forearm Vcap and Vout were evaluated 
in 13 apparently healthy males at rest and following OCC using MSGP. Maximum HG 
strength was determined as the average of 3 maximum consecutive contraction trials 
using a hand-dynamometer and expressed in kilogram. Subsequently, the group was 
divided into above (HI) and below (LO) average HG strength according to the Canadian 
Society of Exercise Physiology classification. As depected in figure 1.8 Pearson 
correlation coefficient showed an association between HG strength and forearm venous 
indices at rest {Vcap: r=0.72; p=0.006; Vout: r=0.72; p=0.006} and following OCC 
{Vcap: r=0.56; p=0.058; Vout: r=0.73; p=0.007} (2).  
 










































r =0.72; p =0.006
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Finally, Student t-test comparison between the HI and LO HG strength groups 
revealed difference in Vcap and Vout at rest and post OCC (table 1.4). These results 
suggest that MSGP is useful technique to differentiate between populations. Furthermore, 
HG strength appears to contribute to venous system hemodynamics implying that 
muscular conditioning might be important for venous health. 
 
In conclusion, the completed research has determined that assessment of arterial 
and venous function using plethysmography is reproducible and reliable, allows 
differentiation between populations, and arterial function is modifiable with training. The 
final aspect of this research is to examine the influence of localized exercise training on 
venous measures. 
1.5. DISCUSSION OF EXPECTED RESULTS 
Due to the relatively small muscle size involved in the exercise-training program, 
physiological adaptations are expected to be limited. Arm ergometer test, measures of 
autonomic nervous system-HRV, body composition are expected to remain unchanged 
throughout the exercise-training program (33, 34). Additionally as previously reported 
arm circumference as well as MVC are expected to increase by 2 (1) and 6-8% (1, 3), 
respectively.   
Table PR1.4. Differences in venous indices between low and high strength groups 
(2) 
Group HG Strength (kg) Vcap at rest Vcap post OCC Vout at rest Vout post OCC 
LO 80.55±16.2 4.5±0.8 3.4±0.7 38.7±9.2 38.0±7.5 
HI 136.8±20.7 5.7±0.5 4.2±0.7 54.3±7.6 54.0±8.2 
Alpha 0.0001 0.002 0.065 0.01 0.007 
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Vascular indexes 
As previously reported, HG exercise training is expected to result in an increase in 
arterial reactivity following 5-minutes of arm occlusion (3, 17, 34, 35). The effect of 
localized exercise training program on venous function have not been evaluated. 
However few studies have examined the effect of exercise-training programs that involve 
large muscle groups and trigger systemic adaptations, including hypervolemia. Therefore 
increase in venous capacitance and venous outflow were attributed to systemic changes 
while ignoring possible changes in the venous function (21, 23, 41). Given the 
importance of the venous system in overall cardiovascular physiology (8, 40) and since 
the venous system will be challenged with exercise training, improvement are expected in 















CHAPTER 2.  METHODS 
2.1. PARTICIPANTS AND DESIGN 
Fifteen apparently healthy sedentary young (ages 18-30) adult males will be recruited to 
participate in the study. Individuals with manifestations of cardiovascular, metabolic, 
orthopedic or neurological disease or are on any medication (e.g., digitalis), which could 
affect the results of this study will be excluded.  
The proposed study is randomized, prospective, controlled and will be executed in 
4 weeks. The study involves once a week evaluation session and 5-time-a-week exercise 
training sessions.  Prior to and at the end of each week, participants will undergo HG 
strength and vascular function evaluations in the dominant and non-dominant arms. The 
primary outcomes of this study include: (1) Vasoreactivity, defined as the change in 
forearm blood flow from rest to the peak blood flow response following 5 minutes of 
forearm occlusion (34, 35); (2) Venous capacitance; defined as the changes in limb blood 
volume following 6 minutes of venous occlusion; and (3) Venous outflow; defined as the 
changes in limb blood volume following the release of venous occlusion (15, 19). 
Additionally, handgrip strength, arm exercise tolerance, and hemodynamic measures (i.e. 
blood pressure, heart rate and heart rate variability) will also be assessed. Following the 
completion of the initial assessment, each subject will be asked to report to the exercise 
physiology laboratory 5 days/week to perform 20 minutes of forearm flexion exercise at a 
cadence of 1 contraction every 4 seconds starting at intensity of 60%. The non-dominant 
arm will be trained while the dominant arm will serve as control.  
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2.2. STUDY MEASUREMENTS:  
2.2.1. Vascular function assessments  
Vascular function indices will be obtained in the dominant and non-dominant forearms 
using MSGP at rest and following OCC (34) at the beginning of the study, and at the end 
of each week throughout the study period. This technique is noninvasive based on the 
assumption that alterations of pressures in strategically placed cuffs allows examination 
of the rate of change of limb volume thought to reflect venous function indices including 
Binf, VR, Vcap and Vout (15, 19). Prior to the experiment, blood pressure cuffs will be 
positioned around the participant’s upper arm and wrist, and a mercury-in-silastic strain 
gauge placed around the forearm approximately 10 cm distal to the olecranon process (3). 
Resting forearm vascular function measures will be obtained following 15 minutes of 
supine rest. Immediately before the measurements, hand circulation will be occluded for 1 
minute by inflating the cuff at the wrist to 240mmHg. Forearm Binf will be obtained 
using an upper arm venous occluding pressure of 7mmHg below diastolic blood pressure. 
Forearm Vcap will be measured after an additional 6 minutes of venous occlusion and 
Vout following the release of pressure (2, 36). Subsequently, forearm vasoreactivity is 
examined following 5 minutes of forearm arterial occlusion achieved by inflating the cuff 
on the upper arm to 240mmHg. Forearm vascular indices will then be determined as 
described above. The exact same procedures will then be performed on the other arm. 
Prior to, during and following each procedure blood pressure and heart rate will be 
obtained.  
2.2.2. Autonomic nervous function assessments:  
Indices of autonomic function will be assessed using measures of heart rate variability. 
These measures will be obtained at the same time as the vascular assessments described 
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above. The ECG electrodes will be placed on the chest and interfaced with a Biopac 
MP100 and its companion software Acqknowledge (model MP100A, Biopac Inc., Santa 
Barbara, CA) to allow for continuous data acquisition. A period of five minutes (at rest 
and during forearm occlusion) of ECG data will be analyzed for mean heart period (mean 
R-R interval), standard deviation (SDNN), low frequency power (LF) and high frequency 
power (HF) using the guidelines set forth by the Task Force of the European Society of 
Cardiology and the North American Society of Pacing and Electrophysiology (9, 39). 
These variables will be obtained at the beginning of the study, and at the end of each 
week of the study period. 
2.2.3. Arm ergometer test 
Arm exercise tolerance will be evaluated using a graded arm ergometer exercise test at 
the beginning and at the end of the study period (6, 25). The test will be performed by 
initially turning the arm ergometer at a speed of 50 rpm and a resistance of 0.5kp for two 
minutes while the participant in a seated position. The resistance will then be increased 
by 0.25kp every two minutes until the subject reaches exhaustion, requests to stop, or 
exhibits signs or symptoms, which require test termination. Prior to, during, and 
following the exercise test heart rate, blood pressure measurements and ratings of 
perceived exertion will also be obtained at the end of each minute throughout the test 
using a standard sphygmomanometer and the Borg's perceived exertion scale, 
respectively.  
2.2.4. Forearm circumference and HG strength assessments  
Participants forearm circumferences and HG maximal voluntary contraction will be 
evaluated at baseline and at the end of each week throughout the study period. Forearm 
circumference will be examined using a weighted measuring tape 10 cm distal to the 
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midpoint between the lateral epicondyle and olecranon process. Handgrip strength will be 
evaluated using a handgrip dynamometer (Lafayette instruments) with the participant 
upright, but slightly bent forward. The test involves an all-out gripping effort for 3 
seconds, without movement of the arm. The average of three consecutive trials will be 
used as the measure of strength.  
2.2.5. Physical activity questionnaire 
The participants will be asked to complete the Aerobic Center Longitudinal Study 
Physical Activity Questionnaire. This Questionnaire is designed to conduct physical 
activity pattern, including leisure and household, during the past 3 months. Information 
regarding walking, stair climbing, jogging, swimming, weightlifting, aerobic dance, and 
household activities are acquired (27).  
2.2.6. Body composition 
Three-site skinfold method will be used to calculate body percents of fat and fat-free 
masses. The recommended body sites for this method are chest, abdominal and thigh. 
Additionally dominant and non-dominant forearm skinfolds will be obtained at the upper 
1/3 of the forearm length (43). 
2.2.7. Computer assessment 
The Biopac system and Acknowledge computer software will be utilized to capture and 
digitize vascular function indices received from the plethysmograph. The data will be 
collected at 500 Hz. then resampled at 4 Hz. 
2.3. DATA REDUCTION AND ANALYSIS 
Resting Binf will be recorded at a paper speed of 5 mm/sec. and values will be derived 
from the slope drawn at a best-fit tangent using the first 2-3 pulses. Calculations will be 
made as a function of 60 seconds divided by the horizontal distance (mm) needed for the 
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slope to rise vertically from baseline to the top of the recording paper and multiplied by 
the full chart range (15, 19). Forearm Binf following OCC will be recorded at a paper 
speed of 25 mm/sec. Analyses will be performed using a slope drawn at a best-fit tangent 
to the curves of the first 3-pulse flows post cuff release. Blood flows will then be 
calculated from 60 seconds multiplied by the paper speed divided by the horizontal 
distance (mm) needed for the volume slope to increase by 20 mm vertically (2, 3). 
Forearm VR will then be calculated by dividing mean arterial pressure by the Binf. 
Forearm Vcap will calculated as the vertical distance (mm) representing the change in 
forearm-volume graph following 6 minutes of venous filling (15). Forearm Vout will be 
derived from a tangent line representing the vertical drop in the volume-graph from the 
excursion line and drawn at 0.5 second and 2 second following the release of the venous 
occlusion pressure (15). All vascular indices will be expressed in ml•100ml tissue-1•min-
1. 
2.4 STATISTICAL ANALYSIS  
All statistical analysis will be completed using the SPSS statistical program (version 
11.00). To examine the influence of 4-weeks of handgrip exercise training on arterial 
reactivity (Hypothesis I) a 2 (Arms) * 2  (Pre and Post training) ANOVA will be used. To 
examine the influence of 4-weeks of handgrip exercise training on venous capacitance 
and venous outflow at rest and following 5-minutes of arm occlusion (Hypothesis II) a 
second 2 (Arms) * 2  (Pre and Post training) ANOVA will be used. Depending on the 
outcome of the 2 * 2 ANOVA Hypothesis III will be examined with a 1 (trained arm) * 5 
(visits) repeated measure ANOVA to examine the time-course of the arterial and venous 
changes. Finally a paired t-test will be used to compare between pre and post training 
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measures of HRV indices, body composition, and physical activity questioner. Alpha will 
be set a-priori al p<0.05  
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